<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset>
	<article
		xmlns:mml="http://www.w3.org/1998/Math/MathML"
		xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article">
		<?properties open_access?>
		<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
			<restricted-by>pmc</restricted-by>
		</processing-meta>
		<front>
			<journal-meta>
				<journal-id journal-id-type="nlm-ta">Bioengineered</journal-id>
				<journal-id journal-id-type="iso-abbrev">Bioengineered</journal-id>
				<journal-title-group>
					<journal-title>Bioengineered</journal-title>
				</journal-title-group>
				<issn pub-type="ppub">2165-5979</issn>
				<issn pub-type="epub">2165-5987</issn>
				<publisher>
					<publisher-name>Taylor &amp; Francis</publisher-name>
				</publisher>
			</journal-meta>
			<article-meta>
				<article-id pub-id-type="pmid">34723746</article-id>
				<article-id pub-id-type="pmc">8809986</article-id>
				<article-id pub-id-type="doi">10.1080/21655979.2021.1997078</article-id>
				<article-id pub-id-type="publisher-id">1997078</article-id>
				<article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" vocab-term="Version of Record" article-version-type="VoR">Version of Record</article-version>
				<article-categories>
					<subj-group subj-group-type="article-type">
						<subject>Review</subject>
					</subj-group>
					<subj-group subj-group-type="heading">
						<subject>Review</subject>
					</subj-group>
				</article-categories>
				<title-group>
					<article-title>PIWI interacting RNAs perspectives: a new avenues in future cancer investigations</article-title>
					<alt-title alt-title-type="left-running-head">P. MOKARRAM ET AL.</alt-title>
					<alt-title alt-title-type="right-running-head">BIOENGINEERED</alt-title>
				</title-group>
				<contrib-group>
					<contrib contrib-type="author">
						<contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9717-0473</contrib-id>
						<name>
							<surname>Mokarram</surname>
							<given-names>Pooneh</given-names>
						</name>
						<xref rid="aff0001" ref-type="aff">
							<sup>a</sup>
						</xref>
						<xref rid="aff0002" ref-type="aff">
							<sup>b</sup>
						</xref>
						<xref rid="an0001" ref-type="corresp"/>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Niknam</surname>
							<given-names>Maryam</given-names>
						</name>
						<xref rid="aff0002" ref-type="aff">
							<sup>b</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Sadeghdoust</surname>
							<given-names>Mohammadamin</given-names>
						</name>
						<xref rid="aff0003" ref-type="aff">
							<sup>c</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Aligolighasemabadi</surname>
							<given-names>Farnaz</given-names>
						</name>
						<xref rid="aff0003" ref-type="aff">
							<sup>c</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Siri</surname>
							<given-names>Morvarid</given-names>
						</name>
						<xref rid="aff0001" ref-type="aff">
							<sup>a</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Dastghaib</surname>
							<given-names>Sanaz</given-names>
						</name>
						<xref rid="aff0004" ref-type="aff">
							<sup>d</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Brim</surname>
							<given-names>Hassan</given-names>
						</name>
						<xref rid="aff0005" ref-type="aff">
							<sup>e</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Ashktorab</surname>
							<given-names>Hassan</given-names>
						</name>
						<xref rid="aff0006" ref-type="aff">
							<sup>f</sup>
						</xref>
					</contrib>
					<aff id="aff0001">
						<label>a</label>Autophagy Research Center,
						<institution-wrap>
							<institution>Shiraz University of Medical Sciences</institution>
						</institution-wrap>,
						<city>Shiraz</city>,
						<country>Iran</country>
					</aff>
					<aff id="aff0002">
						<label>b</label>Department of Biochemistry,
						<institution-wrap>
							<institution>Shiraz University of Medical Sciences</institution>
						</institution-wrap>,
						<city>Shiraz</city>,
						<country>Iran</country>
					</aff>
					<aff id="aff0003">
						<label>c</label>Department of Internal Medicine,
						<institution-wrap>
							<institution>Mashhad Medical Sciences Branch, Islamic Azad University</institution>
						</institution-wrap>,
						<city>Mashhad</city>,
						<country>Iran</country>
					</aff>
					<aff id="aff0004">
						<label>d</label>Endocrinology and Metabolism Research Center,
						<institution-wrap>
							<institution>Shiraz University of Medical Sciences</institution>
						</institution-wrap>,
						<city>Shiraz</city>,
						<country>Iran</country>
					</aff>
					<aff id="aff0005">
						<label>e</label>Pathology and Cancer Center,
						<institution-wrap>
							<institution>Howard University College of Medicine</institution>
						</institution-wrap>,
						<city>Washington</city>,
						<state>DC</state>,
						<country>USA</country>
					</aff>
					<aff id="aff0006">
						<label>f</label>Department of Medicine, Gastroenterology Division and Cancer Center,
						<institution-wrap>
							<institution>Howard University College of Medicine</institution>
						</institution-wrap>,
						<city>Washington</city>,
						<state>Dc</state>,
						<country>USA</country>
					</aff>
				</contrib-group>
				<author-notes>
					<corresp id="an0001">CONTACT Pooneh Mokarram
						<email xlink:href="mailto:mokaram2@gmail.com">mokaram2@gmail.com</email> Department of Biochemistry,
						<institution-wrap>
							<institution>Shiraz University of Medical Sciences</institution>
						</institution-wrap>,
						<city>Shiraz</city>,
						<country>Iran</country>
					</corresp>
				</author-notes>
				<pub-date date-type="pub" publication-format="electronic">
					<day>9</day>
					<month>12</month>
					<year>2021</year>
				</pub-date>
				<pub-date date-type="collection" publication-format="electronic">
					<year>2021</year>
				</pub-date>
				<pub-date pub-type="pmc-release">
					<day>9</day>
					<month>12</month>
					<year>2021</year>
				</pub-date>
				<volume>12</volume>
				<issue>2</issue>
				<fpage seq="99">10401</fpage>
				<lpage>10419</lpage>
				<pub-history>
					<event event-type="tagger">
						<event-desc>Integra</event-desc>
						<date>
							<day>31</day>
							<month>12</month>
							<year>2021</year>
						</date>
					</event>
					<event event-type="final">
						<event-desc>Integra</event-desc>
						<date>
							<day>31</day>
							<month>12</month>
							<year>2021</year>
						</date>
					</event>
					<event event-type="received">
						<date>
							<day>28</day>
							<month>8</month>
							<year>2021</year>
						</date>
					</event>
					<event event-type="revised">
						<date>
							<day>19</day>
							<month>10</month>
							<year>2021</year>
						</date>
					</event>
					<event event-type="accepted">
						<date>
							<day>19</day>
							<month>10</month>
							<year>2021</year>
						</date>
					</event>
				</pub-history>
				<permissions>
					<copyright-statement>&#xA9; 2021 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group.</copyright-statement>
					<copyright-year>2021</copyright-year>
					<copyright-holder>The Author(s)</copyright-holder>
					<license>
						<ali:license_ref
							xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/
						</ali:license_ref>
						<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (
							<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
						</license-p>
					</license>
				</permissions>
				<self-uri content-type="pdf" xlink:href="KBIE_12_1997078.pdf"/>
				<abstract>
					<title>ABSTRACT</title>
					<p>As a currently identified small non-coding RNAs (ncRNAs) category, the PIWI-interacting RNAs (piRNAs) are crucial mediators of cell biology. The human genome comprises over 30.000 piRNA genes. Although considered a new field in cancer research, the piRNA pathway is shown by the existing evidence as an active pathway in a variety of different types of cancers with critical impacts on main aspects of cancer progression. Among the regulatory molecules that contribute to maintaining the dynamics of cancer cells, the P-element Induced WImpy testis (PIWI) proteins and piRNAs, as new players, have not been broadly studied so far. Therefore, the identification of cancer-related piRNAs and the assessment of target genes of piRNAs may lead to better cancer prevention and therapy strategies. This review articleaimed to highlight the role and function of piRNAs based on existing data. Understanding the role of piRNA in cancer may provide perspectives on their applications as particular biomarker signature in diagnosis in early stage, prognosis and therapeutic strategies.</p>
				</abstract>
				<kwd-group kwd-group-type="author">
					<title>KEYWORDS</title>
					<kwd>Non-coding RNAs</kwd>
					<kwd>piRNA</kwd>
					<kwd>PIWI</kwd>
					<kwd>cancer</kwd>
				</kwd-group>
				<support-group>
					<funding-group>
						<award-group>
							<funding-source>
								<institution-wrap>
									<institution>no fund</institution>
								</institution-wrap>
							</funding-source>
						</award-group>
						<funding-statement>This work was supported by the no fund.</funding-statement>
					</funding-group>
				</support-group>
				<counts>
					<fig-count count="2"/>
					<table-count count="3"/>
					<ref-count count="210"/>
					<page-count count="19"/>
				</counts>
			</article-meta>
		</front>
		<body>
			<sec sec-type="intro" disp-level="1" id="s0001">
				<label>1.</label>
				<title>Introduction</title>
				<p>Despite the transcription of over 90% of the human genomes, only 1&#x2013;2% of the genome is composed of genes that code proteins, while the remaining portion of the transcriptome consists of non-coding RNAs (ncRNAs) [
					<xref rid="cit0001" ref-type="bibr">1</xref>, D.-Y.
					<xref rid="cit0002" ref-type="bibr">2</xref>]. ncRNAs play a pivotal role in the development and homeostasis [
					<xref rid="cit0003" ref-type="bibr">3</xref>]. In particular, frequent deregulation of ncRNAs in cancer can contribute to the initiation, progression, and metastasis of tumors [
					<xref rid="cit0004" ref-type="bibr">4</xref>,
					<xref rid="cit0005" ref-type="bibr">5</xref>, Z.
					<xref rid="cit0006" ref-type="bibr">6</xref>]. There are two major ncRNA categories, including regulatory and housekeeping/structural ncRNAs (tRNAs, rRNAs, and snoRNAs). Regulatory ncRNAs are grouped into large (exceeding 200 nucleotides) and small (below 200 nucleotides) ncRNAs [
					<xref rid="cit0007" ref-type="bibr">7</xref>]. Large ncRNAs are primarily comprised of long non-coding RNAs (lncRNAs) as well as circular RNAs (circRNAs) [
					<xref rid="cit0008" ref-type="bibr">8</xref>,
					<xref rid="cit0009" ref-type="bibr">9</xref>.
					<xref rid="cit0010" ref-type="bibr">10</xref>]. Moreover, small ncRNAs are heterogeneous, including P-element-Induced WImpy testis (PIWI)-interacting RNAs (piRNAs), microRNAs (miRNAs), transfer RNAs (tRNAs), small interfering RNAs (siRNAs), ribosomal RNAs (rRNAs), small cytoplasmic RNAs (scRNAs), small nuclear RNAs (snRNAs), and small nucleolar RNAs (snoRNAs) [
					<xref rid="cit0011" ref-type="bibr">11&#x2013;13</xref>]. In
					<xref rid="t0001" ref-type="table">Table 1</xref>, we have described some of the main features of three major types of small ncRNAs, siRNAs, miRNAs, and piRNAs [
					<xref rid="cit0014" ref-type="bibr">14&#x2013;18</xref> J. C.
					<xref rid="cit0019" ref-type="bibr">19</xref>,
					<xref rid="cit0020" ref-type="bibr">20</xref>, L.
					<xref rid="cit0021" ref-type="bibr">21</xref>]. Concerning small non-coding RNAs, it is noteworthy that they have a critical role in the cell growth, proliferation, apoptosis, and differentiation [
					<xref rid="cit0022" ref-type="bibr">22</xref>]. Moreover, their regulatory functions are performed through the Argonaute (AGO) protein family as a major component of RNA silencing complexes, which is highly maintained in all organisms [
					<xref rid="cit0023" ref-type="bibr">23</xref>].
					<table-wrap position="float" id="t0001">
						<label>Table 1.</label>
						<caption>
							<p>Characteristics of major noncoding RNAs (ncRNAs)</p>
						</caption>
						<!--OASIS TABLE HERE-->
						<table frame="hsides" rules="groups">
							<colgroup>
								<col width="15%" align="left"/>
								<col width="27%" align="left"/>
								<col width="27%" align="left"/>
								<col width="31%" align="left"/>
							</colgroup>
							<thead>
								<tr>
									<th align="left">&#xA0;</th>
									<th align="center">piRNA</th>
									<th align="center">miRNA</th>
									<th align="center">siRNA</th>
								</tr>
							</thead>
							<tbody>
								<tr>
									<td align="left">Structure</td>
									<td align="left">5&#x2032; terminal uridine or tenth adenosine and 2&#x2032; O-methyl group on the 3&#x2032; ribose</td>
									<td align="left">phosphorylated 5&#x2B9; ends and hydroxylated 3&#x2B9; ends</td>
									<td align="left">phosphorylated 5&#x2B9; ends and hydroxylated 3&#x2B9; ends with two overhanging nucleotides</td>
								</tr>
								<tr>
									<td align="left">Size</td>
									<td align="left">24&#x2013;32 nt</td>
									<td align="left">20&#x2013;24 nt</td>
									<td align="left">21&#x2013;23 nt</td>
								</tr>
								<tr>
									<td align="left">Processing</td>
									<td align="left">Dicer-independent</td>
									<td align="left">Dicer-dependent</td>
									<td align="left">Dicer-dependent</td>
								</tr>
								<tr>
									<td align="left">Precursor</td>
									<td align="left">single-stranded RNA</td>
									<td align="left">double-stranded RNA</td>
									<td align="left">double-stranded RNA</td>
								</tr>
								<tr>
									<td align="left">Associated protein</td>
									<td align="left">PIWI subfamily proteins (mainly enriched in germline)</td>
									<td align="left">AGO subfamily proteins (ubiquitously expressed)</td>
									<td align="left">AGO subfamily proteins (ubiquitously expressed)</td>
								</tr>
								<tr>
									<td align="left">Organism</td>
									<td align="left">Eukaryotes</td>
									<td align="left">Eukaryotes</td>
									<td align="left">Eukaryotes</td>
								</tr>
								<tr>
									<td align="left">Source</td>
									<td align="left">Genomic loci (transposons, repeats, piRNA loci)</td>
									<td align="left">Genomic loci (miRNA loci, introns)</td>
									<td align="left">Exogenous siRNA: Viral or other exogenous RNAs
										<break/>Endogenous siRNA: Genomic loci (mRNAs, Transposons, repeats), miRNA-cleaved RNAs, bidirectional transcripts
									</td>
								</tr>
								<tr>
									<td align="left">number of loci in the human genome</td>
									<td align="left">&gt;30,000</td>
									<td align="left">2,000</td>
									<td align="left">Endogenous siRNA: More than 200</td>
								</tr>
								<tr>
									<td align="left">Expression</td>
									<td align="left">Highly enriched in the germline</td>
									<td align="left">Broad expression in most cell and tissue types</td>
									<td align="left">Broad expression in most cell and tissue types</td>
								</tr>
								<tr>
									<td align="left">Major target genes</td>
									<td align="left">Transposons and other genes</td>
									<td align="left">Coding genes</td>
									<td align="left">Transposons and exogenous genes</td>
								</tr>
								<tr>
									<td align="left">Primary functional mechanism</td>
									<td align="left">Transcriptional repression, heterochromatin formation (DNA methylation), RNA cleavage</td>
									<td align="left">Translational repression of mRNA, mRNA cleavage</td>
									<td align="left">Exogenous siRNA: Cleavage of exogenous RNA
										<break/>endogenous siRNA:RNA cleavage
									</td>
								</tr>
							</tbody>
						</table>
					</table-wrap>
				</p>
				<p>The third objective of Sustainable Development Goals (SDGs) (
					<ext-link xlink:href="https://www.un.org/sustainabledevelopment/sustainable-development-goals/" ext-link-type="uri">https://www.un.org/sustainabledevelopment/sustainable-development-goals/</ext-link>), that were adopted by United Nations member states in 2015 to be achieved by 2030, is to ensure healthy lives and promote well-being for all at all ages. Cancers are among the main noncommunicable diseases that are regarded as important targets for SDGs. Cancers have a significant health burden, and their incidence rates have increased worldwide since last decades [
					<xref rid="cit0024" ref-type="bibr">24</xref>]. Efforts for finding new effective cancer biomarkers have become an integral part of cancer research because they have multiple clinical implications in different stages of disease [
					<xref rid="cit0025" ref-type="bibr">25&#x2013;27</xref>, S.
					<xref rid="cit0028" ref-type="bibr">28&#x2013;31</xref>].
				</p>
				<p>Cancer detection at early stage and treatment of metastatic and chemoresistant tumors need specific and effective biomarkers [
					<xref rid="cit0025" ref-type="bibr">25</xref>,
					<xref rid="cit0027" ref-type="bibr">27</xref>,
					<xref rid="cit0032" ref-type="bibr">32</xref>,
					<xref rid="cit0033" ref-type="bibr">33</xref>]. Recently, the role of piRNAs as potential biomarkers and therapeutic tools in cancers had been attracting much attention. In this review, biological and clinical aspects of piRNAs in cancer have been reviewed.
				</p>
				<sec disp-level="2" id="s0001-s2001">
					<label>1.1.</label>
					<title>An overview of piRNAs</title>
					<p>In 2001, Aravin et al. identified the presence of piRNAs as repeat-associated small interfering RNAs (rasiRNAs), derived from repeated genomic components in testis and initial embryos of
						<italic toggle="yes">D. melanogaster</italic> [A. A.
						<xref rid="cit0034" ref-type="bibr">34</xref>, A. A.
						<xref rid="cit0035" ref-type="bibr">35</xref>,
						<xref rid="cit0036" ref-type="bibr">36</xref>]. However, at that time, it was unknown that those small ncRNAs were actually piRNAs. They were ultimately named piRNAs in 2006 [A.
						<xref rid="cit0037" ref-type="bibr">37</xref>]. Upon this discovery in Drosophila, it was later identified that there are plenty of piRNAs in gonads of different vertebrate and nonvertebrate species such as humans and mice [
						<xref rid="cit0038" ref-type="bibr">38</xref>]. Immunoprecipitation and northern blot analyses demonstrated the existence of piRNAs in ovaries and testes of fetal and adult human [Z.
						<xref rid="cit0039" ref-type="bibr">39</xref>].
					</p>
					<p>As essential mediators in the biology of cells, piRNAs are considered as the latest, largest, and most various series of ncRNAs in somatic and germ cells [
						<xref rid="cit0040" ref-type="bibr">40</xref>,
						<xref rid="cit0041" ref-type="bibr">41</xref>]. A piRNA is a small noncoding single-stranded RNA, made up of 23&#x2013;35 nucleotides, with a monophosphate group at 5&#x2032; end, a strong uracil base, and 2&#x2032;-O-methylation at 3&#x2032; end, which is indicative of highly conserved functions in different species [A.
						<xref rid="cit0036" ref-type="bibr">36</xref>,
						<xref rid="cit0037" ref-type="bibr">37</xref>,
						<xref rid="cit0042" ref-type="bibr">42</xref>,
						<xref rid="cit0043" ref-type="bibr">43</xref>]. The human genome contains over 30,000 piRNA genes [
						<xref rid="cit0014" ref-type="bibr">14</xref>] that are mainly derived from the intergenic regions [
						<xref rid="cit0015" ref-type="bibr">15</xref>]. In particular, contrary to other ncRNAs, piRNAs are composed of few numbers of RNA precursors, which are long and single-stranded. Moreover, their transcription from transposons, known as &#x2018;piRNA clusters&#x2019;, is performed through a Dicer-independent pathway. These clusters are mainly situated in the peri-centromeric and sub-telomeric parts of the chromosomes [
						<xref rid="cit0044" ref-type="bibr">44&#x2013;46</xref>].
					</p>
					<p>In accordance with multiple origins, piRNAs are divided into three main types: mRNA-derived, lncRNA-derived, and transposon-derived piRNA [
						<xref rid="cit0047" ref-type="bibr">47</xref>,
						<xref rid="cit0048" ref-type="bibr">48</xref>]. Given the presence of some piRNA genes in snoRNAs and tRNAs, these can be regarded as sources of piRNAs as well [
						<xref rid="cit0049" ref-type="bibr">49&#x2013;51</xref>]. It is noteworthy that piRNAs have a silencing impact on genes and protein regulation, PIWI-dependent transposon silencing, as well as on epigenetic regulation, germ stem cell maintenance, genome rearrangement, and reproduction and fertility regulation through attaching to PIWI proteins and forming a silencing ribonucleoprotein complex [A. A.
						<xref rid="cit0052" ref-type="bibr">52&#x2013;55</xref>, W.
						<xref rid="cit0056" ref-type="bibr">56</xref>,
						<xref rid="cit0057" ref-type="bibr">57</xref>, S.
						<xref rid="cit0058" ref-type="bibr">58</xref>].
					</p>
				</sec>
				<sec disp-level="2" id="s0001-s2002">
					<label>1.2.</label>
					<title>PIWI proteins</title>
					<p>PIWI proteins belong to the Argonaute protein family. These proteins attach to small RNAs and are expressed in a wide range of organisms [
						<xref rid="cit0059" ref-type="bibr">59</xref>,
						<xref rid="cit0060" ref-type="bibr">60</xref>]. There are four major types of them in humans: PIWI-like protein 1 (PIWIL1 or human PIWI homolog (HIWI)), PIWIL2 (HILI (Hiwi-like)), PIWIL4 (HIWI2), and PIWIL3 (HIWI3)) [
						<xref rid="cit0061" ref-type="bibr">61</xref>]. These proteins are expressed in different cell types, like follicle cells and germ cells in drosophila ovaries [C.
						<xref rid="cit0059" ref-type="bibr">59</xref>,
						<xref rid="cit0062" ref-type="bibr">62</xref>], along with stem cells [
						<xref rid="cit0063" ref-type="bibr">63&#x2013;66</xref>], cancer cells [J. H.
						<xref rid="cit0067" ref-type="bibr">67</xref>, X.
						<xref rid="cit0068" ref-type="bibr">68</xref>,
						<xref rid="cit0069" ref-type="bibr">69</xref>], or even adult somatic cells [
						<xref rid="cit0070" ref-type="bibr">70</xref>, C.
						<xref rid="cit0071" ref-type="bibr">71</xref>,
						<xref rid="cit0072" ref-type="bibr">72</xref>]. Nevertheless, it is worth mentioning that PIWI expression in out-of-germline tissues is specific to certain species [
						<xref rid="cit0073" ref-type="bibr">73</xref>]. Additionally, PIWI proteins&#x2019; expression can be observed in a broad spectrum of body organs, such as heart, pancreas, lung, liver, kidney and brain [
						<xref rid="cit0074" ref-type="bibr">74</xref>,
						<xref rid="cit0075" ref-type="bibr">75</xref>]. The PIWI proteins comprise three major functional domains that are as follows: PIWI-Argonaute-Zwille (PAZ) domain that acts as binding site of the 3&#x2032;-end of guide small RNA; the middle domain (MID) that identifies 5&#x2032;-uridine (1&#xA0;U-bias) of piRNAs and prescribes transposon orientation in terms of strand bound to piRNA; the PIWI-domain comprises an endonuclease region (RNase-H) which contributes to mRNA cleavage [
						<xref rid="cit0076" ref-type="bibr">76</xref>,
						<xref rid="cit0077" ref-type="bibr">77</xref>]. Traditionally, coimmunoprecipitation and subsequent sequencing or RT-PCR of RNAs revealed piRNAs binding to PIWI proteins [
						<xref rid="cit0078" ref-type="bibr">78</xref>]. Even though these kinds of proteins were initially found to show a crucial role in self-renewal and preservation of germ-line stem-cells (GSC) [
						<xref rid="cit0055" ref-type="bibr">55</xref>,
						<xref rid="cit0079" ref-type="bibr">79</xref>], they have been shown to be vital to piRNAs biogenesis and their chief function via transcriptional and post-transcriptional suppression of Transposable Elements (TEs) or transposons in the cytoplasm and nucleus [
						<xref rid="cit0080" ref-type="bibr">80</xref>].
					</p>
				</sec>
			</sec>
			<sec disp-level="1" id="s0002">
				<label>2.</label>
				<title>Biogenesis of piRNAs</title>
				<p>The recently emerging piRNAs need to be post-transcriptionally processed before they become entirely matured. The biogenesis of mature piRNAs comprises two main steps: the primary pathway and the &#x2018;ping-pong&#x2019; amplification mechanism (
					<xref rid="f0001" ref-type="fig">Figure 1</xref>) [
					<xref rid="cit0041" ref-type="bibr">41</xref>]. The first one occurs in Drosophila&#x2019;s somatic and germline cells; however, the &#x2018;ping-pong&#x2019; cycle was only described in germline cells [
					<xref rid="cit0007" ref-type="bibr">7</xref>].
					<fig position="float" id="f0001" fig-type="figure">
						<label>Figure 1.</label>
						<caption>
							<p>The two pathways of piRNA biogenesis: primary and secondary (Ping-Pong cycle) amplification Aub, Aubergine; Ago3, Argonaute-3; PIWI, P-element-induced wimpy testis; TE, Transposable Element</p>
						</caption>
						<alternatives>
							<graphic xlink:href="KBIE_A_1997078_F0001_OC" content-type="color" specific-use="web-only" position="float"/>
							<graphic xlink:href="KBIE_A_1997078_F0001_PB" content-type="black-white" specific-use="print-only" position="float"/>
						</alternatives>
					</fig>
				</p>
				<sec disp-level="2" id="s0002-s2001">
					<label>2.1.</label>
					<title>Primary amplification</title>
					<p>In the nucleus, Riboendonuclease Zucchini (Zuc) cleaves the primary transcripts of piRNAs, to form a 5&#x2B9;-phosphate residue*** [
						<xref rid="cit0081" ref-type="bibr">81</xref>]. Subsequently, PIWI is combined with a 3&#x2B9; fragment of the transcripts and snipped to the ultimate length by a 3&#x2B9; to 5&#x2B9; exonuclease. It is noteworthy that the 2&#x2B9;-hydroxy group is methylated at the 3&#x2B9; end through a small RNA 2&#x2B9;-O-methyltransferase enzyme, known as Hen1**** [
						<xref rid="cit0082" ref-type="bibr">82</xref>]. It has been shown that there is a substantial bias toward U residues on the part of the PIWI-incorporated 5&#x2B9;-end of the piRNAs. The piRNAs attach PIWI proteins sequentially to form a piRNA/PIWI complex after they are transferred into the cytoplasmic production centers and processed into their final length [
						<xref rid="cit0083" ref-type="bibr">83</xref>]. Later, the complex is translocated to the nucleus where it inhibits the target gene transcription via a complementary base pairing of piRNAs with DNA. As transcriptional regulators, piRNAs recruit histone methyltransferases, thereby functioning on TE sequences via establishing heterochromatin structures [B. W.
						<xref rid="cit0044" ref-type="bibr">44</xref>,
						<xref rid="cit0084" ref-type="bibr">84</xref>].
					</p>
				</sec>
				<sec disp-level="2" id="s0002-s2002">
					<label>2.2.</label>
					<title>Secondary amplification</title>
					<p>Upon the formation of a primary piRNA, piRNA accumulation needs to be augmented by the cytoplasmic &#x2018;ping&#x2013;pong&#x2019; mechanism [
						<xref rid="cit0054" ref-type="bibr">54</xref>]. On the contrary to the primary pathway that correlates with PIWI proteins, piRNAs connect with AUB (Aubergine) or AGO3 proteins in order to form complexes with these proteins with complementary sequences [
						<xref rid="cit0072" ref-type="bibr">72</xref>]. Given its slicer activity, a primary piRNA-associated AUB present in fly germ cells identifies and cleaves active transposon transcripts. These cleavages form the 5&#x2B9; ends of new piRNAs with a sense of orientation to transposons. Next, AGO3&#x2013;piRNA complexes identify and cut cluster transcripts so that they could create antisense piRNAs subsequent to load into AGO3 and become mature through trimming or Zuc [B. W.
						<xref rid="cit0085" ref-type="bibr">85</xref>,
						<xref rid="cit0086" ref-type="bibr">86</xref>]. The piRNAs are amplified and gathered in the cytoplasm through a ping pong cycle that is dependent on sequence-complementary [
						<xref rid="cit0041" ref-type="bibr">41</xref>]. Although ping-pong characteristics have been observed in
						<italic toggle="yes">Drosophila melanogaster</italic>, zebrafish, and sponges, they were not identified in mice, suggesting that this pathway is present in the early evolution [
						<xref rid="cit0087" ref-type="bibr">87</xref>].
					</p>
				</sec>
			</sec>
			<sec disp-level="1" id="s0003">
				<label>3.</label>
				<title>Biological functions of PIWI-piRNAs pathway</title>
				<p>On account of the fact that various species have distinct piRNA sequences and functioning, piRNAs biological functions have been recognized to a limited extent. Nevertheless, according to ample evidence, piRNAs play crucial roles in genes and protein regulation, epigenetic, TEs silencing, genome rearrangement, as well as in the maintenance of homeostasis, fertilization, somatic and germline stem cell self-renewal, and embryogenesis [Y.
					<xref rid="cit0007" ref-type="bibr">7</xref>,
					<xref rid="cit0088" ref-type="bibr">88</xref>].
				</p>
				<sec disp-level="2" id="s0003-s2001">
					<label>3.1.</label>
					<title>Retrotransposons silencing</title>
					<p>TEs comprise a number of genetic units that are capable of moving and propagating within the genome [
						<xref rid="cit0089" ref-type="bibr">89</xref>]. In spite of TEs&#x2019; vital role in improving genetic diversity, they lead to genetic instability via mutations, epigenetic/genetic deregulations, and chromosomes rearrangements [
						<xref rid="cit0090" ref-type="bibr">90</xref>]. As an innate immune-like system, piRNAs can oppose the negative impacts of TEs on the genome to conserve the genome integrity. DNA methylation and chromatin alterations of CpG islands in germline cells to preserve normal gametogenesis are the mechanisms employed by piRNAs to silence TEs [
						<xref rid="cit0015" ref-type="bibr">15</xref>]. Additionally, antisense piRNAs can attach to repeat sequences of TEs and lead to their silencing through degradation of mRNAs, which comprise these repeats, and also via translational inhibition [
						<xref rid="cit0091" ref-type="bibr">91</xref>].
					</p>
				</sec>
				<sec disp-level="2" id="s0003-s2002">
					<label>3.2.</label>
					<title>Genes and proteins regulation</title>
					<p>Since piRNAs have a broad array of applications, this group of ncRNAs is recognized for its master gene expression regulatory function both in germinal and somatic cells. piRNA-mediated gene regulation is performed through a number of processes. Epigenetic mechanisms are the first one as they are involved in histone modifications and DNA methylation [
						<xref rid="cit0092" ref-type="bibr">92</xref>], and the other one is gene regulation mediated by piRNA at the post-transcriptional level, which is conducted through controlling mRNA stability or alternative splicing, plus interaction with RNAs or RNA endonucleolytic splitting [
						<xref rid="cit0093" ref-type="bibr">93</xref>]. The last point, which is of equal significance, is that interfering RNAs/piRNA-like (iRNAs/piRNA-L) are possibly involved in translational or post-translational level of gene expression via the direct connection with the protein-coding genes in physiological and pathophysiological contexts [
						<xref rid="cit0094" ref-type="bibr">94</xref>].
					</p>
					<p>Furthermore, the first studies demonstrated that PIWI proteins participate in the regulation of translation. It has been found that at different steps of mouse spermatogenesis, mouse PIWI homolog (MIWI) and Miwi-like (MILI) are associated with the mRNA cap-binding complex, which is essential for the activation of translation [
						<xref rid="cit0095" ref-type="bibr">95</xref>,
						<xref rid="cit0096" ref-type="bibr">96</xref>]. In addition, AUB was shown to play a crucial role in translational regulation in germline stem cells of Drosophila ovaries [
						<xref rid="cit0097" ref-type="bibr">97</xref>]. Also, in Drosophila cultured cells, a link was found between Aub and eIF4 translation initiation factors [X.
						<xref rid="cit0098" ref-type="bibr">98</xref>].
					</p>
				</sec>
				<sec disp-level="2" id="s0003-s2003">
					<label>3.3.</label>
					<title>Differentiation</title>
					<p>During early embryogenesis, PIWI proteins assume great significance in cell differentiation. As the main PIWI protein involved in cell differentiation by its inhibitory effect on the Transforming Growth Factor-&#x3B2; (TGF-&#x3B2;) signaling pathway, PIWIL2 has a direct interaction with Heat Shock Protein 90 (HSP90) and Mothers against decapentaplegic homolog 4 (Smad4) and impedes the formation of HSP90 &#x2013; TGF-&#x3B2; Receptor (T&#x3B2;R) complex; thereby the TGF-&#x3B2; signaling pathway is inhibited. Moreover, PIWIL2 contributes to T&#x3B2;R and Smad degradation through its involvement in the upregulation of T&#x3B2;R ubiquitination as well as degradation by the ubiquitin E3 ligase Smurf2. Likewise, PIWI proteins assist in the differentiation of germline stem cells through post-transcriptional-level suppression of c-Fos proto-oncogene. Hence, these proteins improve piRNAs&#x2019; synthesis from 3&#x2032; UTR region of c-Fos mRNA, leading to instability of c-Fos mRNA and translation repression [
						<xref rid="cit0099" ref-type="bibr">99</xref>,
						<xref rid="cit0100" ref-type="bibr">100</xref>, J. C.
						<xref rid="cit0019" ref-type="bibr">19</xref>,
						<xref rid="cit0101" ref-type="bibr">101</xref>].
					</p>
				</sec>
				<sec disp-level="2" id="s0003-s2004">
					<label>3.4.</label>
					<title>Cell survival</title>
					<p>Activation of numerous pro-survival molecules is enhanced by the PIWI-piRNA axis. Also, through upregulation of the anti-apoptotic molecule Fibroblast Growth Factor 8 (FGF8) expression and downregulation of pro-apoptotic p21 and Bax expression,PIWIL1 induces cell survival. Additionally, PIWIL2 mainly regulates p53 by directly interacting with c-Src and STAT3 as well as improving a PIWIL2/STAT3/c-Src complex. It would repress p53 phosphorylation and inhibit Fas-mediated apoptosis. The STAT3 activation, induced by PIWIL2, was also reported to lead to the up-regulation of the anti-apoptotic Bcl-XL [X. Zha
						<xref rid="cit0102" ref-type="bibr">102</xref>].
					</p>
				</sec>
				<sec disp-level="2" id="s0003-s2005">
					<label>3.5.</label>
					<title>Fertilization and development</title>
					<p>In Drosophila and murine GSCs, the PIWI-piRNA pathway is largely engaged in germline cell biology, which includes differentiation, maintenance, and function of these cells. Given their transgenerational epigenetic effects, piRNAs result in epigenetic activation of gene expression through euchromatin induction by activating H3K4me3 and inhibiting H3K27me3 in sub-telomeric heterochromatin [
						<xref rid="cit0079" ref-type="bibr">79</xref>,
						<xref rid="cit0099" ref-type="bibr">99&#x2013;101</xref>,
						<xref rid="cit0103" ref-type="bibr">103</xref>,
						<xref rid="cit0104" ref-type="bibr">104</xref>].
					</p>
					<p>The embryonic development, such as nuclear division, cell cycle development, chromatin organization, control of mRNA translation, chromosome integrity in pro-survival molecules during mitosis, and embryonic sex determination are the processes in which the PIWI-piRNA axis is implicated [
						<xref rid="cit0105" ref-type="bibr">105&#x2013;107</xref>, H.
						<xref rid="cit0108" ref-type="bibr">108</xref>]. During mammalian spermatogenesis and oogenesis, along with early embryogenesis, organogenesis, and post-natal, the spatial-temporal regulation and activation of piRNAs and PIWI proteins assume utmost importance [S.
						<xref rid="cit0058" ref-type="bibr">58</xref>]. The regulation of PIWIL2 is performed in germline cells and contributes to genome stability maintenance by preventing gene dysregulation, chromosome rearrangements, oncogenic mutations, and TEs propagation [D.-T.
						<xref rid="cit0109" ref-type="bibr">109</xref>].
					</p>
				</sec>
				<sec disp-level="2" id="s0003-s2006">
					<label>3.6.</label>
					<title>Mitochondrial functions</title>
					<p>piRNAs also have mitochondrial expression, wherein they originate from a sequence of 12S rRNA, tRNA, 16S rRNA, and protein-coding genes of mitochondria, including NADH-ubiquinone oxidoreductase chain 4&#xA0;L (ND4L), CycloOxygenase2 (COX2), and NADH-ubiquinone oxidoreductase chain 5 (ND5) [
						<xref rid="cit0110" ref-type="bibr">110</xref>]. It shows that nuclear and mitochondrial piRNA transcripts have a potential cross-talk, and mitochondrial (mt)-piRNAs are involved in cell responses to oxidative stress and bioenergetics. Regarding the fact that mitochondria is an organelle involved in different cellular key processes like apoptosis and bioenergetics, functional studies are of the utmost significance to better comprehend the piRNAs role in mitochondrial epigenetics and how it affects the development of health and diseases [
						<xref rid="cit0111" ref-type="bibr">111</xref>].
					</p>
				</sec>
				<sec disp-level="2" id="s0003-s2007">
					<label>3.7.</label>
					<title>Somatic functions</title>
					<p>At the somatic level, it was reported that piRNAs are expressed in body fluids and somatic cells [
						<xref rid="cit0112" ref-type="bibr">112&#x2013;115</xref>]. Nevertheless, their functions in the soma are still unknown because there is not enough knowledge on functional assays of piRNAs. A variety of studies have indicated the likelihood of piRNAs involvement in genes&#x2019; epigenetic regulation associated with neuronal activity, neurogenesis, plasticity [E. J.
						<xref rid="cit0116" ref-type="bibr">116&#x2013;118</xref>], and that pseudogenes-derived piRNAs may contribute to the regulation of parental genes [
						<xref rid="cit0119" ref-type="bibr">119</xref>]. Antisense piRNAs were also found to lead to regulation of immune response as well as self-tolerance genes [
						<xref rid="cit0089" ref-type="bibr">89</xref>]. In addition, it has been reported that sno-piRNAs exist in primary CD4&#xA0;+&#xA0;T-lymphocytes and regulate interleukin-4 (IL-4) levels, thereby hindering their differentiation into T-helper 2 (Th2) T-cells [
						<xref rid="cit0051" ref-type="bibr">51</xref>].
					</p>
				</sec>
				<sec disp-level="2" id="s0003-s2008">
					<label>3.8.</label>
					<title>Autophagic regulation</title>
					<p>The regulatory role of piRNAs in cell cycle, apoptosis, and proliferation is becoming increasingly evident. Phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/mammalian Target Of Rapamycin (mTOR) is a classical pathway that serves as a signal transduction pathway and plays a vital biological role in different cellular processes, including autophagy [
						<xref rid="cit0120" ref-type="bibr">120</xref>]. However, the exact role of piRNAs in autophagy needs further investigations since very limited related publications are available.
					</p>
				</sec>
			</sec>
			<sec disp-level="1" id="s0004">
				<label>4.</label>
				<title>The roles of PIWI-piRNAs pathway in cancer</title>
				<sec disp-level="2" id="s0004-s2001">
					<label>4.1.</label>
					<title>piRNAs and cancer</title>
					<p>Given our insufficient knowledge of how piRNAs function, they have long been considered as &#x2018;dark matter&#x2019; of ncRNAs in the genome. Nevertheless, the current document has altered our perception of piRNAs as vital clinical and biological agents in different diseases [
						<xref rid="cit0041" ref-type="bibr">41</xref>]. Likewise, based on recent studies, aberrant piRNAs expression might be introduced as a particular signature of cancer and could have a correlation with clinical characteristics of tumor tissues, suggesting a significant role of these molecules in a wide variety of cancers, such as colorectal, prostate, gastric, bladder, breast, lung, and hepatic cancers, as well as malignant melanoma (
						<xref rid="t0002" ref-type="table">Table 2</xref>) [
						<xref rid="cit0014" ref-type="bibr">14</xref>,
						<xref rid="cit0121" ref-type="bibr">121</xref>,
						<xref rid="cit0122" ref-type="bibr">122</xref>]. Dysregulated expression of piRNAs suggests that they could be considered as tumor suppressors or oncogenes in tumorigenesis (depending on the function of their targeted gene/mRNA/protein), and as such can act as crucial regulators of the major characteristics of cancer, including cancer cell differentiation, proliferation, progression, and metastasis [
						<xref rid="cit0093" ref-type="bibr">93</xref>,
						<xref rid="cit0123" ref-type="bibr">123</xref>].

						<table-wrap position="float" id="t0002">
							<label>Table 2.</label>
							<caption>
								<p>Cancer-associated piRNAs</p>
							</caption>
							<!--OASIS TABLE HERE-->
							<table frame="hsides" rules="groups">
								<colgroup>
									<col width="15%" align="left"/>
									<col width="10%" align="left"/>
									<col width="15%" align="left"/>
									<col width="45%" align="left"/>
									<col width="15%" align="center"/>
								</colgroup>
								<thead>
									<tr>
										<th align="left">Malignancy</th>
										<th align="center">PiRNA</th>
										<th align="center">Expression</th>
										<th align="center">Mechanisms in cancer</th>
										<th align="center">References</th>
									</tr>
								</thead>
								<tbody>
									<tr>
										<td align="left">Breast cancer</td>
										<td align="left">piR-932
											<break/>piR-651
											<break/>piR-021285
											<break/>piR-4987
											<break/>piR-36712
											<break/>piRNA-823
										</td>
										<td align="left">Overexpression
											<break/>Overexpression
											<break/>Overexpression
											<break/>Overexpression
											<break/>Underexpression
											<break/>Overexpression
										</td>
										<td align="left">Stemness, EMT, and invasion
											<break/>Proliferation, invasion, and metastasis
											<break/>Increase ARHGAP11A mRNA expression and invasiveness
											<break/>Associated with lymph node metastasis
											<break/>Restrains breast cancer progression and chemoresistance by interaction with SEPW1 pseudogene SEPW1P RNA
											<break/>Involved in cancer stem cell regulation through altering DNA methylation
										</td>
										<td align="center">[
											<xref rid="cit0124" ref-type="bibr">124</xref>,
											<xref rid="cit0142" ref-type="bibr">142</xref>]
											<break/>[H.
											<xref rid="cit0125" ref-type="bibr">125</xref>]
											<break/>[
											<xref rid="cit0126" ref-type="bibr">126</xref>]
											<break/>[L.
											<xref rid="cit0127" ref-type="bibr">127</xref>]
											<break/>[
											<xref rid="cit0128" ref-type="bibr">128</xref>]
										</td>
									</tr>
									<tr>
										<td align="left">Gastric cancer</td>
										<td align="left">piR-651
											<break/>piR-823
											<break/>piR-59056
										</td>
										<td align="left">Overexpression
											<break/>Underexpression
											<break/>Overexpression
										</td>
										<td align="left">Proliferation, invasion, and metastasis
											<break/>Inhibit cancer cell growth, tumor-node and distant metastasis
											<break/>Associated with recurrence
										</td>
										<td align="center">[
											<xref rid="cit0129" ref-type="bibr">129</xref>]
											<break/>[Y.-N.
											<xref rid="cit0130" ref-type="bibr">130</xref>,
											<xref rid="cit0205" ref-type="bibr">205</xref>]
											<break/>[L.
											<xref rid="cit0147" ref-type="bibr">147</xref>]
										</td>
									</tr>
									<tr>
										<td align="left">Lung cancer</td>
										<td align="left">piR-L-163
											<break/>piR-651
											<break/>piR-55490
										</td>
										<td align="left">Underexpression
											<break/>Overexpression
											<break/>Underexpression
										</td>
										<td align="left">Proliferation and invasion
											<break/>Proliferation, invasion, and metastasis
											<break/>Suppress the activation of Akt/mTOR pathway
										</td>
										<td align="center">[
											<xref rid="cit0094" ref-type="bibr">94</xref>,
											<xref rid="cit0122" ref-type="bibr">122</xref>,
											<xref rid="cit0124" ref-type="bibr">124</xref>]
										</td>
									</tr>
									<tr>
										<td align="left">Colon cancer</td>
										<td align="left">piR-651
											<break/>piR-59056
										</td>
										<td align="left">Overexpression
											<break/>Overexpression
										</td>
										<td align="left">Proliferation, invasion, and metastasis
											<break/>Associated with recurrence-free survival
										</td>
										<td align="center">[Y.
											<xref rid="cit0131" ref-type="bibr">131</xref>]
											<break/>[L.
											<xref rid="cit0147" ref-type="bibr">147</xref>]
										</td>
									</tr>
									<tr>
										<td align="left">Bladder cancer</td>
										<td align="left">piR-ABC
											<break/>piR-60152
										</td>
										<td align="left">Underexpression
											<break/>Underexpression
										</td>
										<td align="left">Proliferation suppression, encourage apoptosis
											<break/>Regulate the expression of TNFSF4
										</td>
										<td align="center">[
											<xref rid="cit0132" ref-type="bibr">132</xref>,
											<xref rid="cit0132" ref-type="bibr">132</xref>]
										</td>
									</tr>
									<tr>
										<td align="left">Liver cancer</td>
										<td align="left">piR-Hep1
											<break/>piR-823
										</td>
										<td align="left">Overexpression
											<break/>Overexpression
										</td>
										<td align="left">Migration and invasion
											<break/>Increase the production of a-SMA and COL1a1
										</td>
										<td align="center">[
											<xref rid="cit0133" ref-type="bibr">133</xref>,
											<xref rid="cit0134" ref-type="bibr">134</xref>,
											<xref rid="cit0143" ref-type="bibr">143</xref>]
										</td>
									</tr>
									<tr>
										<td align="left">Prostate cancer</td>
										<td align="left">piR-001773
											<break/>piR-017184
											<break/>piR-19166
										</td>
										<td align="left">Overexpression
											<break/>Underexpression
										</td>
										<td align="left">Promote cancer progression
											<break/>Inhibits migration and metastasis
										</td>
										<td align="center">[L.
											<xref rid="cit0135" ref-type="bibr">135</xref>]
											<break/>[
											<xref rid="cit0136" ref-type="bibr">136</xref>]
										</td>
									</tr>
									<tr>
										<td align="left">Multiple myeloma</td>
										<td align="left">piR-823
											<break/>piR-004800
										</td>
										<td align="left">Overexpression
											<break/>Overexpression
										</td>
										<td align="left">DNA methylation and angiogenesis
											<break/>Keeps myeloma cell survival by inhibition of apoptotic and autophagic cell death
										</td>
										<td align="center">[H.
											<xref rid="cit0125" ref-type="bibr">125</xref>]
											<break/>[H.
											<xref rid="cit0137" ref-type="bibr">137</xref>]
										</td>
									</tr>
									<tr>
										<td align="left">Glioma</td>
										<td align="left">piR-598</td>
										<td align="left">Overexpression</td>
										<td align="left">Promote cell proliferation</td>
										<td align="center">[
											<xref rid="cit0138" ref-type="bibr">138</xref>]
										</td>
									</tr>
								</tbody>
							</table>
						</table-wrap>
					</p>
					<p>The functions of piRNA pathways are shown to be associated with several processes that occur in cancer, such as genomic instability, aneuploidy, DNA methylation, cell cycle progression, repetitious expression, and cell metabolism [
						<xref rid="cit0017" ref-type="bibr">17</xref>,
						<xref rid="cit0121" ref-type="bibr">121</xref>, Y.
						<xref rid="cit0139" ref-type="bibr">139</xref>]. piRNA pathway genes have been reported to be linked to the regulation of genes that are implicated in the establishment of stem cell features [L.
						<xref rid="cit0140" ref-type="bibr">140</xref>, Y.
						<xref rid="cit0139" ref-type="bibr">139</xref>].
						<xref rid="f0002" ref-type="fig">Figure 2</xref> depicts a trace of the piRNAs in a variety of cancer types [
						<xref rid="cit0093" ref-type="bibr">93</xref>].
						<fig position="float" id="f0002" fig-type="figure">
							<label>Figure 2.</label>
							<caption>
								<p>Biological functions, target genes, and clinical applications of piRNAs in cancer</p>
							</caption>
							<alternatives>
								<graphic xlink:href="KBIE_A_1997078_F0002_OC" content-type="color" specific-use="web-only" position="float"/>
								<graphic xlink:href="KBIE_A_1997078_F0002_PB" content-type="black-white" specific-use="print-only" position="float"/>
							</alternatives>
						</fig>
					</p>
					<p>RT-qPCR analyses, next-generation sequencing and microarray screening have revealed the association between piRNAs and carcinogenesis [J.
						<xref rid="cit0141" ref-type="bibr">141</xref>,
						<xref rid="cit0142" ref-type="bibr">142</xref>]. As one of the most prominent discoveries, piRNAs can influence two of the most classical pathways with involvement in cancer progression, PI3K/PTEN/Akt/mTOR and Ras/Raf/MEK/ERK pathways [
						<xref rid="cit0143" ref-type="bibr">143</xref>]. These pathways are crucial in the regulation of a wide variety of genes, and their stimulation can enhance metabolism, growth, and survival of cancer cells [
						<xref rid="cit0144" ref-type="bibr">144</xref>]. Therefore, the identification of piRNAs, which are related to cancer and functional analysis of their target genes, could be capitalized on in preventive and therapeutic strategies in cancer [J.
						<xref rid="cit0141" ref-type="bibr">141</xref>].
					</p>
				</sec>
				<sec disp-level="2" id="s0004-s2002">
					<label>4.2.</label>
					<title>piRNAs as potential biomarkers and therapeutic tools</title>
					<p>Cancers often become symptomatic when they have already spread, and this makes the treatments and interventions less effective. An effective screening biomarker must be able to distinguish the cancer at an initial stage to decrease the morbidity rate and increase the survival chances. As
						<xref rid="t0003" ref-type="table">Table 3</xref> shows, and in accordance with previous findings, it has been identified that aberrant piRNAs expression is associated with different characteristics of cancer patients. piRNAs are early products of different regulatory and signaling pathways. So, at least theoretically, they might be very important for early detection and treatment of cancers [
						<xref rid="cit0041" ref-type="bibr">41</xref>,
						<xref rid="cit0121" ref-type="bibr">121</xref>,
						<xref rid="cit0145" ref-type="bibr">145</xref>]. With a tissue-specific expression profile, piRNAs are considered as promising tissue-based diagnostic and prognostic biomarkers for cancer [
						<xref rid="cit0146" ref-type="bibr">146</xref>]. In addition, piRNAs are also noninvasive biomarkers that are present in exosomes or as free-circulating in serum, plasma, saliva, and stool [L.
						<xref rid="cit0147" ref-type="bibr">147&#x2013;151</xref>, Z.
						<xref rid="cit0152" ref-type="bibr">152</xref>, X.
						<xref rid="cit0153" ref-type="bibr">153</xref>]. piRNAs can be detected using microarray, sequencing, and qRT-PCR [
						<xref rid="cit0078" ref-type="bibr">78</xref>,
						<xref rid="cit0146" ref-type="bibr">146</xref>]. Alterations in circulating piRNA expression levels might be good cancer biomarkers, with higher specificity and sensitivity compared to circulating miRNAs and lncRNA-based biomarkers [L.
						<xref rid="cit0147" ref-type="bibr">147</xref>]. It should be noted that no enzyme is needed for piRNA processing in the synthesis pathway. Therefore, it is beneficial to utilize synthetic piRNAs with better specificity of targets [
						<xref rid="cit0121" ref-type="bibr">121</xref>]. Fortunately, these small RNAs are capable of passing through the cell membrane, without degradation in the circulation and remain stable in human serum and plasma samples even after frequent freeze-thaw cycles or long-term incubation at room temperature [
						<xref rid="cit0115" ref-type="bibr">115</xref>,
						<xref rid="cit0154" ref-type="bibr">154</xref>]. This requires identifying novel piRNA biomarkers for cancer diagnosis at an early stage and their validation in independent studies with larger sample sizes and long-term clinical trials. Therefore, the combination of circulating miRNAs and piRNAs could increase its specificity and sensitivity cancer diagnosis and provide new approaches to develop a particular panel for early diagnosis and prognosis [
						<xref rid="cit0146" ref-type="bibr">146</xref>].
						<table-wrap position="float" id="t0003">
							<label>Table 3.</label>
							<caption>
								<p>Clinical applications of piRNAs in cancer</p>
							</caption>
							<!--OASIS TABLE HERE-->
							<table frame="hsides" rules="groups">
								<colgroup>
									<col width="20%" align="left"/>
									<col width="45%" align="left"/>
									<col width="25%" align="left"/>
									<col width="10%" align="center"/>
								</colgroup>
								<thead>
									<tr>
										<th align="left">Cancer</th>
										<th align="center">PiRNA</th>
										<th align="center">Clinical application</th>
										<th align="center">References</th>
									</tr>
								</thead>
								<tbody>
									<tr>
										<td align="left">Breast cancer</td>
										<td align="left">piR-932
											<break/>piR-008114 piR-019676 piR-000552 piR-020548 piR-008113
											<break/>piR-016735 piR-020450 piR-017033
											<break/>piR-020365 piR-019675 piR-019914 piR-015249 piR-009294
											<break/>piR-021032 piR-009051 piR-000753 piR-008112 piR-020814
											<break/>piR-001318 piR-006426
											<break/>piR-018,849
											<break/>piR-021285 piR-017184 piR-020829 piR-019912 piR-018780
										</td>
										<td align="left">Therapeutic target
											<break/>Therapeutic targets
										</td>
										<td align="center">[H.
											<xref rid="cit0160" ref-type="bibr">160</xref>]
											<break/>[
											<xref rid="cit0161" ref-type="bibr">161</xref>]
										</td>
									</tr>
									<tr>
										<td align="left">Gastric cancer</td>
										<td align="left">piR-823
											<break/>piR-651
										</td>
										<td align="left">Therapeutic target and diagnostic marker
											<break/>Diagnostic marker
										</td>
										<td align="center">[J.
											<xref rid="cit0156" ref-type="bibr">156</xref>]
											<break/>[L.
											<xref rid="cit0147" ref-type="bibr">147</xref>]
										</td>
									</tr>
									<tr>
										<td align="left">Lung cancer</td>
										<td align="left">piR-651
											<break/>piR-L-163
											<break/>piR-55,490
										</td>
										<td align="left">Therapeutic target
											<break/>Diagnostic marker
											<break/>Therapeutic target
										</td>
										<td align="center">[D.
											<xref rid="cit0162" ref-type="bibr">162</xref>,
											<xref rid="cit0163" ref-type="bibr">163</xref>]
											<break/>[
											<xref rid="cit0094" ref-type="bibr">94</xref>]
											<break/>[L. Pe
											<xref rid="cit0164" ref-type="bibr">164</xref>]
										</td>
									</tr>
									<tr>
										<td align="left">Colorectal cancer</td>
										<td align="left">piR-1245
											<break/>piR-015551
											<break/>piR-020619
											<break/>piR-020450
											<break/>piR-54265
											<break/>piR-823
											<break/>piR-19521
											<break/>piR-18849
											<break/>piR-28876
											<break/>piR-5937
										</td>
										<td align="left">Prognostic marker
											<break/>Risk assessment
											<break/>Diagnostic markers
											<break/>Valuable biomarker for screening, early diagnosis and clinical surveillance
											<break/>Therapeutic target
											<break/>Prognostic marker
											<break/>Prognostic marker
											<break/>Diagnostic marker
											<break/>Diagnostic marker
										</td>
										<td align="center">[
											<xref rid="cit0129" ref-type="bibr">129</xref>,
											<xref rid="cit0165" ref-type="bibr">165</xref>]
											<break/>[Z.
											<xref rid="cit0152" ref-type="bibr">152</xref>]
											<break/>[
											<xref rid="cit0166" ref-type="bibr">166</xref>]
											<break/>[J.
											<xref rid="cit0167" ref-type="bibr">167</xref>]
											<break/>[J.
											<xref rid="cit0168" ref-type="bibr">168</xref>]
											<break/>[
											<xref rid="cit0151" ref-type="bibr">151</xref>]
										</td>
									</tr>
									<tr>
										<td align="left">Multiple myeloma</td>
										<td align="left">piR-823</td>
										<td align="left">Therapeutic target</td>
										<td align="center">[H.
											<xref rid="cit0125" ref-type="bibr">125</xref>]
										</td>
									</tr>
									<tr>
										<td align="left">Prostate cancer</td>
										<td align="left">piR-651
											<break/>piR-823
										</td>
										<td align="left">Therapeutic targets</td>
										<td align="center">[
											<xref rid="cit0169" ref-type="bibr">169</xref>]
										</td>
									</tr>
									<tr>
										<td align="left">Liver cancer</td>
										<td align="left">piR-Hep1</td>
										<td align="left">Prognostic marker</td>
										<td align="center">[
											<xref rid="cit0143" ref-type="bibr">143</xref>]
										</td>
									</tr>
									<tr>
										<td align="left">Kidney cancer</td>
										<td align="left">piR-823
											<break/>piR-43,607
											<break/>piR-32,051
											<break/>piR-39,894
											<break/>piR-38,756
											<break/>piR-30,924
											<break/>piR-51810
											<break/>piR-57125
											<break/>piR-34536
										</td>
										<td align="left">Prognostic marker
											<break/>Prognostic markers
											<break/>Prognostic marker
											<break/>Prognostic marker
											<break/>Prognostic marker
										</td>
										<td align="center">[
											<xref rid="cit0149" ref-type="bibr">149</xref>]
											<break/>[Y.
											<xref rid="cit0131" ref-type="bibr">131</xref>]
											<break/>[
											<xref rid="cit0170" ref-type="bibr">170</xref>]
											<break/>[C.
											<xref rid="cit0010" ref-type="bibr">10</xref>]
											<break/>[
											<xref rid="cit0171" ref-type="bibr">171</xref>]
											<break/>[C.
											<xref rid="cit0010" ref-type="bibr">10</xref>]
										</td>
									</tr>
									<tr>
										<td align="left">Papillary thyroid carcinoma</td>
										<td align="left">piR-13643
											<break/>piR-21238
										</td>
										<td align="left">Diagnostic markers</td>
										<td align="center">[
											<xref rid="cit0172" ref-type="bibr">172</xref>]
										</td>
									</tr>
									<tr>
										<td align="left">Diffuse Large B-Cell Lymphoma(DLBCL)</td>
										<td align="left">PiR-30473</td>
										<td align="left">Prognostic marker</td>
										<td align="center">[H.
											<xref rid="cit0173" ref-type="bibr">173</xref>]
										</td>
									</tr>
								</tbody>
							</table>
						</table-wrap>
						<table-wrap position="float" id="ut0004">
							<label>Table 4.</label>
							<caption>
								<p>Cancer-related PIWI Proteins</p>
							</caption>
							<!--OASIS TABLE HERE-->
							<table frame="hsides" rules="groups">
								<colgroup>
									<col width="15%" align="left"/>
									<col width="20%" align="left"/>
									<col width="10%" align="left"/>
									<col width="30%" align="left"/>
									<col width="25%" align="center"/>
								</colgroup>
								<thead>
									<tr>
										<th align="left">PIWI Proteins</th>
										<th align="center">Cancer</th>
										<th align="center">Expression</th>
										<th align="center">Function</th>
										<th align="center">References</th>
									</tr>
								</thead>
								<tbody>
									<tr>
										<td align="left">PIWIL1/HIWI</td>
										<td align="left">Seminoma Cancer
											<break/>Colorectal cancer
											<break/>Breast cancer
											<break/>Gastric cancer
											<break/>Lung cancer
											<break/>Ovarian cancer
											<break/>Glioma
											<break/>Sarcomas
											<break/>Endometrial cancer
											<break/>Hepatocellular carcinoma
											<break/>Cervix cancer
										</td>
										<td align="left">Increased
											<break/>Increased
											<break/>Increased
											<break/>Increased
											<break/>Increased
											<break/>Increased
											<break/>Increased
											<break/>Increased
											<break/>Decreased
											<break/>Decreased
											<break/>Increased
										</td>
										<td align="left">Encourage cell propagation
											<break/>Inhibit migration and invasion
											<break/>Increase cell proliferation and stemness
											<break/>Encourage cell proliferation
											<break/>CSC self-renewa1
											<break/>Migration and invasion
											<break/>Increase cell propagation
											<break/>Genomic instability
											<break/>Related to DNA hypermethylation
											<break/>Reduce cell proliferation and migration
											<break/>Migration and invasion
										</td>
										<td align="center">[
											<xref rid="cit0061" ref-type="bibr">61</xref>,
											<xref rid="cit0124" ref-type="bibr">124</xref>,
											<xref rid="cit0170" ref-type="bibr">170</xref>,
											<xref rid="cit0182" ref-type="bibr">182&#x2013;190</xref>,
											<xref rid="cit0190" ref-type="bibr">190&#x2013;192</xref>]
										</td>
									</tr>
									<tr>
										<td align="left">PIWIL2/HILI</td>
										<td align="left">Colon cancer
											<break/>Liver cancer
											<break/>Breast cancer
											<break/>Gastric cancer
											<break/>Ovarian cancer
											<break/>Cervix cancer
											<break/>Esophageal cancer
											<break/>Soft-tissue sarcoma
										</td>
										<td align="left">Increased
											<break/>Increased
											<break/>Increased
											<break/>Increased
											<break/>Increased
											<break/>Increased
											<break/>Increased
											<break/>Decreased
										</td>
										<td align="left">Proliferation, migration, and invasion
											<break/>Apoptosis inhibition
											<break/>Proliferation, apoptosis inhibition, migration, and invasion
											<break/>Related to poor prognosis
											<break/>Genomic instability
											<break/>Inhibit apoptosis
											<break/>Related to poor prognosis
											<break/>Reduce cell proliferation and increase apoptosis
										</td>
										<td align="center">[
											<xref rid="cit0193" ref-type="bibr">193</xref>, Z.
											<xref rid="cit0194" ref-type="bibr">194</xref>]
											<break/>[J. H.
											<xref rid="cit0067" ref-type="bibr">67</xref>,
											<xref rid="cit0195" ref-type="bibr">195</xref>]
											<break/>[J. H.
											<xref rid="cit0196" ref-type="bibr">196</xref>, H.
											<xref rid="cit0160" ref-type="bibr">160</xref>]
											<break/>[
											<xref rid="cit0175" ref-type="bibr">175</xref>,
											<xref rid="cit0185" ref-type="bibr">185</xref>,
											<xref rid="cit0190" ref-type="bibr">190</xref>,
											<xref rid="cit0197" ref-type="bibr">197</xref>,
											<xref rid="cit0198" ref-type="bibr">198</xref>]
										</td>
									</tr>
									<tr>
										<td align="left">PIWIL3/HIWI3</td>
										<td align="left">Breast cancer
											<break/>Gastric cancer
										</td>
										<td align="left">Increased
											<break/>Increased
										</td>
										<td align="left">Prognosis relevance
											<break/>Proliferation, migration and invasion
										</td>
										<td align="center">[
											<xref rid="cit0143" ref-type="bibr">143</xref>,
											<xref rid="cit0199" ref-type="bibr">199</xref>]
										</td>
									</tr>
									<tr>
										<td align="left">PIWIL4/HIWI2</td>
										<td align="left">Cervical cancer
											<break/>Lung cancer
											<break/>Colon cancer
											<break/>Breast cancer
										</td>
										<td align="left">Increased
											<break/>Increased
											<break/>Increased
											<break/>Increased
										</td>
										<td align="left">Impair apoptosis, promote invasion
											<break/>Proliferation
											<break/>Migration and invasion
											<break/>Prognosis relevance
										</td>
										<td align="center">[D.-W.
											<xref rid="cit0200" ref-type="bibr">200</xref>, X.
											<break/>[
											<xref rid="cit0201" ref-type="bibr">201</xref>]
											<break/>[L.
											<xref rid="cit0202" ref-type="bibr">202</xref>]
											<break/>[
											<xref rid="cit0143" ref-type="bibr">143</xref>]
										</td>
									</tr>
								</tbody>
							</table>
						</table-wrap>
					</p>
					<p>Despite the fact that we know little about the molecular mechanisms of piRNAs functioning in tumorigenesis, some of their characteristics would make them ideal targets for therapeutic interventions. As an example, the piRNAs&#x2019; role in DNA methylation, which results in gene silencing at the transcriptional level, is applicable in inhibiting the expression of certain oncogenes, or their functions in post-transcriptionally RNA degradation could have therapeutic advantages. Moreover, gene silencing that is mediated by RNA interference (RNAi) utilized for cancer treatment could contribute to selective silencing of oncogenic piRNAs [
						<xref rid="cit0123" ref-type="bibr">123</xref>]. Nevertheless, the efficiency of piRNAs as therapeutic targets is dependent on effective in-vivo delivery strategies, and prior to any application of piRNAs for therapeutic purposes, it is required that in-depth studies be conducted [
						<xref rid="cit0155" ref-type="bibr">155</xref>].
					</p>
					<p>A number of different studies have been documented the clinical significance of piRNAs as potential biomarkers and therapeutic tools in the most common cancers. Recent studies revealed that overexpression of piR-823 in gastric cancer cells led to suppress growth of tumor, suggesting it may be considered as a promising therapeutic agent [J.
						<xref rid="cit0156" ref-type="bibr">156</xref>]. In addition, serum level of piR-823 and piR-651 were significantly lower in gastric cancer patients compared to normal, highlighting its clinical value as a diagnostic biomarker [H.
						<xref rid="cit0157" ref-type="bibr">157</xref>]. In lung cancer, as the most common cause of cancer death, abnormal expression of piRNAs was associated with the growth of lung cancer cells [
						<xref rid="cit0158" ref-type="bibr">158</xref>]. In breast cancer, the most common cancer among females, it was revealed that tumor tissues express eight piRNAs that are believed to be independent prognostic biomarkers (piR-34,736, piR-31,106, piR-36,249, piR-36,026, piR-36,318, piR-34,377, piR-35,407, and piR-36,743) [
						<xref rid="cit0041" ref-type="bibr">41</xref>]. Prognostic biomarkers of breast cancer are of significant importance, since local breast cancer has a 5-year survival rate of at least 90%; however, this rate declines to 60% in metastatic patients if it is regional and 30% if distant [
						<xref rid="cit0159" ref-type="bibr">159</xref>]. Interestingly, a cohort study documented the correlation of these breast cancer prognostic biomarkers with the survival rate. However, comparing sensitivity, specificity, and practicality of piRNAs with traditional tumor markers is a neglected area in this field.
					</p>
					<p>The clinical relevance of piRNAs with cancer is not limited to the above-mentioned examples. As it is shown in
						<xref rid="t0003" ref-type="table">Table 3</xref>, several studies reported other applications of piRNAs in the common cancers such as colorectal cancer, multiple myeloma, clear cell renal cancer, etc. Despite that, clinical researches about applications of piRNAs in targeted therapy are limited. Also, the mechanisms by which piRNA expression is altered in several cancers have not been studied yet.
					</p>
				</sec>
				<sec disp-level="2" id="s0004-s2003">
					<label>4.3.</label>
					<title>PIWI proteins and cancer</title>
					<p>Investigations about piRNAs have mainly been focused at the transcriptional and post-transcriptional levels, and only few researches have studied piRNA function at the post-translational level. It is noteworthy that in addition to clinicopathologic analysis, both in-vivo and in-vitro functional research has recognized all of the four human PIWI proteins as novel molecular agents involved in carcinogenesis [
						<xref rid="cit0174" ref-type="bibr">174</xref>]. The expression of PIWI in cancer was, for the first time, reported in seminoma [
						<xref rid="cit0175" ref-type="bibr">175</xref>]. Other reports on different cancers also revealed that PIWI protein expression profiles had been potentially and functionally associated with a broad range of human cancers, with both somatic and germline origin. Moreover, they have correlations with poor clinical outcomes and aggressive cancers (
						<xref rid="t0003" ref-type="table">Table 3</xref>) [
						<xref rid="cit0041" ref-type="bibr">41</xref>,
						<xref rid="cit0091" ref-type="bibr">91</xref>,
						<xref rid="cit0123" ref-type="bibr">123</xref>]. Hence, these proteins were shown to be involved in the proliferation of cancer cells, metastasis, invasion, apoptosis, migration, division, and survival. As found by immunohistochemical and western blot analysis of PIWI protein expression in tissue specimens from cancer patients, PIWI proteins could be proposed as promising biomarkers for cancer prognosis and diagnosis [Y.
						<xref rid="cit0045" ref-type="bibr">45</xref>,
						<xref rid="cit0088" ref-type="bibr">88</xref>,
						<xref rid="cit0176" ref-type="bibr">176</xref>, Y.
						<xref rid="cit0177" ref-type="bibr">177</xref>].
					</p>
					<p>Since the expression of PIWI proteins is not associated with the presence of large amounts of piRNAs, the mechanisms of their actions in cancers are still debated [
						<xref rid="cit0178" ref-type="bibr">178</xref>]. In addition, it has been reported that PIWI proteins have independent functions of piRNAs in cancer progression and metastasis. Previous studies revealed the independent function of PIWIL1 in pancreatic [F.
						<xref rid="cit0179" ref-type="bibr">179</xref>] and gastric cancer [S.
						<xref rid="cit0180" ref-type="bibr">180</xref>] metastasis. In mouse spermatogenesis, it has also been described that MIWI exerts an independent role of piRNAs in protein regulation [
						<xref rid="cit0181" ref-type="bibr">181</xref>]. Whether PIWI proteins and piRNAs affect the cancer cells independently, or they act on cancer cells together, remains a challenging issue yet to be addressed.

					</p>
				</sec>
			</sec>
			<sec disp-level="1" id="s0005">
				<label>5.</label>
				<title>Database for piRNAs and functional predictions</title>
				<p>The rapid increase in studies conducted on piRNAs has allowed for the generation of several databases, such as piRNA Bank (
					<ext-link xlink:href="http://pirnabank.ibab" ext-link-type="uri">http://pirnabank.ibab</ext-link>. ac.in/) and piRBase (
					<ext-link xlink:href="http://www.regulatoryrna.org/database/piRNA/" ext-link-type="uri">http://www.regulatoryrna.org/database/piRNA/</ext-link>) for the analysis of piRNA function, homologous piRNAs, piRNA clusters, and anticipation of the targeted RNAs [Y.
					<xref rid="cit0203" ref-type="bibr">203</xref>].
				</p>
				<p>Considered as the first piRNA database and a web resource about the grouped and classified piRNAs, the piRNA Bank was established by Lakshmi et al. group [
					<xref rid="cit0204" ref-type="bibr">204</xref>]. The database presents extensive information about 20 million identified sequences and other relevant data on reported piRNAs in human, mouse, rat, and Drosophila [
					<xref rid="cit0041" ref-type="bibr">41</xref>]. This above-mentioned database supports extensive search features of the organism and chromosome such as sequence homology-based search, accession numbers, name or symbol of the gene, localization on chromosomes, clusters, and corresponding repeat elements and genes. It also represents each piRNA or piRNA cluster as a graphical map of genomes (
					<ext-link xlink:href="http://pirnabank.ibab.ac.in/" ext-link-type="uri">http://pirnabank.ibab.ac.in/</ext-link>) [Y.-N.
					<xref rid="cit0205" ref-type="bibr">205</xref>]. However, it should be noted that the above-mentioned database contains only restricted amounts of piRNAs obtained from some species, and the data on the piRNA functions are rarely documented [
					<xref rid="cit0206" ref-type="bibr">206</xref>].
				</p>
				<p>piRBase is a recently produced and special piRNA database included in RNAcentral, [K. P.
					<xref rid="cit0207" ref-type="bibr">207</xref>] and is the primary database with a systematic integration of different piRNA-related data to sustain functional analysis of piRNA. In the latest release of piRBase, the unique piRNA sequences exceeded 173 million, which include 21 species*** [
					<xref rid="cit0208" ref-type="bibr">208</xref>]. Also, the intended mRNA records of piRNA were extended and the piRNA target lncRNAs were included*** [
					<xref rid="cit0209" ref-type="bibr">209</xref>]. The data concerning eight piRNAs associated cancer types such as breast, pancreas, colorectal, gastric, bladder, myeloma, kidney, and liver cancer were also appended to the recent version. It should be noted that the released piRBase v2.0 (
					<ext-link xlink:href="http://www.regulatoryrna.org/database/piRNA/" ext-link-type="uri">http://www.regulatoryrna.org/database/piRNA/</ext-link>) introduces new web tools and enhances user interface [
					<xref rid="cit0206" ref-type="bibr">206</xref>].
				</p>
				<p>More recently, Junyi Xin et al. constructed a user-friendly database, piRNA &#x2013; expression quantitative trait locus (eQTL) (
					<ext-link xlink:href="http://njmu-edu.cn:3838/piRNAeQTL/" ext-link-type="uri">http://njmu-edu.cn:3838/piRNAeQTL/</ext-link>, which is also available at
					<ext-link xlink:href="http://222.190.246" ext-link-type="uri">http://222.190.246</ext-link>. 206:3838/piRNA-eQTL/), using R package
					<italic toggle="yes">Shiny</italic>. As the first online database that provides
					<italic toggle="yes">cis</italic>-piRNA eQTL results via mixing genotype and piRNA expression data across 33 cancer types, it can act as a central source to find the roles of piRNAs and genetic variants in human cancer development [
					<xref rid="cit0210" ref-type="bibr">210</xref>].
				</p>
			</sec>
			<sec disp-level="1" id="s0006">
				<label>6.</label>
				<title>Conclusion and future extension</title>
				<p>piRNAs have currently been revealed to display abnormal expression in a cancer-specific manner in diverse types of cancers. PIWI proteins and piRNAs could be valid prognostic or diagnostic biomarkers in targeted therapies. As a biomarker candidate, piRNA needs to be validated by multiple centers in multiple independent, preferably prospective cohorts with large sample size, and demonstrate benefit over any existing markers. In the future, more studies and clinical trials are required to thoroughly comprehend the underlying biological mechanisms of piRNAs and their interruption. Given the continuous attempts of scientists as well as the advent of modern technologies, effective perspectives research should evaluate the association of piRNAs and cancers, which leads to an elevated piRNAs knowledge to hopefully improve cancer prevention or treatment possibilities for patients.</p>
				<p>In spite of the importance of revealing their precise roles in cancer, there are indeed a number of unanswered questions, like whether the piRNAs&#x2019; abnormal expression explains these types of cancers, or it is a byproduct of other molecular activities. Is there a suitable threshold to differentiate healthy people from patients with specific cancer? Another question is whether metastasis, apoptosis, invasion, and proliferation of cancer cells are independently affected by piRNAs and PIWI proteins, or whether PIWI proteins and piRNAs together impact cancer cells. Likewise, as the abnormal expression of piRNA pathway could provoke stemness, analyzing the association of piRNAs and PIWI proteins with cancer stem cells is likely to establish a new course in future research about the origin of cancer. These ideas mount challenges that should be addressed before using piRNA-based treatments.</p>
				<p>Furthermore, since piRNAs involved in cancers were clarified vastly in recent years, an unbelievable amount of data will be produced in the near future. Therefore, piRNA&#x2013;cancer relationship is able to provide promising insights into piRNAs functional relationship in wide range of cancers. Novel and unique database resource will lead toward further research ideas in the field of cancer. Moreover, it is beneficial to utilize synthetic piRNAs with better specificity of targets via some piRNA target web-based prediction database resource or software based on some innovative algorithms to provide detailed information about piRNAs&#x2019; role in various cancers.</p>
			</sec>
		</body>
		<back>
			<sec disp-level="1" id="s0007">
				<title>Abbreviations</title>
				<p>piRNAs: PIWI-interacting RNAs; PIWI: P-element Induced Wimpy testis; lncRNAs: long non-coding RNAs; ncRNAs: non-coding RNAs; circRNAs: circular RNAs; miRNAs: microRNAs; mRNAs: messenger RNAs; tRNAs: transfer RNAs; siRNAs: small interfering RNAs; rRNAs: ribosomal RNAs; scRNAs: small cytoplasmic RNAs; snRNAs: small nuclear RNAs; snoRNAs: small nucleolar RNAs; AGO: Argonaute; rasiRNAs: repeat-associated small interfering RNAs; UTRs: UnTranslated Regions; GSC: Germ-line Stem-Cells; PIWIL1: PIWI-Like protein 1; PIWIL2: PIWI-Like protein 2; PIWIL3: PIWI-Like protein 3; PIWIL4: PIWI-Like protein 4; HIWI: Human PIWI homolog; HILI: Hiwi-Like; PAZ: PIWI-Argonaute-Zwille; MID: Middle Domain; TEs: Transposable Elements; Zuc: Zucchini; AUB: Aubergine; MIWI: Mouse PIWI homolog; MILI: MIwi-Like; iRNAs/piRNA-L: interfering RNAs/piRNA-Like; eIF4: eukaryotic Initiation Factor 4; TGF-&#x3B2;: Transforming Growth Factor-&#x3B2;; HSP90: Heat Shock Protein90; Smad4: Mothers against decapentaplegic homolog; T&#x3B2;R: TGF-&#x3B2; Receptor; FGF8: Fibroblast Growth Factor 8; STAT3: Signal Transducer and Activator; ND4L: NADH-ubiquinone oxidoreductase chain 4L; COX2: CycloOXygenase 2; ND5: NADH-ubiquinone oxidoreductase chain 5; mt-piRNAs: mitochondrial piRNAs; IL-4: Interleukin-4; Th2: T helper 2; PI3K: Phosphatidyl-Inositol 3-Kinase; mTOR: mammalian Target Of Rapamycin; PTEN: Phosphatase and TENsin homolog; MEK: Mitogen-activated protein kinase; ERK: Extracellular signal-Regulated Kinase; RNAi: RNA interference; cfRNAs: circulating free RNAs; eQTL: expression Quantitative Trait Locu</p>
			</sec>
			<sec sec-type="COI-statement" disp-level="1" id="s0008">
				<title>Disclosure statement</title>
				<p>No potential conflict of interest was reported by the authors.</p>
			</sec>
			<sec disp-level="1" id="s0009">
				<title>Highlights</title>
				<p>
					<list list-type="bullet">
						<list-item>
							<p>As early products of different regulatory and signaling pathways, piRNAs might be very important for early detection and treatment of cancers.</p>
						</list-item>
						<list-item>
							<p>Alterations in circulating piRNA expression levels might be good cancer biomarkers, with higher specificity and sensitivity compared to circulating miRNAs and lncRNA-based biomarkers.</p>
						</list-item>
						<list-item>
							<p>All of the four human PIWI proteins have been recognized as novel molecular agents involved in carcinogenesis.</p>
						</list-item>
					</list>
				</p>
			</sec>
			<sec sec-type="data-availability" disp-level="1" id="s0010">
				<title>Data availability</title>
				<p>Data sharing is not applicable to this article as no new data are created or analyzed in this study.</p>
			</sec>
			<sec disp-level="1" id="s0011">
				<title>Authors&#x2019; contributions</title>
				<p>All authors read and approved the final manuscript.</p>
			</sec>
			<ref-list>
				<title>References</title>
				<ref id="cit0001">
					<label>[1]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Amaral</surname>
								<given-names>PP</given-names>
							</string-name>,
							<string-name>
								<surname>Dinger</surname>
								<given-names>ME</given-names>
							</string-name>,
							<string-name>
								<surname>Mercer</surname>
								<given-names>TR</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>The eukaryotic genome as an RNA machine</article-title>.
						<source>science</source>.
						<year>2008</year>;
						<volume>319</volume>(
						<issue>5871</issue>):
						<fpage>1787</fpage>&#x2013;
						<lpage>1789</lpage>.
						<pub-id pub-id-type="pmid">18369136</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0002">
					<label>[2]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Cui</surname>
								<given-names>D-Y</given-names>
							</string-name>,
							<string-name>
								<surname>Wang</surname>
								<given-names>-J-J</given-names>
							</string-name>,
							<string-name>
								<surname>He</surname>
								<given-names>S-M.</given-names>
							</string-name>
						</person-group>
						<article-title>The research advance of the piRNA function</article-title>.
						<source>Sheng li ke xue jin zhan [Progress in physiology]</source>.
						<year>2016</year>;
						<volume>47</volume>(
						<issue>3</issue>):
						<fpage>182</fpage>&#x2013;
						<lpage>186</lpage>.
					</mixed-citation>
				</ref>
				<ref id="cit0003">
					<label>[3]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Zhu</surname>
								<given-names>X</given-names>
							</string-name>,
							<string-name>
								<surname>Jiang</surname>
								<given-names>S</given-names>
							</string-name>,
							<string-name>
								<surname>Wu</surname>
								<given-names>Z</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis</article-title>.
						<source>Bioengineered</source>.
						<year>2021</year>;
						<volume>12</volume>(
						<issue>1</issue>):
						<fpage>578</fpage>&#x2013;
						<lpage>588</lpage>.
						<pub-id pub-id-type="pmid">33517826</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0004">
					<label>[4]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Iyer</surname>
								<given-names>MK</given-names>
							</string-name>,
							<string-name>
								<surname>Niknafs</surname>
								<given-names>YS</given-names>
							</string-name>,
							<string-name>
								<surname>Malik</surname>
								<given-names>R</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>The landscape of long noncoding RNAs in the human transcriptome</article-title>.
						<source>Nat Genet</source>.
						<year>2015</year>;
						<volume>47</volume>(
						<issue>3</issue>):
						<fpage>199</fpage>&#x2013;
						<lpage>208</lpage>.
						<pub-id pub-id-type="pmid">25599403</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0005">
					<label>[5]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Lewis</surname>
								<given-names>BP</given-names>
							</string-name>,
							<string-name>
								<surname>Burge</surname>
								<given-names>CB</given-names>
							</string-name>,
							<string-name>
								<surname>Bartel</surname>
								<given-names>DP.</given-names>
							</string-name>
						</person-group>
						<article-title>Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets</article-title>.
						<source>cell</source>.
						<year>2005</year>;
						<volume>120</volume>(
						<issue>1</issue>):
						<fpage>15</fpage>&#x2013;
						<lpage>20</lpage>.
						<pub-id pub-id-type="pmid">15652477</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0006">
					<label>[6]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Shi</surname>
								<given-names>Z</given-names>
							</string-name>,
							<string-name>
								<surname>Shen</surname>
								<given-names>C</given-names>
							</string-name>,
							<string-name>
								<surname>Yu</surname>
								<given-names>C</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Long non-coding RNA LINC00997 silencing inhibits the progression and metastasis of colorectal cancer by sponging miR-512-3p</article-title>.
						<source>Bioengineered</source>.
						<year>2021</year>;
						<volume>12</volume>(
						<issue>1</issue>):
						<fpage>627</fpage>&#x2013;
						<lpage>639</lpage>.
						<pub-id pub-id-type="pmid">33570445</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0007">
					<label>[7]</label>
					<mixed-citation publication-type="book">
						<person-group person-group-type="author">
							<string-name>
								<surname>Meseure</surname>
								<given-names>D</given-names>
							</string-name>,
							<string-name>
								<surname>Alsibai</surname>
								<given-names>KD</given-names>
							</string-name>
						</person-group>.
						<part-title>Part 1: The PIWI-piRNA pathway is an immune-like surveillance process that controls genome integrity by silencing transposable elements</part-title>. In: Colin Logie and Tobias Aurelius Knoch (eds)
						<source>Chromatin and Epigenetics</source>.
						<publisher-name>IntechOpen</publisher-name>;
						<year>2018:233-251</year>. London, UK: &#xA0;IntechOpen.
					</mixed-citation>
				</ref>
				<ref id="cit0008">
					<label>[8]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Knauss</surname>
								<given-names>JL</given-names>
							</string-name>,
							<string-name>
								<surname>Sun</surname>
								<given-names>T</given-names>
							</string-name>
						</person-group>.
						<article-title>Regulatory mechanisms of long noncoding RNAs in vertebrate central nervous system development and function</article-title>.
						<source>Neuroscience</source>.
						<year>2013</year>;
						<volume>235</volume>:
						<fpage>200</fpage>&#x2013;
						<lpage>214</lpage>.
						<pub-id pub-id-type="pmid">23337534</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0009">
					<label>[9]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Zhang</surname>
								<given-names>Y-P</given-names>
							</string-name>,
							<string-name>
								<surname>Cheng</surname>
								<given-names>Y-B</given-names>
							</string-name>,
							<string-name>
								<surname>Li</surname>
								<given-names>S</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>An epithelial-mesenchymal transition-related long non-coding RNA signature to predict overall survival and immune microenvironment in kidney renal clear cell carcinoma</article-title>.
						<source>Bioengineered</source>.
						<year>2021</year>;
						<volume>12</volume>(
						<issue>1</issue>):
						<fpage>555</fpage>&#x2013;
						<lpage>564</lpage>.
						<pub-id pub-id-type="pmid">33517850</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0010">
					<label>[10]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Zhao</surname>
								<given-names>C</given-names>
							</string-name>,
							<string-name>
								<surname>Tolkach</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Schmidt</surname>
								<given-names>D</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Mitochondrial PIWI-interacting RNAs are novel biomarkers for clear cell renal cell carcinoma</article-title>.
						<source>World J Urol</source>.
						<year>2019</year>;
						<volume>37</volume>(
						<issue>8</issue>):
						<fpage>1639</fpage>&#x2013;
						<lpage>1647</lpage>.
						<pub-id pub-id-type="pmid">30488095</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0011">
					<label>[11]</label>
					<mixed-citation publication-type="report">
						<person-group person-group-type="author">
							<string-name>
								<surname>Farazi</surname>
								<given-names>TA</given-names>
							</string-name>,
							<string-name>
								<surname>Juranek</surname>
								<given-names>SA</given-names>
							</string-name>,
							<string-name>
								<surname>Tuschl</surname>
								<given-names>T</given-names>
							</string-name>
						</person-group> (
						<year>2008a</year>).
						<article-title>The growing catalog of small RNAs and their association with distinct Argonaute/Piwi family members</article-title>.
					</mixed-citation>
				</ref>
				<ref id="cit0012">
					<label>[12]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Hamilton</surname>
								<given-names>AJ</given-names>
							</string-name>,
							<string-name>
								<surname>Baulcombe</surname>
								<given-names>Dc</given-names>
							</string-name>
						</person-group>.
						<article-title>A species of small antisense RNA in posttranscriptional gene silencing in plants</article-title>.
						<source>science</source>.
						<year>1999</year>;
						<volume>286</volume>(
						<issue>5441</issue>):
						<fpage>950</fpage>&#x2013;
						<lpage>952</lpage>.
						<pub-id pub-id-type="pmid">10542148</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0013">
					<label>[13]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Leung</surname>
								<given-names>YY</given-names>
							</string-name>,
							<string-name>
								<surname>Kuksa</surname>
								<given-names>PP</given-names>
							</string-name>,
							<string-name>
								<surname>Amlie-Wolf</surname>
								<given-names>A</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>DASHR: database of small human noncoding RNAs</article-title>.
						<source>Nucleic Acids Res</source>.
						<year>2016</year>;
						<volume>
							<italic toggle="yes">44</italic>(D1)
						</volume>(
						<issue>D1</issue>):
						<fpage>D216</fpage>&#x2013;
						<lpage>D222</lpage>.
						<pub-id pub-id-type="pmid">26553799</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0014">
					<label>[14]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Chalbatani</surname>
								<given-names>GM</given-names>
							</string-name>,
							<string-name>
								<surname>Dana</surname>
								<given-names>H</given-names>
							</string-name>,
							<string-name>
								<surname>Memari</surname>
								<given-names>F</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Biological function and molecular mechanism of piRNA in cancer</article-title>.
						<source>Pract Lab Med</source>.
						<year>2019</year>;
						<volume>13</volume>:
						<fpage>e00113</fpage>.
						<pub-id pub-id-type="pmid">30705933</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0015">
					<label>[15]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Iwasaki</surname>
								<given-names>YW</given-names>
							</string-name>,
							<string-name>
								<surname>Siomi</surname>
								<given-names>MC</given-names>
							</string-name>,
							<string-name>
								<surname>Siomi</surname>
								<given-names>H</given-names>
							</string-name>
						</person-group>.
						<article-title>PIWI-interacting RNA: its biogenesis and functions</article-title>.
						<source>Annu Rev Biochem</source>.
						<year>2015</year>;
						<volume>84</volume>(
						<issue>1</issue>):
						<page-range>405&#x2013;433</page-range>.
					</mixed-citation>
				</ref>
				<ref id="cit0016">
					<label>[16]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Kang</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Huang</surname>
								<given-names>X</given-names>
							</string-name>,
							<string-name>
								<surname>Dong</surname>
								<given-names>W</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>MicroRNA-1269b inhibits gastric cancer development through regulating methyltransferase-like 3 (METTL3)</article-title>.
						<source>Bioengineered</source>.
						<year>2021</year>;
						<volume>12</volume>(
						<issue>1</issue>):
						<fpage>1150</fpage>&#x2013;
						<lpage>1160</lpage>.
						<pub-id pub-id-type="pmid">33818282</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0017">
					<label>[17]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Ng</surname>
								<given-names>KW</given-names>
							</string-name>,
							<string-name>
								<surname>Anderson</surname>
								<given-names>C</given-names>
							</string-name>,
							<string-name>
								<surname>Marshall</surname>
								<given-names>EA</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Piwi-interacting RNAs in cancer: emerging functions and clinical utility</article-title>.
						<source>Mol Cancer</source>.
						<year>2016</year>;
						<volume>15</volume>(
						<issue>1</issue>):
						<fpage>1</fpage>&#x2013;
						<lpage>13</lpage>.
						<pub-id pub-id-type="pmid">26728659</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0018">
					<label>[18]</label>
					<mixed-citation publication-type="report">
						<person-group person-group-type="author">
							<string-name>
								<surname>Nozawa</surname>
								<given-names>M</given-names>
							</string-name>,
							<string-name>
								<surname>Kinjo</surname>
								<given-names>S</given-names>
							</string-name>
						</person-group> (
						<year>2016</year>).
						<article-title>Noncoding RNAs, origin and evolution of</article-title>.
					</mixed-citation>
				</ref>
				<ref id="cit0019">
					<label>[19]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Peng</surname>
								<given-names>JC</given-names>
							</string-name>,
							<string-name>
								<surname>Lin</surname>
								<given-names>H</given-names>
							</string-name>
						</person-group>.
						<article-title>Beyond transposons: the epigenetic and somatic functions of the Piwi-piRNA mechanism</article-title>.
						<source>Curr Opin Cell Biol</source>.
						<year>2013</year>;
						<volume>25</volume>(
						<issue>2</issue>):
						<fpage>190</fpage>&#x2013;
						<lpage>194</lpage>.
						<pub-id pub-id-type="pmid">23465540</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0020">
					<label>[20]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Rayford</surname>
								<given-names>KJ</given-names>
							</string-name>,
							<string-name>
								<surname>Cooley</surname>
								<given-names>A</given-names>
							</string-name>,
							<string-name>
								<surname>Rumph</surname>
								<given-names>JT</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>piRNAs as modulators of disease pathogenesis</article-title>.
						<source>Int J Mol Sci</source>.
						<year>2021</year>;
						<volume>22</volume>(
						<issue>5</issue>):
						<fpage>2373</fpage>.
						<pub-id pub-id-type="pmid">33673453</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0021">
					<label>[21]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Wang</surname>
								<given-names>L</given-names>
							</string-name>,
							<string-name>
								<surname>Ge</surname>
								<given-names>S</given-names>
							</string-name>,
							<string-name>
								<surname>Zhou</surname>
								<given-names>F</given-names>
							</string-name>
						</person-group>.
						<article-title>MicroRNA-487a-3p inhibits the growth and invasiveness of oral squamous cell carcinoma by targeting PPM1A</article-title>.
						<source>Bioengineered</source>.
						<year>2021</year>;
						<volume>12</volume>(
						<issue>1</issue>):
						<fpage>937</fpage>&#x2013;
						<lpage>947</lpage>.
						<pub-id pub-id-type="pmid">33724144</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0022">
					<label>[22]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Xu</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Yang</surname>
								<given-names>X</given-names>
							</string-name>,
							<string-name>
								<surname>Zhou</surname>
								<given-names>Q</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Biological significance of piRNA in liver cancer: a review</article-title>.
						<source>Biomarkers</source>.
						<year>2020</year>;
						<volume>25</volume>(
						<issue>6</issue>):
						<fpage>436</fpage>&#x2013;
						<lpage>440</lpage>.
						<pub-id pub-id-type="pmid">32662667</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0023">
					<label>[23]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>H&#xF6;ck</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Weinmann</surname>
								<given-names>L</given-names>
							</string-name>,
							<string-name>
								<surname>Ender</surname>
								<given-names>C</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Proteomic and functional analysis of Argonaute&#x2010;containing mRNA&#x2013;protein complexes in human cells</article-title>.
						<source>EMBO Rep</source>.
						<year>2007</year>;
						<volume>8</volume>(
						<issue>11</issue>):
						<fpage>1052</fpage>&#x2013;
						<lpage>1060</lpage>.
						<pub-id pub-id-type="pmid">17932509</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0024">
					<label>[24]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Fitzmaurice</surname>
								<given-names>C</given-names>
							</string-name>,
							<string-name>
								<surname>Dicker</surname>
								<given-names>D</given-names>
							</string-name>,
							<string-name>
								<surname>Pain</surname>
								<given-names>A</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>The global burden of cancer 2013</article-title>.
						<source>JAMA Oncol</source>.
						<year>2015</year>;
						<volume>1</volume>(
						<issue>4</issue>):
						<fpage>505</fpage>&#x2013;
						<lpage>527</lpage>.
						<pub-id pub-id-type="pmid">26181261</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0025">
					<label>[25]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Ashktorab</surname>
								<given-names>H</given-names>
							</string-name>,
							<string-name>
								<surname>Brim</surname>
								<given-names>H</given-names>
							</string-name>
						</person-group>.
						<article-title>Blood-based liquid biopsies: a noninvasive and cost-effective tool for improved risk assessment and identification of lymph node metastasis in patients with submucosal T1 colorectal cancer</article-title>.
						<source>Gastroenterology</source>.
						<year>2021</year>;
						<volume>161</volume>(
						<issue>1</issue>):
						<fpage>29</fpage>&#x2013;
						<lpage>31</lpage>.
						<pub-id pub-id-type="pmid">33895167</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0026">
					<label>[26]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Aziz</surname>
								<given-names>N</given-names>
							</string-name>,
							<string-name>
								<surname>Hong</surname>
								<given-names>YH</given-names>
							</string-name>,
							<string-name>
								<surname>Jo</surname>
								<given-names>M</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Molecular signatures of JMJD10/MINA53 in gastric cancer</article-title>.
						<source>Cancers (Basel)</source>.
						<year>2020</year>;
						<volume>12</volume>(
						<issue>5</issue>):
						<fpage>5</fpage>.
					</mixed-citation>
				</ref>
				<ref id="cit0027">
					<label>[27]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Brim</surname>
								<given-names>H</given-names>
							</string-name>,
							<string-name>
								<surname>Ashktorab</surname>
								<given-names>H</given-names>
							</string-name>
						</person-group>.
						<article-title>Integrating microbiomics in cancer management</article-title>.
						<source>Nat Rev Cancer</source>.
						<year>2021</year>;
						<volume>21</volume>(
						<issue>11</issue>):
						<page-range>684&#x2013;685</page-range>.
					</mixed-citation>
				</ref>
				<ref id="cit0028">
					<label>[28]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Deng</surname>
								<given-names>S</given-names>
							</string-name>,
							<string-name>
								<surname>Zhang</surname>
								<given-names>X</given-names>
							</string-name>,
							<string-name>
								<surname>Qin</surname>
								<given-names>Y</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>miRNA&#x2010;192 and&#x2010;215 activate Wnt/&#x3B2;&#x2010;catenin signaling pathway in gastric cancer via APC</article-title>.
						<source>J Cell Physiol</source>.
						<year>2020</year>;
						<volume>235</volume>(
						<issue>9</issue>):
						<fpage>6218</fpage>&#x2013;
						<lpage>6229</lpage>.
						<pub-id pub-id-type="pmid">32091625</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0029">
					<label>[29]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Erfani</surname>
								<given-names>M</given-names>
							</string-name>,
							<string-name>
								<surname>Hosseini</surname>
								<given-names>SV</given-names>
							</string-name>,
							<string-name>
								<surname>Mokhtari</surname>
								<given-names>M</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Altered ARID1A expression in colorectal cancer</article-title>.
						<source>BMC Cancer</source>.
						<year>2020</year>;
						<volume>20</volume>(
						<issue>1</issue>):
						<fpage>1</fpage>&#x2013;
						<lpage>13</lpage>.
					</mixed-citation>
				</ref>
				<ref id="cit0030">
					<label>[30]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Igder</surname>
								<given-names>S</given-names>
							</string-name>,
							<string-name>
								<surname>Mohammadiasl</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Azadpour</surname>
								<given-names>S</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>KRAS mutation and abnormal expression of Cripto&#x2010;1 as two potential candidate biomarkers for detection of colorectal cancer development</article-title>.
						<source>J Cell Biochem</source>.
						<year>2020</year>;
						<volume>121</volume>(
						<issue>4</issue>):
						<fpage>2901</fpage>&#x2013;
						<lpage>2908</lpage>.
						<pub-id pub-id-type="pmid">31692030</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0031">
					<label>[31]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Zhang</surname>
								<given-names>X</given-names>
							</string-name>,
							<string-name>
								<surname>Peng</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Yuan</surname>
								<given-names>Y</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Histone methyltransferase SET8 is regulated by miR-192/215 and induces oncogene-induced senescence via p53-dependent DNA damage in human gastric carcinoma cells</article-title>.
						<source>Cell Death Dis</source>.
						<year>2020</year>;
						<volume>11</volume>(
						<issue>10</issue>):
						<fpage>937</fpage>.
						<pub-id pub-id-type="pmid">33127874</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0032">
					<label>[32]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Igder</surname>
								<given-names>S</given-names>
							</string-name>,
							<string-name>
								<surname>Mohammadiasl</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Mokarram</surname>
								<given-names>P</given-names>
							</string-name>
						</person-group>.
						<article-title>Altered miR-21, miRNA-148a expression in relation to KRAS mutation status as indicator of adenoma-carcinoma transitional pattern in colorectal adenoma and carcinoma lesions</article-title>.
						<source>Biochem Genet</source>.
						<year>2019</year>;
						<volume>57</volume>(
						<issue>6</issue>):
						<fpage>767</fpage>&#x2013;
						<lpage>780</lpage>.
						<pub-id pub-id-type="pmid">30997628</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0033">
					<label>[33]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Poursheikhani</surname>
								<given-names>A</given-names>
							</string-name>,
							<string-name>
								<surname>Bahmanpour</surname>
								<given-names>Z</given-names>
							</string-name>,
							<string-name>
								<surname>Razmara</surname>
								<given-names>E</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Non-coding RNAs underlying chemoresistance in gastric cancer</article-title>.
						<source>Cell Oncol</source>.
						<year>2020</year>;
						<volume>43</volume>:
						<fpage>961</fpage>&#x2013;
						<lpage>988</lpage>.
					</mixed-citation>
				</ref>
				<ref id="cit0034">
					<label>[34]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Aravin</surname>
								<given-names>AA</given-names>
							</string-name>,
							<string-name>
								<surname>Lagos-Quintana</surname>
								<given-names>M</given-names>
							</string-name>,
							<string-name>
								<surname>Yalcin</surname>
								<given-names>A</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>The small RNA profile during Drosophila melanogaster development</article-title>.
						<source>Dev Cell</source>.
						<year>2003</year>;
						<volume>5</volume>(
						<issue>2</issue>):
						<fpage>337</fpage>&#x2013;
						<lpage>350</lpage>.
						<pub-id pub-id-type="pmid">12919683</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0035">
					<label>[35]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Aravin</surname>
								<given-names>AA</given-names>
							</string-name>,
							<string-name>
								<surname>Naumova</surname>
								<given-names>NM</given-names>
							</string-name>,
							<string-name>
								<surname>Tulin</surname>
								<given-names>AV</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Double-stranded RNA-mediated silencing of genomic tandem repeats and transposable elements in the D. melanogaster germline</article-title>.
						<source>Curr Biol</source>.
						<year>2001</year>;
						<volume>11</volume>(
						<issue>13</issue>):
						<fpage>1017</fpage>&#x2013;
						<lpage>1027</lpage>.
						<pub-id pub-id-type="pmid">11470406</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0036">
					<label>[36]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Vagin</surname>
								<given-names>VV</given-names>
							</string-name>,
							<string-name>
								<surname>Sigova</surname>
								<given-names>A</given-names>
							</string-name>,
							<string-name>
								<surname>Li</surname>
								<given-names>C</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>A distinct small RNA pathway silences selfish genetic elements in the germline</article-title>.
						<source>science</source>.
						<year>2006</year>;
						<volume>313</volume>(
						<issue>5785</issue>):
						<fpage>320</fpage>&#x2013;
						<lpage>324</lpage>.
						<pub-id pub-id-type="pmid">16809489</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0037">
					<label>[37]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Aravin</surname>
								<given-names>A</given-names>
							</string-name>,
							<string-name>
								<surname>Gaidatzis</surname>
								<given-names>D</given-names>
							</string-name>,
							<string-name>
								<surname>Pfeffer</surname>
								<given-names>S</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>A novel class of small RNAs bind to MILI protein in mouse testes</article-title>.
						<source>Nature</source>.
						<year>2006</year>;
						<volume>442</volume>(
						<issue>7099</issue>):
						<fpage>203</fpage>&#x2013;
						<lpage>207</lpage>.
						<pub-id pub-id-type="pmid">16751777</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0038">
					<label>[38]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Kim</surname>
								<given-names>VN</given-names>
							</string-name>
						</person-group>.
						<article-title>Small RNAs just got bigger: Piwi-interacting RNAs (piRNAs) in mammalian testes</article-title>.
						<source>Genes Dev</source>.
						<year>2006</year>;
						<volume>20</volume>(
						<issue>15</issue>):
						<fpage>1993</fpage>&#x2013;
						<lpage>1997</lpage>.
						<pub-id pub-id-type="pmid">16882976</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0039">
					<label>[39]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Williams</surname>
								<given-names>Z</given-names>
							</string-name>,
							<string-name>
								<surname>Morozov</surname>
								<given-names>P</given-names>
							</string-name>,
							<string-name>
								<surname>Mihailovic</surname>
								<given-names>A</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Discovery and characterization of piRNAs in the human fetal ovary</article-title>.
						<source>Cell Rep</source>.
						<year>2015</year>;
						<volume>13</volume>(
						<issue>4</issue>):
						<fpage>854</fpage>&#x2013;
						<lpage>863</lpage>.
						<pub-id pub-id-type="pmid">26489470</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0040">
					<label>[40]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Farazi</surname>
								<given-names>TA</given-names>
							</string-name>,
							<string-name>
								<surname>Juranek</surname>
								<given-names>SA</given-names>
							</string-name>,
							<string-name>
								<surname>Tuschl</surname>
								<given-names>T</given-names>
							</string-name>
						</person-group>.
						<article-title>The growing catalog of small RNAs and their association with distinct Argonaute/Piwi family members</article-title>.
						<source>Development</source>.
						<year>2008b</year>;
						<volume>135</volume>(
						<issue>7</issue>):
						<fpage>1201</fpage>&#x2013;
						<lpage>1214</lpage>.
						<pub-id pub-id-type="pmid">18287206</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0041">
					<label>[41]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Weng</surname>
								<given-names>W</given-names>
							</string-name>,
							<string-name>
								<surname>Li</surname>
								<given-names>H</given-names>
							</string-name>,
							<string-name>
								<surname>Goel</surname>
								<given-names>A</given-names>
							</string-name>
						</person-group>.
						<article-title>Piwi-interacting RNAs (piRNAs) and cancer: emerging biological concepts and potential clinical implications</article-title>.
						<source>Biochim Biophys Acta (BBA)- Rev Cancer</source>.
						<year>2019</year>;
						<volume>1871</volume>(
						<issue>1</issue>):
						<fpage>160</fpage>&#x2013;
						<lpage>169</lpage>.
					</mixed-citation>
				</ref>
				<ref id="cit0042">
					<label>[42]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Kirino</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Mourelatos</surname>
								<given-names>Z</given-names>
							</string-name>
						</person-group>.
						<article-title>Mouse Piwi-interacting RNAs are 2&#x2032;-O-methylated at their 3&#x2032; termini</article-title>.
						<source>Nat Struct Mol Biol</source>.
						<year>2007</year>;
						<volume>14</volume>(
						<issue>4</issue>):
						<fpage>347</fpage>&#x2013;
						<lpage>348</lpage>.
						<pub-id pub-id-type="pmid">17384647</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0043">
					<label>[43]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Saito</surname>
								<given-names>K</given-names>
							</string-name>,
							<string-name>
								<surname>Sakaguchi</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Suzuki</surname>
								<given-names>T</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Pimet, the Drosophila homolog of HEN1, mediates 2&#x2032;-O-methylation of Piwi-interacting RNAs at their 3&#x2032; ends</article-title>.
						<source>Genes Dev</source>.
						<year>2007</year>;
						<volume>21</volume>(
						<issue>13</issue>):
						<fpage>1603</fpage>&#x2013;
						<lpage>1608</lpage>.
						<pub-id pub-id-type="pmid">17606638</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0044">
					<label>[44]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Luteijn</surname>
								<given-names>MJ</given-names>
							</string-name>,
							<string-name>
								<surname>Ketting</surname>
								<given-names>RF</given-names>
							</string-name>
						</person-group>.
						<article-title>PIWI-interacting RNAs: from generation to transgenerational epigenetics</article-title>.
						<source>Nat Rev Genet</source>.
						<year>2013</year>;
						<volume>14</volume>(
						<issue>8</issue>):
						<fpage>523</fpage>&#x2013;
						<lpage>534</lpage>.
						<pub-id pub-id-type="pmid">23797853</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0045">
					<label>[45]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Suzuki</surname>
								<given-names>R</given-names>
							</string-name>,
							<string-name>
								<surname>Honda</surname>
								<given-names>S</given-names>
							</string-name>,
							<string-name>
								<surname>Kirino</surname>
								<given-names>Y</given-names>
							</string-name>
						</person-group>.
						<article-title>PIWI expression and function in cancer</article-title>.
						<source>Front Genet</source>.
						<year>2012</year>;
						<volume>3</volume>:
						<fpage>204</fpage>.
						<pub-id pub-id-type="pmid">23087701</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0046">
					<label>[46]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Yamanaka</surname>
								<given-names>S</given-names>
							</string-name>,
							<string-name>
								<surname>Siomi</surname>
								<given-names>MC</given-names>
							</string-name>,
							<string-name>
								<surname>Siomi</surname>
								<given-names>H</given-names>
							</string-name>
						</person-group>.
						<article-title>piRNA clusters and open chromatin structure</article-title>.
						<source>Mob DNA</source>.
						<year>2014</year>;
						<volume>5</volume>(
						<issue>1</issue>):
						<fpage>1</fpage>&#x2013;
						<lpage>12</lpage>.
						<pub-id pub-id-type="pmid">24382139</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0047">
					<label>[47]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Thomson</surname>
								<given-names>T</given-names>
							</string-name>,
							<string-name>
								<surname>Lin</surname>
								<given-names>H</given-names>
							</string-name>
						</person-group>.
						<article-title>The biogenesis and function of PIWI proteins and piRNAs: progress and prospect</article-title>.
						<source>Annual Review of Cell and Developmental</source>.
						<year>2009</year>;
						<volume>25</volume>(
						<issue>1</issue>):
						<fpage>355</fpage>&#x2013;
						<lpage>376</lpage>.
					</mixed-citation>
				</ref>
				<ref id="cit0048">
					<label>[48]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Weick</surname>
								<given-names>E-M</given-names>
							</string-name>,
							<string-name>
								<surname>Miska</surname>
								<given-names>EA</given-names>
							</string-name>
						</person-group>.
						<article-title>piRNAs: from biogenesis to function</article-title>.
						<source>Development</source>.
						<year>2014</year>;
						<volume>141</volume>(
						<issue>18</issue>):
						<fpage>3458</fpage>&#x2013;
						<lpage>3471</lpage>.
						<pub-id pub-id-type="pmid">25183868</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0049">
					<label>[49]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Keam</surname>
								<given-names>SP</given-names>
							</string-name>,
							<string-name>
								<surname>Young</surname>
								<given-names>PE</given-names>
							</string-name>,
							<string-name>
								<surname>McCorkindale</surname>
								<given-names>AL</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>The human Piwi protein Hiwi2 associates with tRNA-derived piRNAs in somatic cells</article-title>.
						<source>Nucleic Acids Res</source>.
						<year>2014</year>;
						<volume>42</volume>(
						<issue>14</issue>):
						<fpage>8984</fpage>&#x2013;
						<lpage>8995</lpage>.
						<pub-id pub-id-type="pmid">25038252</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0050">
					<label>[50]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Krishnan</surname>
								<given-names>P</given-names>
							</string-name>,
							<string-name>
								<surname>Ghosh</surname>
								<given-names>S</given-names>
							</string-name>,
							<string-name>
								<surname>Wang</surname>
								<given-names>B</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Genome-wide profiling of transfer RNAs and their role as novel prognostic markers for breast cancer</article-title>.
						<source>Sci Rep</source>.
						<year>2016</year>;
						<volume>6</volume>(
						<issue>1</issue>):
						<fpage>32843</fpage>.
						<pub-id pub-id-type="pmid">27604545</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0051">
					<label>[51]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Zhong</surname>
								<given-names>F</given-names>
							</string-name>,
							<string-name>
								<surname>Zhou</surname>
								<given-names>N</given-names>
							</string-name>,
							<string-name>
								<surname>Wu</surname>
								<given-names>K</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>A SnoRNA-derived piRNA interacts with human interleukin-4 pre-mRNA and induces its decay in nuclear exosomes</article-title>.
						<source>Nucleic Acids Res</source>.
						<year>2015</year>;
						<volume>43</volume>(
						<issue>21</issue>):
						<fpage>10474</fpage>&#x2013;
						<lpage>10491</lpage>.
						<pub-id pub-id-type="pmid">26405199</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0052">
					<label>[52]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Aravin</surname>
								<given-names>AA</given-names>
							</string-name>,
							<string-name>
								<surname>Sachidanandam</surname>
								<given-names>R</given-names>
							</string-name>,
							<string-name>
								<surname>Girard</surname>
								<given-names>A</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Developmentally regulated piRNA clusters implicate MILI in transposon control</article-title>.
						<source>science</source>.
						<year>2007</year>;
						<volume>316</volume>(
						<issue>5825</issue>):
						<fpage>744</fpage>&#x2013;
						<lpage>747</lpage>.
						<pub-id pub-id-type="pmid">17446352</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0053">
					<label>[53]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Batista</surname>
								<given-names>PJ</given-names>
							</string-name>,
							<string-name>
								<surname>Ruby</surname>
								<given-names>JG</given-names>
							</string-name>,
							<string-name>
								<surname>Claycomb</surname>
								<given-names>JM</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>PRG-1 and 21U-RNAs interact to form the piRNA complex required for fertility in C. elegans</article-title>.
						<source>Mol Cell</source>.
						<year>2008</year>;
						<volume>31</volume>(
						<issue>1</issue>):
						<fpage>67</fpage>&#x2013;
						<lpage>78</lpage>.
						<pub-id pub-id-type="pmid">18571452</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0054">
					<label>[54]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Brennecke</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Aravin</surname>
								<given-names>AA</given-names>
							</string-name>,
							<string-name>
								<surname>Stark</surname>
								<given-names>A</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Discrete small RNA-generating loci as master regulators of transposon activity in Drosophila</article-title>.
						<source>cell</source>.
						<year>2007</year>;
						<volume>128</volume>(
						<issue>6</issue>):
						<fpage>1089</fpage>&#x2013;
						<lpage>1103</lpage>.
						<pub-id pub-id-type="pmid">17346786</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0055">
					<label>[55]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Cox</surname>
								<given-names>DN</given-names>
							</string-name>,
							<string-name>
								<surname>Chao</surname>
								<given-names>A</given-names>
							</string-name>,
							<string-name>
								<surname>Lin</surname>
								<given-names>H</given-names>
							</string-name>
						</person-group>.
						<article-title>Piwi encodes a nucleoplasmic factor whose activity modulates the number and division rate of germline stem cells</article-title>.
						<source>Development</source>.
						<year>2000</year>;
						<volume>127</volume>(
						<issue>3</issue>):
						<fpage>503</fpage>&#x2013;
						<lpage>514</lpage>.
						<pub-id pub-id-type="pmid">10631171</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0056">
					<label>[56]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Deng</surname>
								<given-names>W</given-names>
							</string-name>,
							<string-name>
								<surname>Lin</surname>
								<given-names>H</given-names>
							</string-name>
						</person-group>.
						<article-title>Miwi, a murine homolog of piwi, encodes a cytoplasmic protein essential for spermatogenesis</article-title>.
						<source>Dev Cell</source>.
						<year>2002</year>;
						<volume>2</volume>(
						<issue>6</issue>):
						<fpage>819</fpage>&#x2013;
						<lpage>830</lpage>.
						<pub-id pub-id-type="pmid">12062093</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0057">
					<label>[57]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Sch&#xFC;pbach</surname>
								<given-names>T</given-names>
							</string-name>,
							<string-name>
								<surname>Wieschaus</surname>
								<given-names>E</given-names>
							</string-name>
						</person-group>.
						<article-title>Female sterile mutations on the second chromosome of Drosophila melanogaster. II. Mutations blocking oogenesis or altering egg morphology</article-title>.
						<source>Genetics</source>.
						<year>1991</year>;
						<volume>129</volume>(
						<issue>4</issue>):
						<fpage>1119</fpage>&#x2013;
						<lpage>1136</lpage>.
						<pub-id pub-id-type="pmid">1783295</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0058">
					<label>[58]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Zhao</surname>
								<given-names>S</given-names>
							</string-name>,
							<string-name>
								<surname>Gou</surname>
								<given-names>L-T</given-names>
							</string-name>,
							<string-name>
								<surname>Zhang</surname>
								<given-names>M</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>piRNA-triggered MIWI ubiquitination and removal by APC/C in late spermatogenesis</article-title>.
						<source>Dev Cell</source>.
						<year>2013</year>;
						<volume>24</volume>(
						<issue>1</issue>):
						<fpage>13</fpage>&#x2013;
						<lpage>25</lpage>.
						<pub-id pub-id-type="pmid">23328397</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0059">
					<label>[59]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Malone</surname>
								<given-names>CD</given-names>
							</string-name>,
							<string-name>
								<surname>Hannon</surname>
								<given-names>GJ</given-names>
							</string-name>
						</person-group>.
						<article-title>Small RNAs as guardians of the genome</article-title>.
						<source>cell</source>.
						<year>2009</year>;
						<volume>136</volume>(
						<issue>4</issue>):
						<fpage>656</fpage>&#x2013;
						<lpage>668</lpage>.
						<pub-id pub-id-type="pmid">19239887</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0060">
					<label>[60]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Siomi</surname>
								<given-names>MC</given-names>
							</string-name>,
							<string-name>
								<surname>Sato</surname>
								<given-names>K</given-names>
							</string-name>,
							<string-name>
								<surname>Pezic</surname>
								<given-names>D</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>PIWI-interacting small RNAs: the vanguard of genome defence</article-title>.
						<source>Nat Rev Mol Cell Biol</source>.
						<year>2011</year>;
						<volume>12</volume>(
						<issue>4</issue>):
						<fpage>246</fpage>&#x2013;
						<lpage>258</lpage>.
						<pub-id pub-id-type="pmid">21427766</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0061">
					<label>[61]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Sasaki</surname>
								<given-names>T</given-names>
							</string-name>,
							<string-name>
								<surname>Shiohama</surname>
								<given-names>A</given-names>
							</string-name>,
							<string-name>
								<surname>Minoshima</surname>
								<given-names>S</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Identification of eight members of the Argonaute family in the human genome&#x2606;</article-title>.
						<source>Genomics</source>.
						<year>2003</year>;
						<volume>82</volume>(
						<issue>3</issue>):
						<fpage>323</fpage>&#x2013;
						<lpage>330</lpage>.
						<pub-id pub-id-type="pmid">12906857</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0062">
					<label>[62]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Li</surname>
								<given-names>C</given-names>
							</string-name>,
							<string-name>
								<surname>Vagin</surname>
								<given-names>VV</given-names>
							</string-name>,
							<string-name>
								<surname>Lee</surname>
								<given-names>S</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Without Argonaute3, Aubergine-bound piRNAs collapse but Piwi-bound piRNAs persist</article-title>.
						<source>cell</source>.
						<year>2009b</year>;
						<volume>137</volume>(
						<issue>3</issue>):
						<fpage>509</fpage>.
						<pub-id pub-id-type="pmid">19395009</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0063">
					<label>[63]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Ali&#xE9;</surname>
								<given-names>A</given-names>
							</string-name>,
							<string-name>
								<surname>Lecl&#xE8;re</surname>
								<given-names>L</given-names>
							</string-name>,
							<string-name>
								<surname>Jager</surname>
								<given-names>M</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Somatic stem cells express Piwi and Vasa genes in an adult ctenophore: ancient association of &#x201C;germline genes&#x201D; with stemness</article-title>.
						<source>Dev Biol</source>.
						<year>2011</year>;
						<volume>350</volume>(
						<issue>1</issue>):
						<fpage>183</fpage>&#x2013;
						<lpage>197</lpage>.
						<pub-id pub-id-type="pmid">21036163</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0064">
					<label>[64]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Rinkevich</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Rosner</surname>
								<given-names>A</given-names>
							</string-name>,
							<string-name>
								<surname>Rabinowitz</surname>
								<given-names>C</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Piwi positive cells that line the vasculature epithelium, underlie whole body regeneration in a basal chordate</article-title>.
						<source>Dev Biol</source>.
						<year>2010</year>;
						<volume>345</volume>(
						<issue>1</issue>):
						<fpage>94</fpage>&#x2013;
						<lpage>104</lpage>.
						<pub-id pub-id-type="pmid">20553710</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0065">
					<label>[65]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Rinkevich</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Voskoboynik</surname>
								<given-names>A</given-names>
							</string-name>,
							<string-name>
								<surname>Rosner</surname>
								<given-names>A</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Repeated, long-term cycling of putative stem cells between niches in a basal chordate</article-title>.
						<source>Dev Cell</source>.
						<year>2013</year>;
						<volume>24</volume>(
						<issue>1</issue>):
						<fpage>76</fpage>&#x2013;
						<lpage>88</lpage>.
						<pub-id pub-id-type="pmid">23260626</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0066">
					<label>[66]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Sharma</surname>
								<given-names>AK</given-names>
							</string-name>,
							<string-name>
								<surname>Nelson</surname>
								<given-names>MC</given-names>
							</string-name>,
							<string-name>
								<surname>Brandt</surname>
								<given-names>JE</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Human CD34+ stem cells express the hiwi gene, a human homologue of the Drosophila gene piwi</article-title>.
						<source>Blood J Am Soc Hematol</source>.
						<year>2001</year>;
						<volume>97</volume>(
						<issue>2</issue>):
						<fpage>426</fpage>&#x2013;
						<lpage>434</lpage>.
					</mixed-citation>
				</ref>
				<ref id="cit0067">
					<label>[67]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Lee</surname>
								<given-names>JH</given-names>
							</string-name>,
							<string-name>
								<surname>Sch&#xFC;tte</surname>
								<given-names>D</given-names>
							</string-name>,
							<string-name>
								<surname>Wulf</surname>
								<given-names>G</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway</article-title>.
						<source>Hum Mol Genet</source>.
						<year>2006</year>;
						<volume>15</volume>(
						<issue>2</issue>):
						<fpage>201</fpage>&#x2013;
						<lpage>211</lpage>.
						<pub-id pub-id-type="pmid">16377660</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0068">
					<label>[68]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Liu</surname>
								<given-names>X</given-names>
							</string-name>,
							<string-name>
								<surname>Sun</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Guo</surname>
								<given-names>J</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Expression of hiwi gene in human gastric cancer was associated with proliferation of cancer cells</article-title>.
						<source>Int J Cancer</source>.
						<year>2006</year>;
						<volume>118</volume>(
						<issue>8</issue>):
						<fpage>1922</fpage>&#x2013;
						<lpage>1929</lpage>.
						<pub-id pub-id-type="pmid">16287078</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0069">
					<label>[69]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Miller</surname>
								<given-names>F</given-names>
							</string-name>,
							<string-name>
								<surname>Pozniak</surname>
								<given-names>C</given-names>
							</string-name>,
							<string-name>
								<surname>Walsh</surname>
								<given-names>G</given-names>
							</string-name>
						</person-group>.
						<article-title>Neuronal life and death: an essential role for the p53 family</article-title>.
						<source>Cell Death Differ</source>.
						<year>2000</year>;
						<volume>7</volume>(
						<issue>10</issue>):
						<fpage>880</fpage>&#x2013;
						<lpage>888</lpage>.
						<pub-id pub-id-type="pmid">11279533</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0070">
					<label>[70]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Brower-Toland</surname>
								<given-names>B</given-names>
							</string-name>,
							<string-name>
								<surname>Findley</surname>
								<given-names>SD</given-names>
							</string-name>,
							<string-name>
								<surname>Jiang</surname>
								<given-names>L</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Drosophila PIWI associates with chromatin and interacts directly with HP1a</article-title>.
						<source>Genes Dev</source>.
						<year>2007</year>;
						<volume>21</volume>(
						<issue>18</issue>):
						<fpage>2300</fpage>&#x2013;
						<lpage>2311</lpage>.
						<pub-id pub-id-type="pmid">17875665</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0071">
					<label>[71]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Li</surname>
								<given-names>C</given-names>
							</string-name>,
							<string-name>
								<surname>Vagin</surname>
								<given-names>VV</given-names>
							</string-name>,
							<string-name>
								<surname>Lee</surname>
								<given-names>S</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Collapse of germline piRNAs in the absence of Argonaute3 reveals somatic piRNAs in flies</article-title>.
						<source>cell</source>.
						<year>2009a</year>;
						<volume>137</volume>(
						<issue>3</issue>):
						<fpage>509</fpage>&#x2013;
						<lpage>521</lpage>.
						<pub-id pub-id-type="pmid">19395009</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0072">
					<label>[72]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Ross</surname>
								<given-names>RJ</given-names>
							</string-name>,
							<string-name>
								<surname>Weiner</surname>
								<given-names>MM</given-names>
							</string-name>,
							<string-name>
								<surname>Lin</surname>
								<given-names>H</given-names>
							</string-name>
						</person-group>.
						<article-title>PIWI proteins and PIWI-interacting RNAs in the soma</article-title>.
						<source>Nature</source>.
						<year>2014</year>;
						<volume>505</volume>(
						<issue>7483</issue>):
						<fpage>353</fpage>&#x2013;
						<lpage>359</lpage>.
						<pub-id pub-id-type="pmid">24429634</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0073">
					<label>[73]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Lenart</surname>
								<given-names>P</given-names>
							</string-name>,
							<string-name>
								<surname>Novak</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Bienertova-Vasku</surname>
								<given-names>J</given-names>
							</string-name>
						</person-group>.
						<article-title>PIWI-piRNA pathway: setting the pace of aging by reducing DNA damage</article-title>.
						<source>Mech Ageing Dev</source>.
						<year>2018</year>;
						<volume>173</volume>:
						<fpage>29</fpage>&#x2013;
						<lpage>38</lpage>.
						<pub-id pub-id-type="pmid">29580825</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0074">
					<label>[74]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Henaoui</surname>
								<given-names>IS</given-names>
							</string-name>,
							<string-name>
								<surname>Jacovetti</surname>
								<given-names>C</given-names>
							</string-name>,
							<string-name>
								<surname>Mollet</surname>
								<given-names>IG</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>PIWI-interacting RNAs as novel regulators of pancreatic beta cell function</article-title>.
						<source>Diabetologia</source>.
						<year>2017</year>;
						<volume>60</volume>(
						<issue>10</issue>):
						<fpage>1977</fpage>&#x2013;
						<lpage>1986</lpage>.
						<pub-id pub-id-type="pmid">28711973</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0075">
					<label>[75]</label>
					<mixed-citation publication-type="confproc">
						<person-group person-group-type="author">
							<string-name>
								<surname>Nandi</surname>
								<given-names>S</given-names>
							</string-name>,
							<string-name>
								<surname>Chandramohan</surname>
								<given-names>D</given-names>
							</string-name>,
							<string-name>
								<surname>Fioriti</surname>
								<given-names>L</given-names>
							</string-name>, et al
						</person-group>. (
						<year>2016</year>).
						<article-title>Roles for small noncoding RNAs in silencing of retrotransposons in the mammalian brain</article-title>.
						<conf-name>
							<italic toggle="yes">Proceedings of the National Academy of Sciences</italic>
						</conf-name>,
						<italic toggle="yes">USA</italic>,
						<volume>113</volume>(
						<comment>45</comment>),
						<fpage>12697</fpage>&#x2013;
						<lpage>12702</lpage>.
					</mixed-citation>
				</ref>
				<ref id="cit0076">
					<label>[76]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Bamezai</surname>
								<given-names>S</given-names>
							</string-name>,
							<string-name>
								<surname>Rawat</surname>
								<given-names>VP</given-names>
							</string-name>,
							<string-name>
								<surname>Buske</surname>
								<given-names>C</given-names>
							</string-name>
						</person-group>.
						<article-title>Concise review: the Piwi&#x2010;piRNA axis: pivotal beyond transposon silencing</article-title>.
						<source>Stem Cells</source>.
						<year>2012</year>;
						<volume>30</volume>(
						<issue>12</issue>):
						<fpage>2603</fpage>&#x2013;
						<lpage>2611</lpage>.
						<pub-id pub-id-type="pmid">22996918</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0077">
					<label>[77]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Cora</surname>
								<given-names>E</given-names>
							</string-name>,
							<string-name>
								<surname>Pandey</surname>
								<given-names>RR</given-names>
							</string-name>,
							<string-name>
								<surname>Xiol</surname>
								<given-names>J</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>The MID-PIWI module of Piwi proteins specifies nucleotide-and strand-biases of piRNAs</article-title>.
						<source>Rna</source>.
						<year>2014</year>;
						<volume>20</volume>(
						<issue>6</issue>):
						<fpage>773</fpage>&#x2013;
						<lpage>781</lpage>.
						<pub-id pub-id-type="pmid">24757166</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0078">
					<label>[78]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Krishnan</surname>
								<given-names>P</given-names>
							</string-name>,
							<string-name>
								<surname>Damaraju</surname>
								<given-names>S</given-names>
							</string-name>
						</person-group>.
						<article-title>The challenges and opportunities in the clinical application of noncoding RNAs: the road map for miRNAs and piRNAs in cancer diagnostics and prognostics</article-title>.
						<source>Int J Genomics</source>.
						<year>2018</year>;
						<volume>2018</volume>:
						<page-range>1&#x2013;18</page-range>.
					</mixed-citation>
				</ref>
				<ref id="cit0079">
					<label>[79]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Cox</surname>
								<given-names>DN</given-names>
							</string-name>,
							<string-name>
								<surname>Chao</surname>
								<given-names>A</given-names>
							</string-name>,
							<string-name>
								<surname>Baker</surname>
								<given-names>J</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>A novel class of evolutionarily conserved genes defined by piwi are essential for stem cell self-renewal</article-title>.
						<source>Genes Dev</source>.
						<year>1998</year>;
						<volume>12</volume>(
						<issue>23</issue>):
						<fpage>3715</fpage>&#x2013;
						<lpage>3727</lpage>.
						<pub-id pub-id-type="pmid">9851978</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0080">
					<label>[80]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>V&#xF6;ller</surname>
								<given-names>D</given-names>
							</string-name>,
							<string-name>
								<surname>Linck</surname>
								<given-names>L</given-names>
							</string-name>,
							<string-name>
								<surname>Bruckmann</surname>
								<given-names>A</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Argonaute family protein expression in normal tissue and cancer entities</article-title>.
						<source>PLoS One</source>.
						<year>2016</year>;
						<volume>11</volume>(
						<issue>8</issue>):
						<fpage>e0161165</fpage>.
						<pub-id pub-id-type="pmid">27518285</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0081">
					<label>[81]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Malone</surname>
								<given-names>CD</given-names>
							</string-name>,
							<string-name>
								<surname>Brennecke</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Dus</surname>
								<given-names>M</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Specialized piRNA pathways act in germline and somatic tissues of the Drosophila ovary</article-title>.
						<source>cell</source>.
						<year>2009</year>;
						<volume>137</volume>(
						<issue>3</issue>):
						<fpage>522</fpage>&#x2013;
						<lpage>535</lpage>.
						<pub-id pub-id-type="pmid">19395010</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0082">
					<label>[82]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Malone</surname>
								<given-names>CD</given-names>
							</string-name>,
							<string-name>
								<surname>Brennecke</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Dus</surname>
								<given-names>M</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Specialized piRNA pathways act in germline and somatic tissues of the Drosophila ovary</article-title>.
						<source>cell</source>.
						<year>2009</year>;
						<volume>137</volume>(
						<issue>3</issue>):
						<fpage>522</fpage>&#x2013;
						<lpage>535</lpage>.
						<pub-id pub-id-type="pmid">19395010</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0083">
					<label>[83]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Bernstein</surname>
								<given-names>BE</given-names>
							</string-name>,
							<string-name>
								<surname>Meer</surname>
								<given-names>A</given-names>
							</string-name>,
							<string-name>
								<surname>Lander</surname>
								<given-names>ES</given-names>
							</string-name>
						</person-group>.
						<article-title>The mammalian epigenome</article-title>.
						<source>cell</source>.
						<year>2007</year>;
						<volume>128</volume>(
						<issue>4</issue>):
						<fpage>669</fpage>&#x2013;
						<lpage>681</lpage>.
						<pub-id pub-id-type="pmid">17320505</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0084">
					<label>[84]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Han</surname>
								<given-names>BW</given-names>
							</string-name>,
							<string-name>
								<surname>Zamore</surname>
								<given-names>PD</given-names>
							</string-name>
						</person-group>.
						<article-title>PiRNAs</article-title>.
						<source>Curr Biol</source>.
						<year>2014</year>;
						<volume>24</volume>(
						<issue>16</issue>):
						<fpage>R730</fpage>&#x2013;
						<lpage>R733</lpage>.
						<pub-id pub-id-type="pmid">25137579</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0085">
					<label>[85]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Han</surname>
								<given-names>BW</given-names>
							</string-name>,
							<string-name>
								<surname>Wang</surname>
								<given-names>W</given-names>
							</string-name>,
							<string-name>
								<surname>Li</surname>
								<given-names>C</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>piRNA-guided transposon cleavage initiates Zucchini-dependent, phased piRNA production</article-title>.
						<source>science</source>.
						<year>2015</year>;
						<volume>348</volume>(
						<issue>6236</issue>):
						<fpage>817</fpage>&#x2013;
						<lpage>821</lpage>.
						<pub-id pub-id-type="pmid">25977554</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0086">
					<label>[86]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Tsaytler</surname>
								<given-names>P</given-names>
							</string-name>,
							<string-name>
								<surname>Harding</surname>
								<given-names>HP</given-names>
							</string-name>,
							<string-name>
								<surname>Ron</surname>
								<given-names>D</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis</article-title>.
						<source>science</source>.
						<year>2011</year>;
						<volume>332</volume>(
						<issue>6025</issue>):
						<fpage>91</fpage>&#x2013;
						<lpage>94</lpage>.
						<pub-id pub-id-type="pmid">21385720</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0087">
					<label>[87]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Grimson</surname>
								<given-names>A</given-names>
							</string-name>,
							<string-name>
								<surname>Srivastava</surname>
								<given-names>M</given-names>
							</string-name>,
							<string-name>
								<surname>Fahey</surname>
								<given-names>B</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Early origins and evolution of microRNAs and Piwi-interacting RNAs in animals</article-title>.
						<source>Nature</source>.
						<year>2008</year>;
						<volume>455</volume>(
						<issue>7217</issue>):
						<fpage>1193</fpage>&#x2013;
						<lpage>1197</lpage>.
						<pub-id pub-id-type="pmid">18830242</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0088">
					<label>[88]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Cheng</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Wang</surname>
								<given-names>Q</given-names>
							</string-name>,
							<string-name>
								<surname>Jiang</surname>
								<given-names>W</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Emerging roles of piRNAs in cancer: challenges and prospects</article-title>.
						<source>Aging (Albany NY)</source>.
						<year>2019</year>;
						<volume>11</volume>(
						<issue>21</issue>):
						<fpage>9932</fpage>.
						<pub-id pub-id-type="pmid">31727866</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0089">
					<label>[89]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Cichocki</surname>
								<given-names>F</given-names>
							</string-name>,
							<string-name>
								<surname>Lenvik</surname>
								<given-names>T</given-names>
							</string-name>,
							<string-name>
								<surname>Sharma</surname>
								<given-names>N</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Cutting edge: KIR antisense transcripts are processed into a 28-base PIWI-like RNA in human NK cells</article-title>.
						<source>J Immunol</source>.
						<year>2010</year>;
						<volume>185</volume>(
						<issue>4</issue>):
						<fpage>20</fpage>10&#x2013;
						<lpage>2012</lpage>.
					</mixed-citation>
				</ref>
				<ref id="cit0090">
					<label>[90]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Kazazian</surname>
								<given-names>HH</given-names>
							</string-name>
						</person-group>.
						<article-title>Mobile elements: drivers of genome evolution</article-title>.
						<source>science</source>.
						<year>2004</year>;
						<volume>303</volume>(
						<issue>5664</issue>):
						<fpage>1626</fpage>&#x2013;
						<lpage>1632</lpage>.
						<pub-id pub-id-type="pmid">15016989</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0091">
					<label>[91]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Moyano</surname>
								<given-names>M</given-names>
							</string-name>,
							<string-name>
								<surname>Stefani</surname>
								<given-names>G</given-names>
							</string-name>
						</person-group>.
						<article-title>piRNA involvement in genome stability and human cancer</article-title>.
						<source>J Hematol Oncol</source>.
						<year>2015</year>;
						<volume>8</volume>(
						<issue>1</issue>):
						<fpage>38</fpage>.
						<pub-id pub-id-type="pmid">25895683</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0092">
					<label>[92]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Wei</surname>
								<given-names>JW</given-names>
							</string-name>,
							<string-name>
								<surname>Huang</surname>
								<given-names>K</given-names>
							</string-name>,
							<string-name>
								<surname>Yang</surname>
								<given-names>C</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Non-coding RNAs as regulators in epigenetics (Review)</article-title>.
						<source>Oncol Rep</source>.
						<year>2017</year>;
						<volume>37</volume>(
						<issue>1</issue>):
						<fpage>3</fpage>&#x2013;
						<lpage>9</lpage>.
						<pub-id pub-id-type="pmid">27841002</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0093">
					<label>[93]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Yu</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Xiao</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Hann</surname>
								<given-names>SS</given-names>
							</string-name>
						</person-group>.
						<article-title>&lt;p&gt;The emerging roles of PIWI-interacting RNA in human cancers</article-title>.
						<source>&lt;![cdata[cancer Management and Research]]&gt;</source>.
						<year>2019</year>;
						<volume>11</volume>:
						<fpage>5895</fpage>.
						<pub-id pub-id-type="pmid">31303794</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0094">
					<label>[94]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Mei</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Wang</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Kumari</surname>
								<given-names>P</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>A piRNA-like small RNA interacts with and modulates p-ERM proteins in human somatic cells</article-title>.
						<source>Nat Commun</source>.
						<year>2015</year>;
						<volume>6</volume>(
						<issue>1</issue>):
						<fpage>7316</fpage>.
						<pub-id pub-id-type="pmid">26095918</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0095">
					<label>[95]</label>
					<mixed-citation publication-type="confproc">
						<person-group person-group-type="author">
							<string-name>
								<surname>Grivna</surname>
								<given-names>ST</given-names>
							</string-name>,
							<string-name>
								<surname>Pyhtila</surname>
								<given-names>B</given-names>
							</string-name>,
							<string-name>
								<surname>Lin</surname>
								<given-names>H</given-names>
							</string-name>
						</person-group> (
						<year>2006</year>).
						<article-title>MIWI associates with translational machinery and PIWI-interacting RNAs (piRNAs) in regulating spermatogenesis</article-title>.
						<conf-name>
							<italic toggle="yes">Proceedings of the National Academy of Sciences</italic>
						</conf-name>,
						<volume>103</volume>(
						<comment>36</comment>),
						<fpage>13415</fpage>&#x2013;
						<lpage>13420</lpage>.
					</mixed-citation>
				</ref>
				<ref id="cit0096">
					<label>[96]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Unhavaithaya</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Hao</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Beyret</surname>
								<given-names>E</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>MILI, a PIWI-interacting RNA-binding protein, is required for germ line stem cell self-renewal and appears to positively regulate translation</article-title>.
						<source>J Biol Chem</source>.
						<year>2009</year>;
						<volume>284</volume>(
						<issue>10</issue>):
						<fpage>6507</fpage>&#x2013;
						<lpage>6519</lpage>.
						<pub-id pub-id-type="pmid">19114715</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0097">
					<label>[97]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Rojas&#x2010;R&#xED;os</surname>
								<given-names>P</given-names>
							</string-name>,
							<string-name>
								<surname>Chartier</surname>
								<given-names>A</given-names>
							</string-name>,
							<string-name>
								<surname>Pierson</surname>
								<given-names>S</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Aubergine and pi RNA s promote germline stem cell self&#x2010;renewal by repressing the proto&#x2010;oncogene Cbl</article-title>.
						<source>EMBO J</source>.
						<year>2017</year>;
						<volume>36</volume>(
						<issue>21</issue>):
						<fpage>3194</fpage>&#x2013;
						<lpage>3211</lpage>.
						<pub-id pub-id-type="pmid">29030484</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0098">
					<label>[98]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Ma</surname>
								<given-names>X</given-names>
							</string-name>,
							<string-name>
								<surname>Zhu</surname>
								<given-names>X</given-names>
							</string-name>,
							<string-name>
								<surname>Han</surname>
								<given-names>Y</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Aubergine controls germline stem cell self-renewal and progeny differentiation via distinct mechanisms</article-title>.
						<source>Dev Cell</source>.
						<year>2017</year>;
						<volume>41</volume>(
						<issue>2</issue>):
						<fpage>157</fpage>&#x2013;
						<lpage>169. e155</lpage>.
						<pub-id pub-id-type="pmid">28441530</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0099">
					<label>[99]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Ashe</surname>
								<given-names>A</given-names>
							</string-name>,
							<string-name>
								<surname>Sapetschnig</surname>
								<given-names>A</given-names>
							</string-name>,
							<string-name>
								<surname>Weick</surname>
								<given-names>E-M</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>piRNAs can trigger a multigenerational epigenetic memory in the germline of C. elegans</article-title>.
						<source>cell</source>.
						<year>2012</year>;
						<volume>150</volume>(
						<issue>1</issue>):
						<fpage>88</fpage>&#x2013;
						<lpage>99</lpage>.
						<pub-id pub-id-type="pmid">22738725</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0100">
					<label>[100]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Pek</surname>
								<given-names>JW</given-names>
							</string-name>,
							<string-name>
								<surname>Kai</surname>
								<given-names>T</given-names>
							</string-name>
						</person-group>.
						<article-title>Non-coding RNAs enter mitosis: functions, conservation and implications</article-title>.
						<source>Cell Div</source>.
						<year>2011</year>;
						<volume>6</volume>(
						<issue>1</issue>):
						<fpage>1</fpage>&#x2013;
						<lpage>6</lpage>.
						<pub-id pub-id-type="pmid">21255415</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0101">
					<label>[101]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Szakmary</surname>
								<given-names>A</given-names>
							</string-name>,
							<string-name>
								<surname>Cox</surname>
								<given-names>DN</given-names>
							</string-name>,
							<string-name>
								<surname>Wang</surname>
								<given-names>Z</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Regulatory relationship among piwi, pumilio, and bag-of-marbles in Drosophila germline stem cell self-renewal and differentiation</article-title>.
						<source>Curr Biol</source>.
						<year>2005</year>;
						<volume>15</volume>(
						<issue>2</issue>):
						<fpage>171</fpage>&#x2013;
						<lpage>178</lpage>.
						<pub-id pub-id-type="pmid">15668175</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0102">
					<label>[102]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Zhang</surname>
								<given-names>X</given-names>
							</string-name>,
							<string-name>
								<surname>He</surname>
								<given-names>X</given-names>
							</string-name>,
							<string-name>
								<surname>Liu</surname>
								<given-names>C</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>IL-4 inhibits the biogenesis of an epigenetically suppressive PIWI-interacting RNA to upregulate CD1a molecules on monocytes/dendritic cells</article-title>.
						<source>J Immunol</source>.
						<year>2016</year>;
						<volume>196</volume>(
						<issue>4</issue>):
						<fpage>1591</fpage>&#x2013;
						<lpage>1603</lpage>.
						<pub-id pub-id-type="pmid">26755820</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0103">
					<label>[103]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Shirayama</surname>
								<given-names>M</given-names>
							</string-name>,
							<string-name>
								<surname>Seth</surname>
								<given-names>M</given-names>
							</string-name>,
							<string-name>
								<surname>Lee</surname>
								<given-names>H-C</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>piRNAs initiate an epigenetic memory of nonself RNA in the C. elegans germline</article-title>.
						<source>cell</source>.
						<year>2012</year>;
						<volume>150</volume>(
						<issue>1</issue>):
						<fpage>65</fpage>&#x2013;
						<lpage>77</lpage>.
						<pub-id pub-id-type="pmid">22738726</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0104">
					<label>[104]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Stuwe</surname>
								<given-names>E</given-names>
							</string-name>,
							<string-name>
								<surname>Toth</surname>
								<given-names>KF</given-names>
							</string-name>,
							<string-name>
								<surname>Aravin</surname>
								<given-names>AA</given-names>
							</string-name>
						</person-group>.
						<article-title>Small but sturdy: small RNAs in cellular memory and epigenetics</article-title>.
						<source>Genes Dev</source>.
						<year>2014</year>;
						<volume>28</volume>(
						<issue>5</issue>):
						<fpage>423</fpage>&#x2013;
						<lpage>431</lpage>.
						<pub-id pub-id-type="pmid">24589774</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0105">
					<label>[105]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Kawaoka</surname>
								<given-names>S</given-names>
							</string-name>,
							<string-name>
								<surname>Izumi</surname>
								<given-names>N</given-names>
							</string-name>,
							<string-name>
								<surname>Katsuma</surname>
								<given-names>S</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>3&#x2032; end formation of PIWI-interacting RNAs in vitro</article-title>.
						<source>Mol Cell</source>.
						<year>2011</year>;
						<volume>43</volume>(
						<issue>6</issue>):
						<fpage>1015</fpage>&#x2013;
						<lpage>1022</lpage>.
						<pub-id pub-id-type="pmid">21925389</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0106">
					<label>[106]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Khurana</surname>
								<given-names>JS</given-names>
							</string-name>,
							<string-name>
								<surname>Xu</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Weng</surname>
								<given-names>Z</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Distinct functions for the Drosophila piRNA pathway in genome maintenance and telomere protection</article-title>.
						<source>PLoS Genet</source>.
						<year>2010</year>;
						<volume>6</volume>(
						<issue>12</issue>):
						<fpage>e1001246</fpage>.
						<pub-id pub-id-type="pmid">21179579</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0107">
					<label>[107]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Schwager</surname>
								<given-names>EE</given-names>
							</string-name>,
							<string-name>
								<surname>Meng</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Extavour</surname>
								<given-names>CG</given-names>
							</string-name>
						</person-group>.
						<article-title>vasa and piwi are required for mitotic integrity in early embryogenesis in the spider Parasteatoda tepidariorum</article-title>.
						<source>Dev Biol</source>.
						<year>2015</year>;
						<volume>402</volume>(
						<issue>2</issue>):
						<fpage>276</fpage>&#x2013;
						<lpage>290</lpage>.
						<pub-id pub-id-type="pmid">25257304</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0108">
					<label>[108]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Yin</surname>
								<given-names>H</given-names>
							</string-name>,
							<string-name>
								<surname>Lin</surname>
								<given-names>H</given-names>
							</string-name>
						</person-group>.
						<article-title>An epigenetic activation role of Piwi and a Piwi-associated piRNA in Drosophila melanogaster</article-title>.
						<source>Nature</source>.
						<year>2007</year>;
						<volume>450</volume>(
						<issue>7167</issue>):
						<fpage>304</fpage>&#x2013;
						<lpage>308</lpage>.
						<pub-id pub-id-type="pmid">17952056</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0109">
					<label>[109]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Yin</surname>
								<given-names>D-T</given-names>
							</string-name>,
							<string-name>
								<surname>Wang</surname>
								<given-names>Q</given-names>
							</string-name>,
							<string-name>
								<surname>Chen</surname>
								<given-names>L</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Germline stem cell gene PIWIL2 mediates DNA repair through relaxation of chromatin</article-title>.
						<source>PLoS One</source>.
						<year>2011</year>;
						<volume>6</volume>(
						<issue>11</issue>):
						<fpage>e27154</fpage>.
						<pub-id pub-id-type="pmid">22110608</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0110">
					<label>[110]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Kwon</surname>
								<given-names>C</given-names>
							</string-name>,
							<string-name>
								<surname>Tak</surname>
								<given-names>H</given-names>
							</string-name>,
							<string-name>
								<surname>Rho</surname>
								<given-names>M</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Detection of PIWI and piRNAs in the mitochondria of mammalian cancer cells</article-title>.
						<source>Biochem Biophys Res Commun</source>.
						<year>2014</year>;
						<volume>446</volume>(
						<issue>1</issue>):
						<fpage>218</fpage>&#x2013;
						<lpage>223</lpage>.
						<pub-id pub-id-type="pmid">24602614</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0111">
					<label>[111]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Fonseca Cabral</surname>
								<given-names>G</given-names>
							</string-name>,
							<string-name>
								<surname>Azevedo Dos Santos Pinheiro</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Vidal</surname>
								<given-names>AF</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>piRNAs in gastric cancer: a new approach towards translational research</article-title>.
						<source>Int J Mol Sci</source>.
						<year>2020</year>;
						<volume>21</volume>(
						<issue>6</issue>):
						<fpage>2126</fpage>.
					</mixed-citation>
				</ref>
				<ref id="cit0112">
					<label>[112]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Bahn</surname>
								<given-names>JH</given-names>
							</string-name>,
							<string-name>
								<surname>Zhang</surname>
								<given-names>Q</given-names>
							</string-name>,
							<string-name>
								<surname>Li</surname>
								<given-names>F</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>The landscape of microRNA, Piwi-interacting RNA, and circular RNA in human saliva</article-title>.
						<source>Clin Chem</source>.
						<year>2015</year>;
						<volume>61</volume>(
						<issue>1</issue>):
						<fpage>221</fpage>&#x2013;
						<lpage>230</lpage>.
						<pub-id pub-id-type="pmid">25376581</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0113">
					<label>[113]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Roy</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Sarkar</surname>
								<given-names>A</given-names>
							</string-name>,
							<string-name>
								<surname>Parida</surname>
								<given-names>S</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Small RNA sequencing revealed dysregulated piRNAs in Alzheimer&#x2019;s disease and their probable role in pathogenesis</article-title>.
						<source>Mol Biosyst</source>.
						<year>2017</year>;
						<volume>13</volume>(
						<issue>3</issue>):
						<fpage>565</fpage>&#x2013;
						<lpage>576</lpage>.
						<pub-id pub-id-type="pmid">28127595</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0114">
					<label>[114]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Wang</surname>
								<given-names>S</given-names>
							</string-name>,
							<string-name>
								<surname>Wang</surname>
								<given-names>Z</given-names>
							</string-name>,
							<string-name>
								<surname>Tao</surname>
								<given-names>R</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>The potential use of Piwi-interacting RNA biomarkers in forensic body fluid identification: a proof-of-principle study</article-title>.
						<source>Forensic Sci Int Genet</source>.
						<year>2019</year>;
						<volume>39</volume>:
						<fpage>129</fpage>&#x2013;
						<lpage>135</lpage>.
						<pub-id pub-id-type="pmid">30640084</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0115">
					<label>[115]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Yang</surname>
								<given-names>X</given-names>
							</string-name>,
							<string-name>
								<surname>Cheng</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Lu</surname>
								<given-names>Q</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Detection of stably expressed piRNAs in human blood</article-title>.
						<source>Int J Clin Exp Med</source>.
						<year>2015</year>;
						<volume>8</volume>(
						<issue>8</issue>):
						<fpage>13353</fpage>.
						<pub-id pub-id-type="pmid">26550265</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0116">
					<label>[116]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Lee</surname>
								<given-names>EJ</given-names>
							</string-name>,
							<string-name>
								<surname>Banerjee</surname>
								<given-names>S</given-names>
							</string-name>,
							<string-name>
								<surname>Zhou</surname>
								<given-names>H</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Identification of piRNAs in the central nervous system</article-title>.
						<source>Rna</source>.
						<year>2011</year>;
						<volume>17</volume>(
						<issue>6</issue>):
						<fpage>1090</fpage>&#x2013;
						<lpage>1099</lpage>.
						<pub-id pub-id-type="pmid">21515829</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0117">
					<label>[117]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Rajasethupathy</surname>
								<given-names>P</given-names>
							</string-name>,
							<string-name>
								<surname>Antonov</surname>
								<given-names>I</given-names>
							</string-name>,
							<string-name>
								<surname>Sheridan</surname>
								<given-names>R</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>A role for neuronal piRNAs in the epigenetic control of memory-related synaptic plasticity</article-title>.
						<source>cell</source>.
						<year>2012</year>;
						<volume>149</volume>(
						<issue>3</issue>):
						<fpage>693</fpage>&#x2013;
						<lpage>707</lpage>.
						<pub-id pub-id-type="pmid">22541438</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0118">
					<label>[118]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Roque</surname>
								<given-names>CG</given-names>
							</string-name>,
							<string-name>
								<surname>Hengst</surname>
								<given-names>U</given-names>
							</string-name>
						</person-group>.
						<article-title>Wimpy nerves: piRNA pathway curbs axon regrowth after injury</article-title>.
						<source>Neuron</source>.
						<year>2018</year>;
						<volume>97</volume>(
						<issue>3</issue>):
						<fpage>477</fpage>&#x2013;
						<lpage>478</lpage>.
						<pub-id pub-id-type="pmid">29420927</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0119">
					<label>[119]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Pantano</surname>
								<given-names>L</given-names>
							</string-name>,
							<string-name>
								<surname>Jodar</surname>
								<given-names>M</given-names>
							</string-name>,
							<string-name>
								<surname>Bak</surname>
								<given-names>M</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>The small RNA content of human sperm reveals pseudogene-derived piRNAs complementary to protein-coding genes</article-title>.
						<source>Rna</source>.
						<year>2015</year>;
						<volume>21</volume>(
						<issue>6</issue>):
						<fpage>1085</fpage>&#x2013;
						<lpage>1095</lpage>.
						<pub-id pub-id-type="pmid">25904136</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0120">
					<label>[120]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Zeng</surname>
								<given-names>Q</given-names>
							</string-name>,
							<string-name>
								<surname>Wan</surname>
								<given-names>H</given-names>
							</string-name>,
							<string-name>
								<surname>Zhao</surname>
								<given-names>S</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Role of PIWI&#x2010;interacting RNAs on cell survival: proliferation, apoptosis, and cycle</article-title>.
						<source>IUBMB Life</source>.
						<year>2020</year>;
						<volume>72</volume>(
						<issue>9</issue>):
						<fpage>1870</fpage>&#x2013;
						<lpage>1878</lpage>.
						<pub-id pub-id-type="pmid">32697419</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0121">
					<label>[121]</label>
					<mixed-citation publication-type="book">
						<person-group person-group-type="author">
							<string-name>
								<surname>Meseure</surname>
								<given-names>D</given-names>
							</string-name>,
							<string-name>
								<surname>Alsibai</surname>
								<given-names>KD</given-names>
							</string-name>
						</person-group>.
						<part-title>Part 2: Deregulated expressions of PIWI proteins and piRNAs as new candidate biomarkers and potential therapeutic tools in cancer</part-title>. In: Colin Logie and Tobias Aurelius Knoch (eds).,&#xA0;
						<source>Chromatin and epigenetics</source>. London, United Kingdom:
						<publisher-name>IntechOpen</publisher-name>;
						<year>2020:263-274</year>.
					</mixed-citation>
				</ref>
				<ref id="cit0122">
					<label>[122]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Siddiqi</surname>
								<given-names>S</given-names>
							</string-name>,
							<string-name>
								<surname>Matushansky</surname>
								<given-names>I</given-names>
							</string-name>
						</person-group>.
						<article-title>Piwis and piwi&#x2010;interacting RNAs in the epigenetics of cancer</article-title>.
						<source>J Cell Biochem</source>.
						<year>2012</year>;
						<volume>113</volume>(
						<issue>2</issue>):
						<fpage>373</fpage>&#x2013;
						<lpage>380</lpage>.
						<pub-id pub-id-type="pmid">21928326</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0123">
					<label>[123]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Mei</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Clark</surname>
								<given-names>D</given-names>
							</string-name>,
							<string-name>
								<surname>Mao</surname>
								<given-names>L</given-names>
							</string-name>
						</person-group>.
						<article-title>Novel dimensions of piRNAs in cancer</article-title>.
						<source>Cancer Lett</source>.
						<year>2013</year>;
						<volume>336</volume>(
						<issue>1</issue>):
						<fpage>46</fpage>&#x2013;
						<lpage>52</lpage>.
						<pub-id pub-id-type="pmid">23603435</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0124">
					<label>[124]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Lim</surname>
								<given-names>SL</given-names>
							</string-name>,
							<string-name>
								<surname>Ricciardelli</surname>
								<given-names>C</given-names>
							</string-name>,
							<string-name>
								<surname>Oehler</surname>
								<given-names>MK</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Overexpression of piRNA pathway genes in epithelial ovarian cancer</article-title>.
						<source>PLoS One</source>.
						<year>2014</year>;
						<volume>9</volume>(
						<issue>6</issue>):
						<fpage>e99687</fpage>.
						<pub-id pub-id-type="pmid">24932571</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0125">
					<label>[125]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Yan</surname>
								<given-names>H</given-names>
							</string-name>,
							<string-name>
								<surname>Wu</surname>
								<given-names>Q</given-names>
							</string-name>,
							<string-name>
								<surname>Sun</surname>
								<given-names>C</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>piRNA-823 contributes to tumorigenesis by regulating de novo DNA methylation and angiogenesis in multiple myeloma</article-title>.
						<source>Leukemia</source>.
						<year>2015</year>;
						<volume>29</volume>(
						<issue>1</issue>):
						<fpage>196</fpage>&#x2013;
						<lpage>206</lpage>.
						<pub-id pub-id-type="pmid">24732595</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0126">
					<label>[126]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Martinez</surname>
								<given-names>VD</given-names>
							</string-name>,
							<string-name>
								<surname>Vucic</surname>
								<given-names>EA</given-names>
							</string-name>,
							<string-name>
								<surname>Thu</surname>
								<given-names>KL</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Unique somatic and malignant expression patterns implicate PIWI-interacting RNAs in cancer-type specific biology</article-title>.
						<source>Sci Rep</source>.
						<year>2015</year>;
						<volume>5</volume>(
						<issue>1</issue>):
						<fpage>1</fpage>&#x2013;
						<lpage>17</lpage>.
					</mixed-citation>
				</ref>
				<ref id="cit0127">
					<label>[127]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Tan</surname>
								<given-names>L</given-names>
							</string-name>,
							<string-name>
								<surname>Mai</surname>
								<given-names>D</given-names>
							</string-name>,
							<string-name>
								<surname>Zhang</surname>
								<given-names>B</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>PIWI-interacting RNA-36712 restrains breast cancer progression and chemoresistance by interaction with SEPW1 pseudogene SEPW1P RNA</article-title>.
						<source>Mol Cancer</source>.
						<year>2019</year>;
						<volume>18</volume>(
						<issue>1</issue>):
						<fpage>1</fpage>&#x2013;
						<lpage>15</lpage>.
						<pub-id pub-id-type="pmid">30609930</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0128">
					<label>[128]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Ding</surname>
								<given-names>X</given-names>
							</string-name>,
							<string-name>
								<surname>Li</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>L&#xFC;</surname>
								<given-names>J</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>piRNA-823 is involved in cancer stem cell regulation through altering DNA methylation in association with luminal breast cancer</article-title>.
						<source>Front Cell Dev Biol</source>.
						<year>2021</year>;
						<volume>9</volume>. DOI:
						<pub-id pub-id-type="doi">10.3389/fcell.2021.641052</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0129">
					<label>[129]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Weng</surname>
								<given-names>W</given-names>
							</string-name>,
							<string-name>
								<surname>Liu</surname>
								<given-names>N</given-names>
							</string-name>,
							<string-name>
								<surname>Toiyama</surname>
								<given-names>Y</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Novel evidence for a PIWI-interacting RNA (piRNA) as an oncogenic mediator of disease progression, and a potential prognostic biomarker in colorectal cancer</article-title>.
						<source>Mol Cancer</source>.
						<year>2018</year>;
						<volume>17</volume>(
						<issue>1</issue>):
						<fpage>16</fpage>.
						<pub-id pub-id-type="pmid">29382334</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0130">
					<label>[130]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Jacobs</surname>
								<given-names>DI</given-names>
							</string-name>,
							<string-name>
								<surname>Qin</surname>
								<given-names>Q</given-names>
							</string-name>,
							<string-name>
								<surname>Lerro</surname>
								<given-names>MC</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>PIWI-interacting RNAs in gliomagenesis: evidence from post-GWAS and functional analyses</article-title>.
						<source>Cancer Epidemiol Prev Biomarkers</source>.
						<year>2016</year>;
						<volume>25</volume>(
						<issue>7</issue>):
						<fpage>1073</fpage>&#x2013;
						<lpage>1080</lpage>.
					</mixed-citation>
				</ref>
				<ref id="cit0131">
					<label>[131]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Li</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Wu</surname>
								<given-names>X</given-names>
							</string-name>,
							<string-name>
								<surname>Gao</surname>
								<given-names>H</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Piwi-interacting RNAs (piRNAs) are dysregulated in renal cell carcinoma and associated with tumor metastasis and cancer-specific survival</article-title>.
						<source>Mol Med</source>.
						<year>2015</year>;
						<volume>21</volume>(
						<issue>1</issue>):
						<fpage>381</fpage>&#x2013;
						<lpage>388</lpage>.
						<pub-id pub-id-type="pmid">25998508</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0132">
					<label>[132]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Chu</surname>
								<given-names>H</given-names>
							</string-name>,
							<string-name>
								<surname>Hui</surname>
								<given-names>G</given-names>
							</string-name>,
							<string-name>
								<surname>Yuan</surname>
								<given-names>L</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Identification of novel piRNAs in bladder cancer</article-title>.
						<source>Cancer Lett</source>.
						<year>2015</year>;
						<volume>356</volume>(
						<issue>2</issue>):
						<fpage>561</fpage>&#x2013;
						<lpage>567</lpage>.
						<pub-id pub-id-type="pmid">25305452</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0133">
					<label>[133]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Xiao</surname>
								<given-names>Z</given-names>
							</string-name>,
							<string-name>
								<surname>Shen</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Zhang</surname>
								<given-names>L</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: recent progress and future prospects</article-title>.
						<source>Oncol Lett</source>.
						<year>2018</year>;
						<volume>15</volume>(
						<issue>3</issue>):
						<fpage>3395</fpage>&#x2013;
						<lpage>3402</lpage>.
						<pub-id pub-id-type="pmid">29467864</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0134">
					<label>[134]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Tang</surname>
								<given-names>X</given-names>
							</string-name>,
							<string-name>
								<surname>Xie</surname>
								<given-names>X</given-names>
							</string-name>,
							<string-name>
								<surname>Wang</surname>
								<given-names>X</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>The combination of piR-823 and eukaryotic initiation factor 3 B (EIF3B) activates hepatic stellate cells via upregulating TGF-&#x3B2;1 in liver fibrogenesis</article-title>.
						<source>Med Sci Monit</source>.
						<year>2018</year>;
						<volume>24</volume>:
						<fpage>9151</fpage>.
						<pub-id pub-id-type="pmid">30556540</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0135">
					<label>[135]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Zhang</surname>
								<given-names>L</given-names>
							</string-name>,
							<string-name>
								<surname>Meng</surname>
								<given-names>X</given-names>
							</string-name>,
							<string-name>
								<surname>Li</surname>
								<given-names>D</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>piR-001773 and piR-017184 promote prostate cancer progression by interacting with PCDH9</article-title>.
						<source>Cell Signal</source>.
						<year>2020</year>;
						<volume>76</volume>:
						<fpage>109780</fpage>.
						<pub-id pub-id-type="pmid">32949716</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0136">
					<label>[136]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Qi</surname>
								<given-names>T</given-names>
							</string-name>,
							<string-name>
								<surname>Cao</surname>
								<given-names>H</given-names>
							</string-name>,
							<string-name>
								<surname>Sun</surname>
								<given-names>H</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>piR-19166 inhibits migration and metastasis through CTTN/MMPs pathway in prostate carcinoma</article-title>.
						<source>Aging (Albany NY)</source>.
						<year>2020</year>;
						<volume>12</volume>(
						<issue>18</issue>):
						<fpage>18209</fpage>.
						<pub-id pub-id-type="pmid">32881713</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0137">
					<label>[137]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Ma</surname>
								<given-names>H</given-names>
							</string-name>,
							<string-name>
								<surname>Wang</surname>
								<given-names>H</given-names>
							</string-name>,
							<string-name>
								<surname>Tian</surname>
								<given-names>F</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>PIWI-interacting RNA-004800 is regulated by S1P receptor signaling pathway to keep myeloma cell survival</article-title>.
						<source>Front Oncol</source>.
						<year>2020</year>;
						<volume>10</volume>:
						<fpage>438</fpage>.
						<pub-id pub-id-type="pmid">32351883</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0138">
					<label>[138]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Baylin</surname>
								<given-names>SB</given-names>
							</string-name>,
							<string-name>
								<surname>Jones</surname>
								<given-names>PA</given-names>
							</string-name>
						</person-group>.
						<article-title>A decade of exploring the cancer epigenome&#x2014;biological and translational implications</article-title>.
						<source>Nat Rev Cancer</source>.
						<year>2011</year>;
						<volume>11</volume>(
						<issue>10</issue>):
						<fpage>726</fpage>&#x2013;
						<lpage>734</lpage>.
						<pub-id pub-id-type="pmid">21941284</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0139">
					<label>[139]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Tan</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Liu</surname>
								<given-names>L</given-names>
							</string-name>,
							<string-name>
								<surname>Liao</surname>
								<given-names>M</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Emerging roles for PIWI proteins in cancer</article-title>.
						<source>Acta Biochim Biophys Sin (Shanghai)</source>.
						<year>2015</year>;
						<volume>47</volume>(
						<issue>5</issue>):
						<fpage>315</fpage>&#x2013;
						<lpage>324</lpage>.
						<pub-id pub-id-type="pmid">25854579</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0140">
					<label>[140]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Liu</surname>
								<given-names>L</given-names>
							</string-name>,
							<string-name>
								<surname>Dai</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Chen</surname>
								<given-names>J</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial&#x2010;mesenchymal transition by way of Akt/GSK&#x2010;3&#x3B2;/Snail signaling</article-title>.
						<source>Hepatology</source>.
						<year>2014</year>;
						<volume>59</volume>(
						<issue>2</issue>):
						<fpage>531</fpage>&#x2013;
						<lpage>543</lpage>.
						<pub-id pub-id-type="pmid">23929794</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0141">
					<label>[141]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Cheng</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Guo</surname>
								<given-names>J-M</given-names>
							</string-name>,
							<string-name>
								<surname>Xiao</surname>
								<given-names>B-X</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells</article-title>.
						<source>Clin Chim Acta</source>.
						<year>2011</year>;
						<volume>412</volume>(
						<issue>17&#x2013;18</issue>):
						<fpage>1621</fpage>&#x2013;
						<lpage>1625</lpage>.
						<pub-id pub-id-type="pmid">21616063</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0142">
					<label>[142]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Huang</surname>
								<given-names>G-L</given-names>
							</string-name>,
							<string-name>
								<surname>Hu</surname>
								<given-names>H</given-names>
							</string-name>,
							<string-name>
								<surname>Xue</surname>
								<given-names>X</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Altered expression of piRNAs and their relation with clinicopathologic features of breast cancer</article-title>.
						<source>Clin Transl Oncol</source>.
						<year>2013</year>;
						<volume>15</volume>(
						<issue>7</issue>):
						<fpage>563</fpage>&#x2013;
						<lpage>568</lpage>.
						<pub-id pub-id-type="pmid">23229900</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0143">
					<label>[143]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Law</surname>
								<given-names>PT-Y</given-names>
							</string-name>,
							<string-name>
								<surname>Qin</surname>
								<given-names>H</given-names>
							</string-name>,
							<string-name>
								<surname>Ching</surname>
								<given-names>A-K-K</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma</article-title>.
						<source>J Hepatol</source>.
						<year>2013</year>;
						<volume>58</volume>(
						<issue>6</issue>):
						<fpage>1165</fpage>&#x2013;
						<lpage>1173</lpage>.
						<pub-id pub-id-type="pmid">23376363</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0144">
					<label>[144]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Asati</surname>
								<given-names>V</given-names>
							</string-name>,
							<string-name>
								<surname>Mahapatra</surname>
								<given-names>DK</given-names>
							</string-name>,
							<string-name>
								<surname>Bharti</surname>
								<given-names>SK</given-names>
							</string-name>
						</person-group>.
						<article-title>PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives</article-title>.
						<source>Eur J Med Chem</source>.
						<year>2016</year>;
						<volume>109</volume>:
						<fpage>314</fpage>&#x2013;
						<lpage>341</lpage>.
						<pub-id pub-id-type="pmid">26807863</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0145">
					<label>[145]</label>
					<mixed-citation publication-type="book">
						<person-group person-group-type="author">
							<string-name>
								<surname>Wu</surname>
								<given-names>X</given-names>
							</string-name>,
							<string-name>
								<surname>Pan</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Fang</surname>
								<given-names>Y</given-names>
							</string-name>, et al
						</person-group>.
						<part-title>The biogenesis and functions of piRNAs in human diseases</part-title>. In
						<source>Molecular Therapy-Nucleic Acids</source>.
						<year>2020a;21:108-120</year>. USA: Elsevier.
					</mixed-citation>
				</ref>
				<ref id="cit0146">
					<label>[146]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Jeong</surname>
								<given-names>H</given-names>
							</string-name>,
							<string-name>
								<surname>Park</surname>
								<given-names>K-H</given-names>
							</string-name>,
							<string-name>
								<surname>Lee</surname>
								<given-names>Y</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>The regulation and role of piRNAs and PIWI proteins in cancer</article-title>.
						<source>Processes</source>.
						<year>2021</year>;
						<volume>9</volume>(
						<issue>7</issue>):
						<fpage>1208</fpage>.
					</mixed-citation>
				</ref>
				<ref id="cit0147">
					<label>[147]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Cui</surname>
								<given-names>L</given-names>
							</string-name>,
							<string-name>
								<surname>Lou</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Zhang</surname>
								<given-names>X</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using piRNAs as markers</article-title>.
						<source>Clin Biochem</source>.
						<year>2011</year>;
						<volume>44</volume>(
						<issue>13</issue>):
						<fpage>1050</fpage>&#x2013;
						<lpage>1057</lpage>.
						<pub-id pub-id-type="pmid">21704610</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0148">
					<label>[148]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Gu</surname>
								<given-names>X</given-names>
							</string-name>,
							<string-name>
								<surname>Wang</surname>
								<given-names>C</given-names>
							</string-name>,
							<string-name>
								<surname>Deng</surname>
								<given-names>H</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Exosomal piRNA profiling revealed unique circulating piRNA signatures of cholangiocarcinoma and gallbladder carcinoma</article-title>.
						<source>Acta Biochim Biophys Sin (Shanghai)</source>.
						<year>2020</year>;
						<volume>52</volume>(
						<issue>5</issue>):
						<fpage>475</fpage>&#x2013;
						<lpage>484</lpage>.
						<pub-id pub-id-type="pmid">32369104</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0149">
					<label>[149]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Iliev</surname>
								<given-names>R</given-names>
							</string-name>,
							<string-name>
								<surname>Fedorko</surname>
								<given-names>M</given-names>
							</string-name>,
							<string-name>
								<surname>Machackova</surname>
								<given-names>T</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Expression levels of PIWI-interacting RNA, piR-823, are deregulated in tumor tissue, blood serum and urine of patients with renal cell carcinoma</article-title>.
						<source>Anticancer Res</source>.
						<year>2016</year>;
						<volume>36</volume>(
						<issue>12</issue>):
						<fpage>6419</fpage>&#x2013;
						<lpage>6423</lpage>.
						<pub-id pub-id-type="pmid">27919963</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0150">
					<label>[150]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Ogawa</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Taketomi</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Murakami</surname>
								<given-names>M</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Small RNA transcriptomes of two types of exosomes in human whole saliva determined by next generation sequencing</article-title>.
						<source>Biol Pharm Bull</source>.
						<year>2013</year>;
						<volume>36</volume>(
						<issue>1</issue>):
						<fpage>66</fpage>&#x2013;
						<lpage>75</lpage>.
						<pub-id pub-id-type="pmid">23302638</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0151">
					<label>[151]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Vychytilova-Faltejskova</surname>
								<given-names>P</given-names>
							</string-name>,
							<string-name>
								<surname>Stitkovcova</surname>
								<given-names>K</given-names>
							</string-name>,
							<string-name>
								<surname>Radova</surname>
								<given-names>L</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Circulating PIWI-interacting RNAs piR-5937 and piR-28876 are promising diagnostic biomarkers of colon cancer</article-title>.
						<source>Cancer Epidemiology Biomarkers &amp; Prevention</source>.
						<year>2018</year>;
						<volume>27</volume>(
						<issue>9</issue>):
						<fpage>1019</fpage>&#x2013;
						<lpage>1028</lpage>.
					</mixed-citation>
				</ref>
				<ref id="cit0152">
					<label>[152]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Wang</surname>
								<given-names>Z</given-names>
							</string-name>,
							<string-name>
								<surname>Yang</surname>
								<given-names>H</given-names>
							</string-name>,
							<string-name>
								<surname>Ma</surname>
								<given-names>D</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Serum PIWI-interacting RNAs piR-020619 and piR-020450 are promising novel biomarkers for early detection of colorectal cancer</article-title>.
						<source>Cancer Epidemiol Prev Biomarkers</source>.
						<year>2020</year>;
						<volume>29</volume>(
						<issue>5</issue>):
						<fpage>990</fpage>&#x2013;
						<lpage>998</lpage>.
					</mixed-citation>
				</ref>
				<ref id="cit0153">
					<label>[153]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Zhou</surname>
								<given-names>X</given-names>
							</string-name>,
							<string-name>
								<surname>Liu</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Meng</surname>
								<given-names>A</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Gastric juice piR&#x2010;1245: a promising prognostic biomarker for gastric cancer</article-title>.
						<source>J Clin Lab Anal</source>.
						<year>2020</year>;
						<volume>34</volume>(
						<issue>4</issue>):
						<fpage>e23131</fpage>.
						<pub-id pub-id-type="pmid">31777102</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0154">
					<label>[154]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Houwing</surname>
								<given-names>S</given-names>
							</string-name>,
							<string-name>
								<surname>Kamminga</surname>
								<given-names>LM</given-names>
							</string-name>,
							<string-name>
								<surname>Berezikov</surname>
								<given-names>E</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>A role for Piwi and piRNAs in germ cell maintenance and transposon silencing in Zebrafish</article-title>.
						<source>cell</source>.
						<year>2007</year>;
						<volume>129</volume>(
						<issue>1</issue>):
						<fpage>69</fpage>&#x2013;
						<lpage>82</lpage>.
						<pub-id pub-id-type="pmid">17418787</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0155">
					<label>[155]</label>
					<mixed-citation publication-type="book">
						<person-group person-group-type="author">
							<string-name>
								<surname>Sarkar</surname>
								<given-names>A</given-names>
							</string-name>,
							<string-name>
								<surname>Ghosh</surname>
								<given-names>Z</given-names>
							</string-name>
						</person-group>.
						<part-title>Rejuvenation of piRNAs in emergence of cancer and other diseases</part-title>. In: Bibekanand Mallick
						<source>AGO-driven non-coding RNAs</source>. USA:
						<publisher-name>Elsevier</publisher-name>;
						<year>2019</year>. p.
						<fpage>319</fpage>&#x2013;
						<lpage>333</lpage>.
					</mixed-citation>
				</ref>
				<ref id="cit0156">
					<label>[156]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Cheng</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Deng</surname>
								<given-names>H</given-names>
							</string-name>,
							<string-name>
								<surname>Xiao</surname>
								<given-names>B</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>piR-823, a novel non-coding small RNA, demonstrates in vitro and in vivo tumor suppressive activity in human gastric cancer cells</article-title>.
						<source>Cancer Lett</source>.
						<year>2012</year>;
						<volume>315</volume>(
						<issue>1</issue>):
						<fpage>12</fpage>&#x2013;
						<lpage>17</lpage>.
						<pub-id pub-id-type="pmid">22047710</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0157">
					<label>[157]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Zhou</surname>
								<given-names>H</given-names>
							</string-name>,
							<string-name>
								<surname>Guo</surname>
								<given-names>J-M</given-names>
							</string-name>,
							<string-name>
								<surname>Lou</surname>
								<given-names>Y-R</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker</article-title>.
						<source>J Mol Med</source>.
						<year>2010</year>;
						<volume>88</volume>(
						<issue>7</issue>):
						<fpage>709</fpage>&#x2013;
						<lpage>717</lpage>.
						<pub-id pub-id-type="pmid">20349219</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0158">
					<label>[158]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Wu</surname>
								<given-names>X</given-names>
							</string-name>,
							<string-name>
								<surname>Pan</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Fang</surname>
								<given-names>Y</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>The biogenesis and functions of piRNAs in human diseases</article-title>.
						<source>Mol Ther Nucleic Acids</source>.
						<year>2020b</year>;
						<volume>21</volume>:
						<fpage>108</fpage>&#x2013;
						<lpage>120</lpage>.
						<pub-id pub-id-type="pmid">32516734</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0159">
					<label>[159]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Ren</surname>
								<given-names>Z</given-names>
							</string-name>,
							<string-name>
								<surname>Li</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Hameed</surname>
								<given-names>O</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Prognostic factors in patients with metastatic breast cancer at the time of diagnosis</article-title>.
						<source>Pathol Res Pract</source>.
						<year>2014</year>;
						<volume>210</volume>(
						<issue>5</issue>):
						<fpage>301</fpage>&#x2013;
						<lpage>306</lpage>.
						<pub-id pub-id-type="pmid">24635972</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0160">
					<label>[160]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Zhang</surname>
								<given-names>H</given-names>
							</string-name>,
							<string-name>
								<surname>Ren</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Xu</surname>
								<given-names>H</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>The expression of stem cell protein Piwil2 and piR-932 in breast cancer</article-title>.
						<source>Surg Oncol</source>.
						<year>2013</year>;
						<volume>22</volume>(
						<issue>4</issue>):
						<fpage>217</fpage>&#x2013;
						<lpage>223</lpage>.
						<pub-id pub-id-type="pmid">23992744</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0161">
					<label>[161]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Krishnan</surname>
								<given-names>P</given-names>
							</string-name>,
							<string-name>
								<surname>Ghosh</surname>
								<given-names>S</given-names>
							</string-name>,
							<string-name>
								<surname>Graham</surname>
								<given-names>K</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Piwi-interacting RNAs and PIWI genes as novel prognostic markers for breast cancer</article-title>.
						<source>Oncotarget</source>.
						<year>2016</year>;
						<volume>7</volume>(
						<issue>25</issue>):
						<fpage>37944</fpage>.
						<pub-id pub-id-type="pmid">27177224</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0162">
					<label>[162]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Li</surname>
								<given-names>D</given-names>
							</string-name>,
							<string-name>
								<surname>Luo</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Gao</surname>
								<given-names>Y</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>piR-651 promotes tumor formation in non-small cell lung carcinoma through the upregulation of cyclin D1 and CDK4</article-title>.
						<source>Int J Mol Med</source>.
						<year>2016</year>;
						<volume>38</volume>(
						<issue>3</issue>):
						<fpage>927</fpage>&#x2013;
						<lpage>936</lpage>.
						<pub-id pub-id-type="pmid">27431575</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0163">
					<label>[163]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Yao</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Wang</surname>
								<given-names>YW</given-names>
							</string-name>,
							<string-name>
								<surname>Fang</surname>
								<given-names>BB</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>piR-651 and its function in 95-D lung cancer cells</article-title>.
						<source>Biomed Rep</source>.
						<year>2016</year>;
						<volume>4</volume>(
						<issue>5</issue>):
						<fpage>546</fpage>&#x2013;
						<lpage>550</lpage>.
						<pub-id pub-id-type="pmid">27123245</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0164">
					<label>[164]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Peng</surname>
								<given-names>L</given-names>
							</string-name>,
							<string-name>
								<surname>Song</surname>
								<given-names>L</given-names>
							</string-name>,
							<string-name>
								<surname>Liu</surname>
								<given-names>C</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>piR-55490 inhibits the growth of lung carcinoma by suppressing mTOR signaling</article-title>.
						<source>Tumor Biol</source>.
						<year>2016</year>;
						<volume>37</volume>(
						<issue>2</issue>):
						<fpage>2749</fpage>&#x2013;
						<lpage>2756</lpage>.
					</mixed-citation>
				</ref>
				<ref id="cit0165">
					<label>[165]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Chu</surname>
								<given-names>H</given-names>
							</string-name>,
							<string-name>
								<surname>Xia</surname>
								<given-names>L</given-names>
							</string-name>,
							<string-name>
								<surname>Qiu</surname>
								<given-names>X</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Genetic variants in noncoding PIWI&#x2010;interacting RNA and colorectal cancer risk</article-title>.
						<source>Cancer</source>.
						<year>2015</year>;
						<volume>121</volume>(
						<issue>12</issue>):
						<fpage>2044</fpage>&#x2013;
						<lpage>2052</lpage>.
						<pub-id pub-id-type="pmid">25740697</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0166">
					<label>[166]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Mai</surname>
								<given-names>D</given-names>
							</string-name>,
							<string-name>
								<surname>Zheng</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Guo</surname>
								<given-names>H</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Serum piRNA-54265 is a new biomarker for early detection and clinical surveillance of human colorectal cancer</article-title>.
						<source>Theranostics</source>.
						<year>2020</year>;
						<volume>10</volume>(
						<issue>19</issue>):
						<fpage>8468</fpage>.
						<pub-id pub-id-type="pmid">32754257</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0167">
					<label>[167]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Yin</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Jiang</surname>
								<given-names>XY</given-names>
							</string-name>,
							<string-name>
								<surname>Qi</surname>
								<given-names>W</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>piR&#x2010;823 contributes to colorectal tumorigenesis by enhancing the transcriptional activity of HSF 1</article-title>.
						<source>Cancer Sci</source>.
						<year>2017</year>;
						<volume>108</volume>(
						<issue>9</issue>):
						<fpage>1746</fpage>&#x2013;
						<lpage>1756</lpage>.
						<pub-id pub-id-type="pmid">28618124</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0168">
					<label>[168]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Yin</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Qi</surname>
								<given-names>W</given-names>
							</string-name>,
							<string-name>
								<surname>Ji</surname>
								<given-names>CG</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Small RNA sequencing revealed aberrant piRNA expression profiles in colorectal cancer</article-title>.
						<source>Oncol Rep</source>.
						<year>2019</year>;
						<volume>42</volume>(
						<issue>1</issue>):
						<fpage>263</fpage>&#x2013;
						<lpage>272</lpage>.
						<pub-id pub-id-type="pmid">31115555</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0169">
					<label>[169]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>&#xD6;ner</surname>
								<given-names>&#xC7;</given-names>
							</string-name>,
							<string-name>
								<surname>Turgut Co&#x15F;an</surname>
								<given-names>D</given-names>
							</string-name>,
							<string-name>
								<surname>&#xC7;olak</surname>
								<given-names>E</given-names>
							</string-name>
						</person-group>.
						<article-title>Estrogen and androgen hormone levels modulate the expression of PIWI interacting RNA in prostate and breast cancer</article-title>.
						<source>PLoS One</source>.
						<year>2016</year>;
						<volume>11</volume>(
						<issue>7</issue>):
						<fpage>e0159044</fpage>.
						<pub-id pub-id-type="pmid">27414029</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0170">
					<label>[170]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Busch</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Ralla</surname>
								<given-names>B</given-names>
							</string-name>,
							<string-name>
								<surname>Jung</surname>
								<given-names>M</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Piwi-interacting RNAs as novel prognostic markers in clear cell renal cell carcinomas</article-title>.
						<source>J Exp Clin Cancer Res</source>.
						<year>2015b</year>;
						<volume>34</volume>(
						<issue>1</issue>):
						<fpage>61</fpage>.
						<pub-id pub-id-type="pmid">26071182</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0171">
					<label>[171]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Busch</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Ralla</surname>
								<given-names>B</given-names>
							</string-name>,
							<string-name>
								<surname>Jung</surname>
								<given-names>M</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Piwi-interacting RNAs as novel prognostic markers in clear cell renal cell carcinomas</article-title>.
						<source>J Exp Clin Cancer Res</source>.
						<year>2015a</year>;
						<volume>34</volume>(
						<issue>1</issue>):
						<fpage>1</fpage>&#x2013;
						<lpage>11</lpage>.
						<pub-id pub-id-type="pmid">25592960</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0172">
					<label>[172]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Chang</surname>
								<given-names>Z</given-names>
							</string-name>,
							<string-name>
								<surname>Ji</surname>
								<given-names>G</given-names>
							</string-name>,
							<string-name>
								<surname>Huang</surname>
								<given-names>R</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>PIWI-interacting RNAs piR-13643 and piR-21238 are promising diagnostic biomarkers of papillary thyroid carcinoma</article-title>.
						<source>Aging (Albany NY)</source>.
						<year>2020</year>;
						<volume>12</volume>(
						<issue>10</issue>):
						<fpage>9292</fpage>.
						<pub-id pub-id-type="pmid">32428871</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0173">
					<label>[173]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Han</surname>
								<given-names>H</given-names>
							</string-name>,
							<string-name>
								<surname>Fan</surname>
								<given-names>G</given-names>
							</string-name>,
							<string-name>
								<surname>Song</surname>
								<given-names>S</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>piRNA-30473 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in DLBCL</article-title>.
						<source>Blood</source>.
						<year>2021</year>;
						<volume>137</volume>(
						<issue>12</issue>):
						<fpage>1603</fpage>&#x2013;
						<lpage>1614</lpage>.
						<pub-id pub-id-type="pmid">32967010</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0174">
					<label>[174]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Litwin</surname>
								<given-names>M</given-names>
							</string-name>,
							<string-name>
								<surname>Szczepa&#x144;ska&#x2011;Buda</surname>
								<given-names>A</given-names>
							</string-name>,
							<string-name>
								<surname>Piotrowska</surname>
								<given-names>A</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>The meaning of PIWI proteins in cancer development</article-title>.
						<source>Oncol Lett</source>.
						<year>2017</year>;
						<volume>13</volume>(
						<issue>5</issue>):
						<fpage>3354</fpage>&#x2013;
						<lpage>3362</lpage>.
						<pub-id pub-id-type="pmid">28529570</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0175">
					<label>[175]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Qiao</surname>
								<given-names>D</given-names>
							</string-name>,
							<string-name>
								<surname>Zeeman</surname>
								<given-names>A-M</given-names>
							</string-name>,
							<string-name>
								<surname>Deng</surname>
								<given-names>W</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Molecular characterization of hiwi, a human member of the piwi gene family whose overexpression is correlated to seminomas</article-title>.
						<source>Oncogene</source>.
						<year>2002</year>;
						<volume>21</volume>(
						<issue>25</issue>):
						<fpage>3988</fpage>&#x2013;
						<lpage>3999</lpage>.
						<pub-id pub-id-type="pmid">12037681</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0176">
					<label>[176]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Gao</surname>
								<given-names>C-L</given-names>
							</string-name>,
							<string-name>
								<surname>Sun</surname>
								<given-names>R</given-names>
							</string-name>,
							<string-name>
								<surname>Li</surname>
								<given-names>D-H</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>PIWI-like protein 1 upregulation promotes gastric cancer invasion and metastasis</article-title>.
						<source>Onco Targets Ther</source>.
						<year>2018</year>;
						<volume>11</volume>:
						<fpage>8783</fpage>.
						<pub-id pub-id-type="pmid">30584336</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0177">
					<label>[177]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Wang</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Liu</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Shen</surname>
								<given-names>X</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>The PIWI protein acts as a predictive marker for human gastric cancer</article-title>.
						<source>Int J Clin Exp Pathol</source>.
						<year>2012</year>;
						<volume>5</volume>(
						<issue>4</issue>):
						<fpage>315</fpage>.
						<pub-id pub-id-type="pmid">22670175</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0178">
					<label>[178]</label>
					<mixed-citation publication-type="confproc">
						<person-group person-group-type="author">
							<string-name>
								<surname>Genzor</surname>
								<given-names>P</given-names>
							</string-name>,
							<string-name>
								<surname>Cordts</surname>
								<given-names>SC</given-names>
							</string-name>,
							<string-name>
								<surname>Bokil</surname>
								<given-names>NV</given-names>
							</string-name>, et al
						</person-group>. (
						<year>2019</year>).
						<article-title>Aberrant expression of select piRNA-pathway genes does not reactivate piRNA silencing in cancer cells</article-title>.
						<conf-name>
							<italic toggle="yes">Proceedings of the National Academy of Sciences</italic>
						</conf-name>,
						<italic toggle="yes">USA</italic>,
						<volume>116</volume>(
						<comment>23</comment>),
						<fpage>11111</fpage>&#x2013;
						<lpage>11112</lpage>.
					</mixed-citation>
				</ref>
				<ref id="cit0179">
					<label>[179]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Li</surname>
								<given-names>F</given-names>
							</string-name>,
							<string-name>
								<surname>Yuan</surname>
								<given-names>P</given-names>
							</string-name>,
							<string-name>
								<surname>Rao</surname>
								<given-names>M</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>piRNA-independent function of PIWIL1 as a co-activator for anaphase promoting complex/cyclosome to drive pancreatic cancer metastasis</article-title>.
						<source>Nat Cell Biol</source>.
						<year>2020</year>;
						<volume>22</volume>(
						<issue>4</issue>):
						<fpage>425</fpage>&#x2013;
						<lpage>438</lpage>.
						<pub-id pub-id-type="pmid">32203416</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0180">
					<label>[180]</label>
					<mixed-citation publication-type="confproc">
						<person-group person-group-type="author">
							<string-name>
								<surname>Shi</surname>
								<given-names>S</given-names>
							</string-name>,
							<string-name>
								<surname>Yang</surname>
								<given-names>-Z-Z</given-names>
							</string-name>,
							<string-name>
								<surname>Liu</surname>
								<given-names>S</given-names>
							</string-name>, et al
						</person-group>. (
						<year>2020</year>).
						<article-title>PIWIL1 promotes gastric cancer via a piRNA-independent mechanism</article-title>.
						<conf-name>
							<italic toggle="yes">Proceedings of the National Academy of Sciences</italic>
						</conf-name>,
						<italic toggle="yes">USA</italic>,
						<volume>117</volume>(
						<comment>36</comment>),
						<fpage>22390</fpage>&#x2013;
						<lpage>22401</lpage>.
					</mixed-citation>
				</ref>
				<ref id="cit0181">
					<label>[181]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Gou</surname>
								<given-names>L-T</given-names>
							</string-name>,
							<string-name>
								<surname>Kang</surname>
								<given-names>J-Y</given-names>
							</string-name>,
							<string-name>
								<surname>Dai</surname>
								<given-names>P</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Ubiquitination-deficient mutations in human Piwi cause male infertility by impairing histone-to-protamine exchange during spermiogenesis</article-title>.
						<source>cell</source>.
						<year>2017</year>;
						<volume>169</volume>(
						<issue>6</issue>):
						<fpage>1090</fpage>&#x2013;
						<lpage>1104. e1013</lpage>.
						<pub-id pub-id-type="pmid">28552346</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0182">
					<label>[182]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Su</surname>
								<given-names>C</given-names>
							</string-name>,
							<string-name>
								<surname>Ren</surname>
								<given-names>Z-J</given-names>
							</string-name>,
							<string-name>
								<surname>Wang</surname>
								<given-names>F</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>PIWIL4 regulates cervical cancer cell line growth and is involved in down-regulating the expression of p14ARF and p53</article-title>.
						<source>FEBS Lett</source>.
						<year>2012</year>;
						<volume>586</volume>(
						<issue>9</issue>):
						<fpage>1356</fpage>&#x2013;
						<lpage>1362</lpage>.
						<pub-id pub-id-type="pmid">22483988</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0183">
					<label>[183]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Litwin</surname>
								<given-names>M</given-names>
							</string-name>,
							<string-name>
								<surname>Dubis</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Arczy&#x144;ska</surname>
								<given-names>K</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Correlation of HIWI and HILI expression with cancer stem cell markers in colorectal cancer</article-title>.
						<source>Anticancer Res</source>.
						<year>2015</year>;
						<volume>35</volume>(
						<issue>6</issue>):
						<fpage>3317</fpage>&#x2013;
						<lpage>3324</lpage>.
						<pub-id pub-id-type="pmid">26026091</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0184">
					<label>[184]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Martinez</surname>
								<given-names>VD</given-names>
							</string-name>,
							<string-name>
								<surname>Enfield</surname>
								<given-names>KS</given-names>
							</string-name>,
							<string-name>
								<surname>Rowbotham</surname>
								<given-names>DA</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>An atlas of gastric PIWI-interacting RNA transcriptomes and their utility for identifying signatures of gastric cancer recurrence</article-title>.
						<source>Gastric Cancer</source>.
						<year>2016</year>;
						<volume>19</volume>(
						<issue>2</issue>):
						<fpage>660</fpage>&#x2013;
						<lpage>665</lpage>.
						<pub-id pub-id-type="pmid">25779424</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0185">
					<label>[185]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Sugimoto</surname>
								<given-names>K</given-names>
							</string-name>,
							<string-name>
								<surname>Kage</surname>
								<given-names>H</given-names>
							</string-name>,
							<string-name>
								<surname>Aki</surname>
								<given-names>N</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>The induction of H3K9 methylation by PIWIL4 at the p16Ink4a locus</article-title>.
						<source>Biochem Biophys Res Commun</source>.
						<year>2007</year>;
						<volume>359</volume>(
						<issue>3</issue>):
						<fpage>497</fpage>&#x2013;
						<lpage>502</lpage>.
						<pub-id pub-id-type="pmid">17544373</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0186">
					<label>[186]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Liang</surname>
								<given-names>D</given-names>
							</string-name>,
							<string-name>
								<surname>Yang</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Liu</surname>
								<given-names>Y</given-names>
							</string-name>
						</person-group>.
						<article-title>The role Hiwi gene in the maintenance of lung cancer stem cell populations</article-title>.
						<source>Neoplasma</source>.
						<year>2013</year>. DOI:
						<pub-id pub-id-type="doi">10.4149/neo_2014_022</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0187">
					<label>[187]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Singh</surname>
								<given-names>G</given-names>
							</string-name>,
							<string-name>
								<surname>Roy</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Rout</surname>
								<given-names>P</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Genome-wide profiling of the PIWI-interacting RNA-mRNA regulatory networks in epithelial ovarian cancers</article-title>.
						<source>PLoS One</source>.
						<year>2018</year>;
						<volume>13</volume>(
						<issue>1</issue>):
						<fpage>e0190485</fpage>.
						<pub-id pub-id-type="pmid">29320577</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0188">
					<label>[188]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Lu</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Zhang</surname>
								<given-names>K</given-names>
							</string-name>,
							<string-name>
								<surname>Li</surname>
								<given-names>C</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Piwil2 suppresses p53 by inducing phosphorylation of signal transducer and activator of transcription 3 in tumor cells</article-title>.
						<source>PLoS One</source>.
						<year>2012</year>;
						<volume>7</volume>(
						<issue>1</issue>):
						<fpage>e30999</fpage>.
						<pub-id pub-id-type="pmid">22303479</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0189">
					<label>[189]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Network</surname>
								<given-names>CGAR</given-names>
							</string-name>
						</person-group>.
						<article-title>Comprehensive genomic characterization defines human glioblastoma genes and core pathways</article-title>.
						<source>Nature</source>.
						<year>2008</year>;
						<volume>455</volume>(
						<issue>7216</issue>):
						<fpage>1061</fpage>.
						<pub-id pub-id-type="pmid">18772890</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0190">
					<label>[190]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Taubert</surname>
								<given-names>H</given-names>
							</string-name>,
							<string-name>
								<surname>Greither</surname>
								<given-names>T</given-names>
							</string-name>,
							<string-name>
								<surname>Kaushal</surname>
								<given-names>D</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Expression of the stem cell self-renewal gene Hiwi and risk of tumour-related death in patients with soft-tissue sarcoma</article-title>.
						<source>Oncogene</source>.
						<year>2007</year>;
						<volume>26</volume>(
						<issue>7</issue>):
						<fpage>1098</fpage>&#x2013;
						<lpage>1100</lpage>.
						<pub-id pub-id-type="pmid">16953229</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0191">
					<label>[191]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Sun</surname>
								<given-names>G</given-names>
							</string-name>,
							<string-name>
								<surname>Wang</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Sun</surname>
								<given-names>L</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Clinical significance of Hiwi gene expression in gliomas</article-title>.
						<source>Brain Res</source>.
						<year>2011</year>;
						<volume>1373</volume>:
						<fpage>183</fpage>&#x2013;
						<lpage>188</lpage>.
						<pub-id pub-id-type="pmid">21138738</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0192">
					<label>[192]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Ye</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Yin</surname>
								<given-names>D-T</given-names>
							</string-name>,
							<string-name>
								<surname>Chen</surname>
								<given-names>L</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Identification of Piwil2-like (PL2L) proteins that promote tumorigenesis</article-title>.
						<source>PLoS One</source>.
						<year>2010</year>;
						<volume>5</volume>(
						<issue>10</issue>):
						<fpage>e13406</fpage>.
						<pub-id pub-id-type="pmid">20975993</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0193">
					<label>[193]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Oh</surname>
								<given-names>S-J</given-names>
							</string-name>,
							<string-name>
								<surname>Kim</surname>
								<given-names>S-M</given-names>
							</string-name>,
							<string-name>
								<surname>Kim</surname>
								<given-names>Y-O</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Clinicopathologic implications of PIWIL2 expression in colorectal cancer</article-title>.
						<source>Korean J Pathol</source>.
						<year>2012</year>;
						<volume>46</volume>(
						<issue>4</issue>):
						<fpage>318</fpage>.
						<pub-id pub-id-type="pmid">23110023</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0194">
					<label>[194]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Yan</surname>
								<given-names>Z</given-names>
							</string-name>,
							<string-name>
								<surname>Qu</surname>
								<given-names>L-K</given-names>
							</string-name>,
							<string-name>
								<surname>Lin</surname>
								<given-names>M</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>HIWI expression profile in cancer cells and its prognostic value for patients with colorectal cancer</article-title>.
						<source>Chin Med J (Engl)</source>.
						<year>2011</year>;
						<volume>124</volume>(
						<issue>14</issue>):
						<fpage>2144</fpage>&#x2013;
						<lpage>2149</lpage>.
						<pub-id pub-id-type="pmid">21933617</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0195">
					<label>[195]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Xie</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Yang</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Ji</surname>
								<given-names>D</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Hiwi downregulation, mediated by shRNA, reduces the proliferation and migration of human hepatocellular carcinoma cells</article-title>.
						<source>Mol Med Rep</source>.
						<year>2015</year>;
						<volume>11</volume>(
						<issue>2</issue>):
						<fpage>1455</fpage>&#x2013;
						<lpage>1461</lpage>.
						<pub-id pub-id-type="pmid">25370791</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0196">
					<label>[196]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Lee</surname>
								<given-names>JH</given-names>
							</string-name>,
							<string-name>
								<surname>Jung</surname>
								<given-names>C</given-names>
							</string-name>,
							<string-name>
								<surname>Javadian-Elyaderani</surname>
								<given-names>P</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Pathways of proliferation and antiapoptosis driven in breast cancer stem cells by stem cell protein piwil2</article-title>.
						<source>Cancer Res</source>.
						<year>2010</year>;
						<volume>70</volume>(
						<issue>11</issue>):
						<fpage>4569</fpage>&#x2013;
						<lpage>4579</lpage>.
						<pub-id pub-id-type="pmid">20460541</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0197">
					<label>[197]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Klein</surname>
								<given-names>JD</given-names>
							</string-name>,
							<string-name>
								<surname>Qu</surname>
								<given-names>C</given-names>
							</string-name>,
							<string-name>
								<surname>Yang</surname>
								<given-names>X</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>c-Fos repression by piwi regulates Drosophila ovarian germline formation and tissue morphogenesis</article-title>.
						<source>PLoS Genet</source>.
						<year>2016</year>;
						<volume>12</volume>(
						<issue>9</issue>):
						<fpage>e1006281</fpage>.
						<pub-id pub-id-type="pmid">27622269</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0198">
					<label>[198]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>He</surname>
								<given-names>G</given-names>
							</string-name>,
							<string-name>
								<surname>Chen</surname>
								<given-names>L</given-names>
							</string-name>,
							<string-name>
								<surname>Ye</surname>
								<given-names>Y</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Piwil2 expressed in various stages of cervical neoplasia is a potential complementary marker for p16INK4a</article-title>.
						<source>Am J Transl Res</source>.
						<year>2010</year>;
						<volume>2</volume>(
						<issue>2</issue>):
						<fpage>156</fpage>.
						<pub-id pub-id-type="pmid">20407605</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0199">
					<label>[199]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Jiang</surname>
								<given-names>L</given-names>
							</string-name>,
							<string-name>
								<surname>Wang</surname>
								<given-names>W-J</given-names>
							</string-name>,
							<string-name>
								<surname>Li</surname>
								<given-names>Z-W</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Downregulation of Piwil3 suppresses cell proliferation, migration and invasion in gastric cancer</article-title>.
						<source>Cancer Biomarkers</source>.
						<year>2017</year>;
						<volume>20</volume>(
						<issue>4</issue>):
						<fpage>499</fpage>&#x2013;
						<lpage>509</lpage>.
						<pub-id pub-id-type="pmid">28869440</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0200">
					<label>[200]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Wang</surname>
								<given-names>D-W</given-names>
							</string-name>,
							<string-name>
								<surname>Wang</surname>
								<given-names>Z-H</given-names>
							</string-name>,
							<string-name>
								<surname>Wang</surname>
								<given-names>-L-L</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Overexpression of hiwi promotes growth of human breast cancer cells</article-title>.
						<source>Asian Pac J Cancer Prev</source>.
						<year>2014</year>;
						<volume>15</volume>(
						<issue>18</issue>):
						<fpage>7553</fpage>&#x2013;
						<lpage>7558</lpage>.
						<pub-id pub-id-type="pmid">25292027</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0201">
					<label>[201]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Qu</surname>
								<given-names>X</given-names>
							</string-name>,
							<string-name>
								<surname>Liu</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Zhong</surname>
								<given-names>X</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>PIWIL2 promotes progression of non-small cell lung cancer by inducing CDK2 and Cyclin A expression</article-title>.
						<source>J Transl Med</source>.
						<year>2015</year>;
						<volume>13</volume>(
						<issue>1</issue>):
						<fpage>301</fpage>.
						<pub-id pub-id-type="pmid">26373553</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0202">
					<label>[202]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Li</surname>
								<given-names>L</given-names>
							</string-name>,
							<string-name>
								<surname>Yu</surname>
								<given-names>C</given-names>
							</string-name>,
							<string-name>
								<surname>Gao</surname>
								<given-names>H</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Argonaute proteins: potential biomarkers for human colon cancer</article-title>.
						<source>BMC Cancer</source>.
						<year>2010</year>;
						<volume>10</volume>(
						<issue>1</issue>):
						<fpage>38</fpage>.
						<pub-id pub-id-type="pmid">20146808</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0203">
					<label>[203]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Liu</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Dou</surname>
								<given-names>M</given-names>
							</string-name>,
							<string-name>
								<surname>Song</surname>
								<given-names>X</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>The emerging role of the piRNA/piwi complex in cancer</article-title>.
						<source>Mol Cancer</source>.
						<year>2019</year>;
						<volume>18</volume>(
						<issue>1</issue>):
						<fpage>123</fpage>.
						<pub-id pub-id-type="pmid">31399034</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0204">
					<label>[204]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Sai Lakshmi</surname>
								<given-names>S</given-names>
							</string-name>,
							<string-name>
								<surname>Agrawal</surname>
								<given-names>S</given-names>
							</string-name>
						</person-group>.
						<article-title>piRNABank: a web resource on classified and clustered Piwi-interacting RNAs</article-title>.
						<source>Nucleic Acids Res</source>.
						<year>2008</year>;
						<volume>36</volume>(
						<issue>suppl_1</issue>):
						<fpage>D173</fpage>&#x2013;
						<lpage>D177</lpage>.
						<pub-id pub-id-type="pmid">17881367</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0205">
					<label>[205]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Han</surname>
								<given-names>Y-N</given-names>
							</string-name>,
							<string-name>
								<surname>Li</surname>
								<given-names>Y</given-names>
							</string-name>,
							<string-name>
								<surname>Xia</surname>
								<given-names>S-Q</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>PIWI proteins and PIWI-interacting RNA: emerging roles in cancer</article-title>.
						<source>Cell Physiol Biochem</source>.
						<year>2017</year>;
						<volume>44</volume>(
						<issue>1</issue>):
						<fpage>1</fpage>&#x2013;
						<lpage>20</lpage>.
						<pub-id pub-id-type="pmid">29130960</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0206">
					<label>[206]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Wang</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Zhang</surname>
								<given-names>P</given-names>
							</string-name>,
							<string-name>
								<surname>Lu</surname>
								<given-names>Y</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>piRBase: a comprehensive database of piRNA sequences</article-title>.
						<source>Nucleic Acids Res</source>.
						<year>2019</year>;
						<volume>47</volume>(
						<issue>D1</issue>):
						<fpage>D175</fpage>&#x2013;
						<lpage>D180</lpage>.
						<pub-id pub-id-type="pmid">30371818</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0207">
					<label>[207]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Williams</surname>
								<given-names>KP</given-names>
							</string-name>,
							<string-name>
								<surname>Lau</surname>
								<given-names>BY</given-names>
							</string-name>
						</person-group>.
						<article-title>RNAcentral: a comprehensive database of non-coding RNA sequences</article-title>.
						<source>Nucleic Acids Res</source>.
						<year>2016</year>;
						<volume>45</volume>:
						<page-range>SAND-2017-0752J</page-range>.
					</mixed-citation>
				</ref>
				<ref id="cit0208">
					<label>[208]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Wang</surname>
								<given-names>X</given-names>
							</string-name>,
							<string-name>
								<surname>Tong</surname>
								<given-names>X</given-names>
							</string-name>,
							<string-name>
								<surname>Gao</surname>
								<given-names>H</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Silencing HIWI suppresses the growth, invasion and migration of glioma cells</article-title>.
						<source>Int J Oncol</source>.
						<year>2014</year>;
						<volume>45</volume>(
						<issue>6</issue>):
						<fpage>2385</fpage>&#x2013;
						<lpage>2392</lpage>.
						<pub-id pub-id-type="pmid">25269862</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0209">
					<label>[209]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Wang</surname>
								<given-names>Z</given-names>
							</string-name>,
							<string-name>
								<surname>Ma</surname>
								<given-names>K</given-names>
							</string-name>,
							<string-name>
								<surname>Pitts</surname>
								<given-names>S</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Novel circular RNA circNF1 acts as a molecular sponge, promoting gastric cancer by absorbing miR-16</article-title>.
						<source>Endocr Relat Cancer</source>.
						<year>2019</year>;
						<volume>26</volume>(
						<issue>3</issue>):
						<fpage>265</fpage>&#x2013;
						<lpage>277</lpage>.
						<pub-id pub-id-type="pmid">30576282</pub-id>
					</mixed-citation>
				</ref>
				<ref id="cit0210">
					<label>[210]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<string-name>
								<surname>Xin</surname>
								<given-names>J</given-names>
							</string-name>,
							<string-name>
								<surname>Du</surname>
								<given-names>M</given-names>
							</string-name>,
							<string-name>
								<surname>Jiang</surname>
								<given-names>X</given-names>
							</string-name>, et al
						</person-group>.
						<article-title>Systematic evaluation of the effects of genetic variants on PIWI-interacting RNA expression across 33 cancer types</article-title>.
						<source>Nucleic Acids Res</source>.
						<year>2021</year>;
						<volume>49</volume>(
						<issue>1</issue>):
						<fpage>90</fpage>&#x2013;
						<lpage>97</lpage>.
						<pub-id pub-id-type="pmid">33330918</pub-id>
					</mixed-citation>
				</ref>
			</ref-list>
		</back>
	</article>
	<article
		xmlns:mml="http://www.w3.org/1998/Math/MathML"
		xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
		<?properties open_access?>
		<front>
			<journal-meta>
				<journal-id journal-id-type="nlm-ta">J Cell Biol</journal-id>
				<journal-id journal-id-type="iso-abbrev">J Cell Biol</journal-id>
				<journal-id journal-id-type="publisher-id">jcb</journal-id>
				<journal-title-group>
					<journal-title>The Journal of Cell Biology</journal-title>
				</journal-title-group>
				<issn pub-type="ppub">0021-9525</issn>
				<issn pub-type="epub">1540-8140</issn>
				<publisher>
					<publisher-name>Rockefeller University Press</publisher-name>
				</publisher>
			</journal-meta>
			<article-meta>
				<article-id pub-id-type="pmid">33704371</article-id>
				<article-id pub-id-type="pmc">7953258</article-id>
				<article-id pub-id-type="publisher-id">jcb.202008030</article-id>
				<article-id pub-id-type="doi">10.1083/jcb.202008030</article-id>
				<article-categories>
					<subj-group subj-group-type="heading">
						<subject>Article</subject>
					</subj-group>
					<subj-group subj-group-type="category">
						<subject>DNA biology</subject>
						<subject>Biochemistry</subject>
					</subj-group>
				</article-categories>
				<title-group>
					<article-title>FUS-dependent liquid&#x2013;liquid phase separation is important for DNA repair initiation</article-title>
					<alt-title alt-title-type="short">FUS-dependent LLPS in DDR signaling</alt-title>
				</title-group>
				<contrib-group>
					<contrib contrib-type="author">
						<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3368-4261</contrib-id>
						<name>
							<surname>Levone</surname>
							<given-names>Brunno R.</given-names>
						</name>
						<xref ref-type="aff" rid="aff1">1</xref>
					</contrib>
					<contrib contrib-type="author">
						<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5759-8133</contrib-id>
						<name>
							<surname>Lenzken</surname>
							<given-names>Silvia C.</given-names>
						</name>
						<xref ref-type="aff" rid="aff1">1</xref>
					</contrib>
					<contrib contrib-type="author">
						<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5255-465X</contrib-id>
						<name>
							<surname>Antonaci</surname>
							<given-names>Marco</given-names>
						</name>
						<xref ref-type="aff" rid="aff1">1</xref>
					</contrib>
					<contrib contrib-type="author">
						<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2349-5822</contrib-id>
						<name>
							<surname>Maiser</surname>
							<given-names>Andreas</given-names>
						</name>
						<xref ref-type="aff" rid="aff2">2</xref>
						<xref ref-type="author-notes" rid="afn1">*</xref>
					</contrib>
					<contrib contrib-type="author">
						<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9108-3929</contrib-id>
						<name>
							<surname>Rapp</surname>
							<given-names>Alexander</given-names>
						</name>
						<xref ref-type="aff" rid="aff3">3</xref>
						<xref ref-type="author-notes" rid="afn1">*</xref>
					</contrib>
					<contrib contrib-type="author">
						<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0842-9314</contrib-id>
						<name>
							<surname>Conte</surname>
							<given-names>Francesca</given-names>
						</name>
						<xref ref-type="aff" rid="aff1">1</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Reber</surname>
							<given-names>Stefan</given-names>
						</name>
						<xref ref-type="aff" rid="aff4">4</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Mechtersheimer</surname>
							<given-names>Jonas</given-names>
						</name>
						<xref ref-type="aff" rid="aff4">4</xref>
					</contrib>
					<contrib contrib-type="author">
						<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3905-1038</contrib-id>
						<name>
							<surname>Ronchi</surname>
							<given-names>Antonella E.</given-names>
						</name>
						<xref ref-type="aff" rid="aff1">1</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>M&#xFC;hlemann</surname>
							<given-names>Oliver</given-names>
						</name>
						<xref ref-type="aff" rid="aff5">5</xref>
					</contrib>
					<contrib contrib-type="author">
						<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5086-6449</contrib-id>
						<name>
							<surname>Leonhardt</surname>
							<given-names>Heinrich</given-names>
						</name>
						<xref ref-type="aff" rid="aff2">2</xref>
					</contrib>
					<contrib contrib-type="author">
						<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8427-8859</contrib-id>
						<name>
							<surname>Cardoso</surname>
							<given-names>M. Cristina</given-names>
						</name>
						<xref ref-type="aff" rid="aff3">3</xref>
					</contrib>
					<contrib contrib-type="author">
						<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3264-9800</contrib-id>
						<name>
							<surname>Ruepp</surname>
							<given-names>Marc-David</given-names>
						</name>
						<xref ref-type="aff" rid="aff4">4</xref>
					</contrib>
					<contrib contrib-type="author">
						<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3584-4417</contrib-id>
						<name>
							<surname>Barabino</surname>
							<given-names>Silvia M.L.</given-names>
						</name>
						<xref ref-type="aff" rid="aff1">1</xref>
						<xref ref-type="corresp" rid="cor1"/>
					</contrib>
				</contrib-group>
				<aff id="aff1">
					<label>1</label>
					<institution>Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy</institution>
				</aff>
				<aff id="aff2">
					<label>2</label>
					<institution>Department of Biology II, Center for Integrated Protein Science Munich, Ludwig Maximilian University of Munich, Planegg-Martinsried, Germany</institution>
				</aff>
				<aff id="aff3">
					<label>3</label>
					<institution>Department of Biology, Technical University of Darmstadt, Darmstadt, Germany</institution>
				</aff>
				<aff id="aff4">
					<label>4</label>
					<institution>UK Dementia Research Institute, Institute of Psychiatry, Psychology &amp; Neuroscience, King&#x2019;s College London, London, UK</institution>
				</aff>
				<aff id="aff5">
					<label>5</label>
					<institution>Department of Chemistry and Biochemistry, University of Bern, Bern, Switzerland</institution>
				</aff>
				<author-notes>
					<corresp id="cor1">Correspondence to Silvia M.L. Barabino:
						<email>silvia.barabino@unimib.it</email>
					</corresp>
					<fn fn-type="equal" id="afn1" specific-use="equal">
						<label>*</label>
						<p>A. Maiser and A. Rapp contributed equally to this paper.</p>
					</fn>
					<fn fn-type="present-address" id="afn2" specific-use="present-address">
						<p>F. Conte&#x2019;s present address is Institute of Molecular Biology, Mainz, Germany.</p>
					</fn>
				</author-notes>
				<pub-date iso-8601-date="2021-05-03" pub-type="collection">
					<day>03</day>
					<month>5</month>
					<year>2021</year>
				</pub-date>
				<pub-date pub-type="epub" iso-8601-date="2021-03-11">
					<day>11</day>
					<month>3</month>
					<year>2021</year>
				</pub-date>
				<volume>220</volume>
				<issue>5</issue>
				<elocation-id>e202008030</elocation-id>
				<history>
					<date date-type="received" iso-8601-date="2020-08-08">
						<day>08</day>
						<month>8</month>
						<year>2020</year>
					</date>
					<date date-type="rev-recd" iso-8601-date="2021-01-17">
						<day>17</day>
						<month>1</month>
						<year>2021</year>
					</date>
					<date date-type="accepted" iso-8601-date="2021-02-04">
						<day>04</day>
						<month>2</month>
						<year>2021</year>
					</date>
				</history>
				<permissions>
					<copyright-statement>&#xA9; 2021 Levone et al.</copyright-statement>
					<copyright-year>2021</copyright-year>
					<ali:free_to_read
						xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2021-11-01"/>
						<license>
							<ali:license_ref
								xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://www.rupress.org/terms/
							</ali:license_ref>
							<ali:license_ref
								xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="vor" start_date="2021-11-01">https://creativecommons.org/licenses/by-nc-sa/4.0/
							</ali:license_ref>
							<license-p>This article is distributed under the terms of an Attribution&#x2013;Noncommercial&#x2013;Share Alike&#x2013;No Mirror Sites license for the first six months after the publication date (see
								<ext-link ext-link-type="uri" xlink:href="http://www.rupress.org/terms/">http://www.rupress.org/terms/</ext-link>). After six months it is available under a Creative Commons License (Attribution&#x2013;Noncommercial&#x2013;Share Alike 4.0 International license, as described at
								<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/">https://creativecommons.org/licenses/by-nc-sa/4.0/</ext-link>).
							</license-p>
						</license>
					</permissions>
					<self-uri xlink:href="JCB_202008030.pdf"/>
					<abstract abstract-type="teaser">
						<p>FUS-dependent liquid&#x2013;liquid phase separation is a critical process in the early activation of the DNA damage response and in the recruitment of key proteins, which facilitates the proper assembly of double-strand break repair complexes.</p>
					</abstract>
					<abstract>
						<p>RNA-binding proteins (RBPs) are emerging as important effectors of the cellular DNA damage response (DDR). The RBP FUS is implicated in RNA metabolism and DNA repair, and it undergoes reversible liquid&#x2013;liquid phase separation (LLPS) in vitro. Here, we demonstrate that FUS-dependent LLPS is necessary for the initiation of the DDR. Using laser microirradiation in FUS-knockout cells, we show that FUS is required for the recruitment to DNA damage sites of the DDR factors KU80, NBS1, and 53BP1 and of SFPQ, another RBP implicated in the DDR. The relocation of KU80, NBS1, and SFPQ is similarly impaired by LLPS inhibitors, or LLPS-deficient FUS variants. We also show that LLPS is necessary for efficient &#x3B3;H2AX foci formation. Finally, using superresolution structured illumination microscopy, we demonstrate that the absence of FUS impairs the proper arrangement of &#x3B3;H2AX nanofoci into higher-order clusters. These findings demonstrate the early requirement for FUS-dependent LLPS in the activation of the DDR and the proper assembly of DSB repair complexes.</p>
					</abstract>
					<funding-group>
						<award-group>
							<funding-source>
								<institution-wrap>
									<institution>Swiss National Fond Sinergia</institution>
								</institution-wrap>
							</funding-source>
							<award-id>CRSII3_136222</award-id>
						</award-group>
						<award-group>
							<funding-source>
								<institution-wrap>
									<institution>UK Dementia Research Institute</institution>
								</institution-wrap>
							</funding-source>
						</award-group>
						<award-group>
							<funding-source>
								<institution-wrap>
									<institution>NOMIS Foundation</institution>
								</institution-wrap>
							</funding-source>
						</award-group>
						<award-group>
							<funding-source>
								<institution-wrap>
									<institution>Deutsche Forschungsgemeinschaft</institution>
									<institution-id institution-id-type="DOI">http://dx.doi.org/10.13039/501100001659</institution-id>
								</institution-wrap>
							</funding-source>
							<award-id>LE 721/18-1</award-id>
							<award-id>CA 198/16-1</award-id>
						</award-group>
					</funding-group>
					<counts>
						<page-count count="20"/>
					</counts>
				</article-meta>
			</front>
			<body>
				<sec sec-type="introduction" id="s1">
					<title>Introduction</title>
					<p>Unrepaired DNA damage can lead to genome instability, a hallmark of cancer cells. To counteract DNA damage, cells have evolved a complex cellular response, commonly referred to as DNA damage response (DDR). The early DDR events have been best elucidated at sites of DNA double-strand breaks (DSBs), which are the most dangerous type of DNA lesions. After the occurrence of a DSB, the sensor protein kinases DNA-dependent protein kinase (DNA-PK), ataxia telangiectasia mutated (ATM), and ATM and Rad3-related (ATR) are rapidly activated, and the KU70/KU80 (XRCC6/XRCC5) heterodimer is recruited to the broken DNA ends. Phosphorylation of the histone variant H2AX at S139 (known as &#x3B3;H2AX) by ATM serves as an early mark of DNA damage and as a platform for the recruitment of early DDR factors such as MDC1 and the MRN complex (consisting of MRE11, RAD50, and NBS1;
						<xref rid="bib73" ref-type="bibr">Stucki and Jackson, 2006</xref>). In mammalian cells, the accumulation of DDR factors at sites of DNA damage gives rise to subnuclear foci that can be readily visualized microscopically. Using superresolution microscopy, we and others have recently shown that these foci correspond to clusters of nanodomains, and this clustering is required for an efficient DNA damage repair (
						<xref rid="bib45" ref-type="bibr">Lopez Perez et al., 2016</xref>;
						<xref rid="bib57" ref-type="bibr">Natale et al., 2017</xref>). In mammals, DSBs are eventually repaired via two main pathways, depending on the cell cycle phase: homologous recombination (HR), which repairs DSBs in late S and G2 phases, and nonhomologous end joining (NHEJ), which is active throughout the entire cell cycle.
					</p>
					<p>In addition to canonical DDR factors, large-scale proteomic and genomic studies have identified several RNA-binding proteins (RBPs) as potential novel DDR factors, either as targets of the apical DDR kinases (
						<xref rid="bib49" ref-type="bibr">Matsuoka et al., 2007</xref>) or as proteins that, when absent, lead to the activation of the DDR (
						<xref rid="bib60" ref-type="bibr">Paulsen et al., 2009</xref>). RBPs have been shown to contribute both directly and indirectly to genome stability. For example, the loss of pre-mRNA splicing or mRNA export factors can favor the accumulation of RNA:DNA hybrids (R-loops) that can be processed to DSBs (
						<xref rid="bib2" ref-type="bibr">Aguirre et al., 2005</xref>;
						<xref rid="bib13" ref-type="bibr">Chuang et al., 2019</xref>). In addition, an increasing number of studies have shown that several RBPs are recruited to sites of DNA damage and participate in DSB repair (
						<xref rid="bib51" ref-type="bibr">Mikolaskova et al., 2018</xref>).
					</p>
					<p>The multifunctional DNA/RNA-binding protein fused in sarcoma (FUS) is involved in splicing, translation, and mRNA transport (
						<xref rid="bib19" ref-type="bibr">Dormann and Haass, 2013</xref>). Both in vivo and in vitro observations point toward a role for FUS in maintaining genome stability. Mice lacking FUS are hypersensitive to ionizing radiation and show defects in spermatogenesis and chromosomal instability (
						<xref rid="bib28" ref-type="bibr">Hicks et al., 2000</xref>;
						<xref rid="bib41" ref-type="bibr">Kuroda et al., 2000</xref>). In vitro, FUS stimulates the formation of DNA loops between complementary DNA molecules, structures that correspond to one of the first steps in HR (
						<xref rid="bib6" ref-type="bibr">Baechtold et al., 1999</xref>). In cells, FUS is recruited very early to sites of DNA damage (
						<xref rid="bib4" ref-type="bibr">Aleksandrov et al., 2018</xref>;
						<xref rid="bib48" ref-type="bibr">Mastrocola et al., 2013</xref>), and its silencing leads to an impairment of DSB repair by both HR and NHEJ (
						<xref rid="bib48" ref-type="bibr">Mastrocola et al., 2013</xref>;
						<xref rid="bib50" ref-type="bibr">Michelini et al., 2017</xref>). In addition, FUS is an ATM and DNA-PK substrate (
						<xref rid="bib18" ref-type="bibr">Deng et al., 2014b</xref>;
						<xref rid="bib23" ref-type="bibr">Gardiner et al., 2008</xref>).
					</p>
					<p>The N-terminal region of FUS (residues 1&#x2013;165) is a highly conserved low-complexity domain (LCD) composed primarily of glutamine, glycine, serine, and tyrosine (QGSY-rich). This domain mediates protein&#x2013;protein interactions and drives the aggregation of FUS into protein inclusions (
						<xref rid="bib75" ref-type="bibr">Sun et al., 2011</xref>). Several studies have shown that the LCD of FUS undergoes a reversible dynamic phase transition between a disperse state, liquid droplets, and hydrogels (
						<xref rid="bib36" ref-type="bibr">Kato et al., 2012</xref>;
						<xref rid="bib54" ref-type="bibr">Murakami et al., 2015</xref>;
						<xref rid="bib59" ref-type="bibr">Patel et al., 2015</xref>). FUS liquid&#x2013;liquid phase separation (LLPS) occurs both in vivo and in vitro at physiological concentrations (
						<xref rid="bib11" ref-type="bibr">Burke et al., 2015</xref>;
						<xref rid="bib54" ref-type="bibr">Murakami et al., 2015</xref>).
					</p>
					<p>It is increasingly recognized that LLPS provides a molecular basis for the formation of subcellular membraneless organelles such as Cajal bodies, paraspeckles, and stress granules (SGs;
						<xref rid="bib8" ref-type="bibr">Boeynaems et al., 2018</xref>). Paraspeckles are subnuclear compartments that assemble on the long noncoding RNA (lncRNA) NEAT1, which induces phase separation of four core RBPs: splicing factor proline- and glutamine-rich (SFPQ), non-POU domain-containing octamer-binding (NONO), FUS, and RBM14 (
						<xref rid="bib29" ref-type="bibr">Hirose et al., 2019</xref>), all of which contain LCDs of variable length (
						<xref rid="bib26" ref-type="bibr">Harrison and Shorter, 2017</xref>). The LCDs of FUS and RBM14 are required for in vitro phase separation and in vivo paraspeckle formation (
						<xref rid="bib27" ref-type="bibr">Hennig et al., 2015</xref>). SFPQ, its paralog NONO, and RBM14 are also RBPs implicated in DNA repair (
						<xref rid="bib80" ref-type="bibr">West et al., 2016</xref>). SFPQ silencing was reported to sensitize cells to DNA cross-linking and alkylating agents and to reduce DSB repair by HR (
						<xref rid="bib64" ref-type="bibr">Rajesh et al., 2011</xref>). SFPQ has DNA reannealing and strand-invasion activity that may lead to the formation of DNA loop structures (
						<xref rid="bib3" ref-type="bibr">Akhmedov and Lopez, 2000</xref>). In addition, SFPQ, NONO, and RBM14 promote NHEJ (
						<xref rid="bib7" ref-type="bibr">Bladen et al., 2005</xref>;
						<xref rid="bib32" ref-type="bibr">Jaafar et al., 2017</xref>;
						<xref rid="bib47" ref-type="bibr">Marchesini et al., 2017</xref>).
					</p>
					<p>Despite all the observations implicating FUS and SFPQ in DNA damage repair, their precise molecular function remains to be fully elucidated. Here we show that FUS is required for the recruitment of SFPQ and the retention of KU80 on DSBs. Consistent with recent results indicating a role for LLPS in DNA damage repair (
						<xref rid="bib37" ref-type="bibr">Kilic et al., 2019</xref>;
						<xref rid="bib61" ref-type="bibr">Pessina et al., 2019</xref>), we show that LLPS inhibitors impair the formation of &#x3B3;H2AX and 53BP1 foci and the proper recruitment of FUS, SFPQ, KU80, and NBS1. Moreover, LLPS-deficient variants of FUS affect accumulation of SFPQ and KU80 at sites of laser-induced DNA damage. Finally, we demonstrate that FUS is needed for the higher-order clustering of &#x3B3;H2AX chromatin nanodomains, which is required for efficient DNA damage repair (
						<xref rid="bib57" ref-type="bibr">Natale et al., 2017</xref>).
					</p>
				</sec>
				<sec sec-type="results" id="s2">
					<title>Results</title>
					<sec id="s3">
						<title>FUS-KO sensitizes human cells to DNA damage</title>
						<p>To shed light on the role of FUS in DDR and genome stability, we generated human HeLa and SH-SY5Y cells in which the FUS gene was knocked out by CRISPR-trap genome editing technique (
							<xref rid="bib66" ref-type="bibr">Reber et al., 2018</xref>). Western blot analysis revealed that HeLa and SH-SY5Y FUS-KO cells display an 8.1-fold and 2.6-fold increase in the phosphorylation of H2AX (&#x3B3;H2AX), respectively (
							<xref ref-type="fig" rid="fig1">Fig. 1 A</xref>, and
							<xref ref-type="fig" rid="figS1">Fig. S1 A</xref>, respectively). Consistently, immunofluorescence analyses showed increased formation of &#x3B3;H2AX foci in FUS-KO cells (
							<xref ref-type="fig" rid="fig1">Fig. 1, B and C</xref>; and
							<xref ref-type="fig" rid="figS1">Fig. S1, B and C</xref>). These observations suggest that, in the absence of FUS, cells generate more DNA damage, repair DNA damage less efficiently, or both. Indeed, transient transfection of HeLa FUS-KO cells with exogenous Flag-tagged FUS reduced the number of &#x3B3;H2AX foci by 37% (
							<xref ref-type="fig" rid="fig1">Fig. 1 D</xref>).
						</p>
						<fig fig-type="figure" id="fig1" orientation="portrait" position="float">
							<label>Figure 1.</label>
							<caption>
								<p>
									<bold>Loss of FUS results in accumulation of DNA damage and sensitization to genotoxic insult in HeLa cells.</bold>
									<bold>(A)</bold> Total extracts of WT and FUS-KO HeLa cells were analyzed by Western blotting with anti-FUS and anti-&#x3B3;H2AX antibodies (loading control: Tubulin). FUS-KO cells display an 8.1-fold increase in the level of endogenous &#x3B3;H2AX in comparison to WT cells.
									<bold>(B)</bold> Representative confocal micrographs of &#x3B3;H2AX foci in WT and FUS-KO HeLa cells. Scale bar: 20 &#xB5;m. Cropped single cells are enlarged 2&#xD7; (scale bar: 5 &#xB5;m).
									<bold>(C)</bold> Quantification of &#x3B3;H2AX foci. The number of foci per nucleus was counted using ImageJ. WT cells have an average of 1.02 foci per cell, compared with 1.82 in FUS-KO cells. Data are from two biological replicates (170 cells each). Statistics: Student&#x2019;s
									<italic>t</italic> test.
									<bold>(D)</bold> HeLa FUS-KO cells were transiently transfected with a plasmid expressing FUS-Flag and stained with anti-Flag and anti-&#x3B3;H2AX. Foci were quantified by ImageJ. Data are from two biological replicates (65 cells each; only transfected cells were included). Statistics: Student&#x2019;s
									<italic>t</italic> test.
									<bold>(E)</bold> HeLa WT and FUS-KO cell viability assessed by Trypan blue staining upon treatment with CPT (0.1 or 0.5 &#xB5;M) or ETO (0.5 or 1 &#xB5;M). Percentage survival was calculated by normalizing the number of surviving cells by their respective DMSO group. Statistics: two-way ANOVA, Bonferroni post hoc test. In all panels: *, P &lt; 0.05; **, P &lt; 0.01; ***, P &lt; 0.001.
								</p>
							</caption>
							<graphic xlink:href="JCB_202008030_Fig1"/>
						</fig>
						<fig fig-type="figure" id="figS1" orientation="portrait" position="float">
							<label>Figure S1.</label>
							<caption>
								<p>
									<bold>Loss of FUS results in accumulation of DNA damage and sensitization to genotoxic insult in SH-SY5Y cells.</bold>
									<bold>(A)</bold> Total extracts of WT and FUS-KO SH-SY5Y cells were analyzed by Western blotting with anti-FUS and anti-&#x3B3;H2AX antibodies. FUS-KO cells display a 2.6-fold increase in the level of endogenous &#x3B3;H2AX in comparison to WT cells. Tubulin was used as loading control. MW, molecular weight.
									<bold>(B)</bold> Representative confocal micrographs of &#x3B3;H2AX foci in WT and FUS-KO SH-SY5Y cells. Scale bar: 20 &#xB5;m. Cropped single cells are enlarged 2&#xD7; (scale bar: 5 &#xB5;m).
									<bold>(C)</bold> Quantification of B. The number of foci per nucleus was counted using ImageJ and plotted as a violin plot. Data from two biological replicates, with 170 cells per replicate. The average foci number in WT cells is 1.01, compared with 1.71 in FUS-KO cells. Statistics: Student&#x2019;s
									<italic>t</italic> test (***, P &lt; 0.001).
									<bold>(D)</bold> SH.SY5Y WT and FUS-KO cell viability assessed by Trypan blue staining upon treatment with increasing concentrations of CPT (0.1 or 0.5 &#xB5;M) or ETO (0.5 or 1 &#xB5;M). Statistics: two-way ANOVA followed by Bonferroni post hoc test (*, P &lt; 0.05; **, P &lt; 0.01; ***, P &lt; 0.001).
								</p>
							</caption>
							<graphic xlink:href="JCB_202008030_FigS1"/>
						</fig>
						<p>To exclude that increased DDR activation in FUS-KO cells could result from alternative splicing alterations in DNA damage genes, we reanalyzed the RNA sequencing dataset of SH-SY5Y FUS-KO cells (
							<xref rid="bib67" ref-type="bibr">Reber et al., 2016</xref>) using gene set enrichment analysis (
							<xref rid="bib83" ref-type="bibr">Mootha et al., 2003</xref>;
							<xref rid="bib84" ref-type="bibr">Subramanian et al., 2005</xref>) and concluded that the KO of FUS did not affect alternative splicing of DNA damage genes (data not shown). We also verified that the KO of FUS did not affect the assembly of cytoplasmic membraneless organelles by assessing SG formation upon treatment with an oxidative stress inducer, sodium arsenite (
							<xref ref-type="fig" rid="figS2">Fig. S2</xref>).
						</p>
						<fig fig-type="figure" id="figS2" orientation="portrait" position="float">
							<label>Figure S2.</label>
							<caption>
								<p>
									<bold>Loss of FUS does not affect SG assembly.</bold> HeLa WT and FUS-KO cells were stressed by treatment with 0.5 mM sodium arsenite for 1 h and immunostained for FUS and TIA-1 (a eukaryotic SG marker). Consistent with previous observations (
									<xref rid="bib86" ref-type="bibr">Sama et al., 2013</xref>;
									<xref rid="bib85" ref-type="bibr">Hock et al., 2018</xref>), FUS remained nuclear in WT cells upon arsenite incubation, and SGs could be detected in the cytoplasm of both WT and FUS-KO cells. Scale bar: 50 &#xB5;m (10 &#xB5;m for cropped image).
								</p>
							</caption>
							<graphic xlink:href="JCB_202008030_FigS2"/>
						</fig>
						<p>Next, we investigated whether the KO of FUS results in DNA damage sensitization. WT and FUS-KO HeLa and SH-SY5Y cells were compared for their sensitivity to DNA damage induced by camptothecin (CPT) and by etoposide (ETO), inhibitors of topoisomerase I and II, respectively. The viability was assessed by Trypan blue staining. FUS-KO cells showed a reduction in cell viability, similar to what had been reported in FUS knockdown lines (
							<xref rid="bib79" ref-type="bibr">Ward et al., 2014</xref>). Upon exposure to either CPT or ETO, both HeLa FUS-KO and SH-SY5Y FUS-KO cells showed a significantly stronger reduction in viability relative to their respective WT cells (
							<xref ref-type="fig" rid="fig1">Fig. 1 E</xref>, and
							<xref ref-type="fig" rid="figS1">Fig. S1 D</xref>, respectively). Overall, these observations indicate that FUS is required for the maintenance of genome integrity.
						</p>
					</sec>
					<sec id="s4">
						<title>FUS KO affects ATM-dependent signaling and recruitment of DDR factors</title>
						<p>Next, we asked whether FUS could be directly involved in DDR signaling. HeLa WT and FUS-KO cells were treated with ETO for 1 h and allowed to recover in ETO-free medium for 2 h (ETO release). Western blot analysis showed that DMSO-treated FUS-KO cells display a basal activation of the ATM-dependent DDR signaling, in addition to increased phosphorylation of H2AX (
							<xref ref-type="fig" rid="fig2">Fig. 2, A and B</xref>). This observation strengthens the idea that, in the absence of FUS, the DDR is chronically activated, and is consistent with previous reports that showed increased &#x3B3;H2AX immunoreactivity in neurons expressing amyotrophic lateral sclerosis&#x2013;linked FUS mutants (
							<xref rid="bib78" ref-type="bibr">Wang et al., 2013</xref>). Upon incubation of cells with ETO, we observed increased phosphorylation of ATM, CHK1, CHK2, and TRIM28, in addition to increased levels of &#x3B3;H2AX in both cell lines (
							<xref ref-type="fig" rid="fig2">Fig. 2, A and B</xref>). We also assessed ATR and BRCA1, but we failed to detect consistent changes in their phosphorylation level (
							<xref ref-type="fig" rid="figS3">Fig. S3 A</xref>). In FUS-KO cells, the phosphorylation of ATM, CHK1, CHK2, and TRIM28 was slightly higher compared with WT cells, possibly reflecting preexisting DDR activation. Interestingly, 2 h after ETO release, while phosphorylation of most proteins started to reduce in WT cells, it remained higher in FUS-KO cells (
							<xref ref-type="fig" rid="fig2">Fig. 2, A and B</xref>). This indicates that the activation of the DDR, and in particular of the ATM pathway, occurred normally in the absence of FUS, but that DNA damage signaling persisted longer after release from the genotoxic treatment. These data reinforce the concept that cells lacking FUS generate more DNA damage than WT cells upon ETO treatment, repair the DNA damage less efficiently, or both.
						</p>
						<fig fig-type="figure" id="fig2" orientation="portrait" position="float">
							<label>Figure 2.</label>
							<caption>
								<p>
									<bold>Loss of FUS perturbs DDR signaling and foci formation upon genotoxic insult.</bold>
									<bold>(A)</bold> Representative Western blot of DDR proteins in HeLa WT and FUS-KO cells upon ETO treatment. Cells were treated with 10 &#xB5;M ETO for 1 h and were allowed to recover in ETO-free medium for 2 h (ETO release). Cells were collected at the indicated time points, lysed in the presence of phosphatase inhibitors, separated on a gradient SDS-PAGE, and processed for Western blotting (loading control: Actin). MW, molecular weight.
									<bold>(B)</bold> Quantification of the blots from two independent experiments as in A (
									<italic>n</italic> = 2).
									<bold>(C)</bold> Quantification of ETO-induced &#x3B3;H2AX foci. Data are from two biological replicates (170 cells each). Statistics: two-way ANOVA, Bonferroni post hoc test.
									<bold>(D)</bold> Quantification of ETO-induced 53BP1 foci analyzed as in C. *, P &lt; 0.05; ***, P &lt; 0.001.
								</p>
							</caption>
							<graphic xlink:href="JCB_202008030_Fig2"/>
						</fig>
						<fig fig-type="figure" id="figS3" orientation="portrait" position="float">
							<label>Figure S3.</label>
							<caption>
								<p>
									<bold>FUS is required for efficient DSB repair and DNA damage foci formation upon genotoxic insult.</bold>
									<bold>(A)</bold> DDR activation in HeLa WT and FUS-KO cells upon ETO treatment. Cells were treated with 10 &#xB5;M ETO for 1 h and were allowed to recover in ETO-free medium for 2 h (ETO release). Cells were collected at the indicated time points, lysed in the presence of phosphatase inhibitors, separated on a gradient SDS-PAGE, and processed for Western blotting (loading control: Actin). ATR and BRCA1 were probed on the same blot as the proteins shown in
									<xref ref-type="fig" rid="fig2">Fig. 2 B</xref>. MW, molecular weight.
									<bold>(B)</bold> DSB repair efficiency was quantified in U2OS cells containing a stably integrated NHEJ reporter system. Cells were silenced for FUS, KU80, or both. Right: Western blot demonstrating the silencing of the respective proteins. Data are presented as the mean &#xB1; SEM (experiments done in triplicate, with at least 10,000 cells analyzed per experiment). Statistics: one-way ANOVA, followed by Bonferroni post hoc test. *, P &lt; 0.05.
									<bold>(C)</bold> DSB repair efficiency was quantified in U2OS cells containing a stably integrated HR reporter system. Cells were silenced for FUS, TOPBP1, or both. Right: Western blot demonstrating the silencing of the respective proteins. Statistical analysis as in A. ***, P &lt; 0.001.
									<bold>(D)</bold> HeLa WT and FUS-KO cells were stained with &#x3B3;H2AX and counterstained with DAPI. Cells were treated with DMSO, ETO for 1 h, or ETO plus 2-h recovery from ETO treatment (ETO/2h). These are representative figures for graph shown in
									<xref ref-type="fig" rid="fig2">Fig. 2 C</xref>. Scale bar: 20 &#xB5;m.
									<bold>(E)</bold> HeLa WT and FUS-KO cells were stained with 53BP1 and counterstained with DAPI. Cells were treated with DMSO, ETO for 1 h, or ETO plus 2-h recovery from ETO treatment (ETO/2h). These are representative figures for graph shown in
									<xref ref-type="fig" rid="fig2">Fig. 2 D</xref>. Scale bar: 20 &#xB5;m.
									<bold>(F)</bold> 53BP1 expression is affected by neither KO of FUS nor by the ETO exposure. Loading control: Tubulin.
								</p>
							</caption>
							<graphic xlink:href="JCB_202008030_FigS3"/>
						</fig>
						<p>To evaluate the impact of FUS depletion on DSB repair, we used U2OS cells stably transfected with GFP reporter constructs that allow the measurement of HR- and NHEJ-mediated repair (
							<xref rid="bib24" ref-type="bibr">Gunn and Stark, 2012</xref>). Consistent with previous reports (
							<xref rid="bib48" ref-type="bibr">Mastrocola et al., 2013</xref>;
							<xref rid="bib78" ref-type="bibr">Wang et al., 2013</xref>), we observed that depletion of FUS affected both DSB repair pathways (
							<xref ref-type="fig" rid="figS3">Fig. S3, B and C</xref>).
						</p>
						<p>Next, we determined whether the absence of FUS affected the formation of DNA damage foci. As shown in
							<xref ref-type="fig" rid="fig2">Fig. 2 C</xref>, after 1-h ETO exposure, we observed a similar number of &#x3B3;H2AX foci in HeLa WT and FUS-KO cells, indicating that the absence of FUS does not prevent the initial sensing of DSBs. However, after 2-h recovery from ETO (ETO/2h), FUS-KO cells had significantly more &#x3B3;H2AX foci than WT cells (
							<xref ref-type="fig" rid="fig2">Fig. 2 C</xref>, and
							<xref ref-type="fig" rid="figS3">Fig. S3 D</xref>). In addition, FUS-KO cells showed significantly less 53BP1 foci than WT cells after 1-h ETO (
							<xref ref-type="fig" rid="fig2">Fig. 2 D</xref>, and
							<xref ref-type="fig" rid="figS3">Fig. S3 E</xref>), which was not due to differential expression or degradation of 53BP1 (
							<xref ref-type="fig" rid="figS3">Fig. S3 F</xref>). 53BP1 foci formation was restored 2 h after recovery (
							<xref ref-type="fig" rid="fig2">Fig. 2 D</xref>), indicating that the absence of FUS results in a delay in the assembly of DNA repair complexes.
						</p>
						<p>To gain insight into the molecular function of FUS during early DDR events, we analyzed the recruitment kinetics to DNA damage sites of two apical DDR factors, the 86-kD subunit of the KU heterodimer and NBS1, one of the subunits of the MRN complex. HeLa WT and FUS-KO cells transiently expressing KU80-GFP or NBS1-GFP were subjected to microirradiation with a 405-nm laser to induce time-specific and localized DNA damage. Real-time recording revealed that, in WT cells, KU80-GFP was promptly recruited to &#x3B3;H2AX-positive irradiation spots (
							<xref ref-type="fig" rid="figS4">Fig. S4 A</xref>), reaching a peak of recruitment within 5 s after microirradiation and remaining until the end of the assessment (180 s;
							<xref ref-type="fig" rid="fig3">Fig. 3 A</xref>). In FUS-KO cells, KU80 showed similar recruitment kinetics, but its accumulation was severely impaired. In contrast to KU80, NBS1 showed slower recruitment kinetics, reaching a peak &#x223C;130 s after microirradiation (
							<xref ref-type="fig" rid="fig3">Fig. 3 B</xref>). However, in the absence of FUS, NBS1 was more efficiently recruited compared with WT cells. Transfection levels of GFP-tagged proteins in WT and FUS-KO cells were comparable (
							<xref ref-type="fig" rid="figS4">Fig. S4, B and C</xref>). Overall, these observations demonstrate that FUS plays an apical role in DDR activation, in particular in the retention of KU80 at the DNA broken ends. In addition, our results suggest that when stable KU80 binding is impaired, the MRN complex can more effectively gain access to the DNA ends.
						</p>
						<fig fig-type="figure" id="figS4" orientation="portrait" position="float">
							<label>Figure S4.</label>
							<caption>
								<p>
									<bold>Microirradiation experiments are not influenced by differential expression of KU80-GFP or NBS1-GFP in WT versus FUS-KO cell lines.</bold>
									<bold>(A)</bold> KU80-GFP is recruited to the microirradiated area and colocalizes with &#x3B3;H2AX staining. Scale bar: 2 &#xB5;m.
									<bold>(B)</bold> The raw fluorescence intensity of HeLa WT and FUS-KO cells transiently transfected with KU80-GFP was assessed to rule out the possibility that differential expression levels could affect the observed effect in
									<xref ref-type="fig" rid="fig3">Fig. 3 A</xref>.
									<bold>(C)</bold> The raw fluorescence intensity of HeLa WT and FUS-KO cells transiently transfected with NBS1-GFP was assessed to rule out the possibility that differential expression levels could affect the observed effect in
									<xref ref-type="fig" rid="fig3">Fig. 3 B</xref>.
								</p>
							</caption>
							<graphic xlink:href="JCB_202008030_FigS4"/>
						</fig>
						<fig fig-type="figure" id="fig3" orientation="portrait" position="float">
							<label>Figure 3.</label>
							<caption>
								<p>
									<bold>Loss of FUS changes the pattern of recruitment of HR- and NHEJ-related proteins to DSBs.</bold>
									<bold>(A)</bold> HeLa WT and FUS-KO cells were transiently transfected with a KU80-GFP expressing plasmid. Upper panel: Representative micrographs of selected time points. Lower panel: Time course of the normalized fluorescence intensity of KU80-GFP recruitment at the microirradiated sites. All microirradiation experiments were performed in two biological replicates (with 10 cells each, except for BRCA1 recruitment, which was done in four biological replicates with 10 cells each).
									<bold>(B)</bold> HeLa WT and FUS-KO cells were transiently transfected with a NBS1-GFP&#x2013;expressing plasmid. Upper panel: Representative micrographs of selected time points. Lower panel: Time course for NBS1-GFP recruitment.
									<bold>(C)</bold> HeLa WT and FUS-KO cells were transiently transfected with a 53BP1-GFP&#x2013;expressing plasmid. Upper panel: Representative micrographs of selected time points. Lower panel: Time course for 53BP1-GFP recruitment.
									<bold>(D)</bold> HeLa WT and FUS-KO cells were transiently transfected with BRCA1-GFP&#x2013;expressing plasmids. Upper panel: Representative micrographs of selected time points. Lower panel: Time course for BRCA1-GFP recruitment. In all graphs, data are plotted as normalized average &#xB1; SEM. Scale bars: 2 &#xB5;m. Arrows indicate microirradiated area.
								</p>
							</caption>
							<graphic xlink:href="JCB_202008030_Fig3"/>
						</fig>
						<p>We next studied the recruitment of the effector proteins 53BP1 and BRCA1. In HeLa WT cells, 53BP1-GFP displayed a biphasic behavior: after microirradiation, fluorescence decreased in the first 5 min and then progressively increased, reaching a peak after 15 min (
							<xref ref-type="fig" rid="fig3">Fig. 3 C</xref>). The initial reduction in 53BP1-GFP fluorescence may possibly be due to chromatin reorganization (
							<xref rid="bib31" ref-type="bibr">Izhar et al., 2015</xref>) that leads to a transient 53BP1 eviction, allowing the recruitment of DDR sensor proteins. In FUS-KO cells, the initial decrease in fluorescence was less pronounced than in WT cells. In addition, consistent with the delayed appearance of 53BP1 foci observed upon ETO incubation of FUS-KO cells, we observed a reduction in the maximal recruitment of 53BP1-GFP (
							<xref ref-type="fig" rid="fig3">Fig. 3 C</xref>). To determine if FUS could contribute to the choice of DSB repair pathway, we also tested the recruitment of BRCA1-GFP. As shown in
							<xref ref-type="fig" rid="fig3">Fig. 3 D</xref>, BRCA1 was recruited slightly more efficiently and appeared to be retained longer at DNA damage sites in FUS-KO compared with WT cells. Since 53BP1 was shown to inhibit BRCA1 accumulation at DSB sites (
							<xref rid="bib20" ref-type="bibr">Escribano-D&#xED;az et al., 2013</xref>), the increased BRCA1 recruitment observed in FUS-KO cells could be a consequence of the impaired accumulation of 53BP1 rather than the result of the absence of FUS. This hypothesis is supported by the results of the GFP repair reporter assay (
							<xref ref-type="fig" rid="figS3">Fig. S3, B and C</xref>;
							<xref rid="bib48" ref-type="bibr">Mastrocola et al., 2013</xref>;
							<xref rid="bib78" ref-type="bibr">Wang et al., 2013</xref>), which suggest that FUS is important for both HR- and NHEJ-mediated DSB repair.
						</p>
					</sec>
					<sec id="s5">
						<title>FUS promotes the recruitment of SFPQ to sites of DNA damage</title>
						<p>We reported earlier (
							<xref rid="bib67" ref-type="bibr">Reber et al., 2016</xref>) the interactome analysis of FUS. Gene ontology analysis revealed a substantial number of proteins involved in the DDR, including PARP1/2, XRCC6/KU70, and XRCC5/KU80 (
							<xref rid="tbl1" ref-type="table">Table 1</xref>). In addition, we found a significant enrichment for RBPs with LCDs (
							<xref rid="tbl2" ref-type="table">Table 2</xref>), some of which have been linked to DNA damage repair. Among potential FUS interactors, we further explored the functional interaction with SFPQ, because of its involvement in the DDR (
							<xref rid="bib32" ref-type="bibr">Jaafar et al., 2017</xref>;
							<xref rid="bib68" ref-type="bibr">Salton et al., 2010</xref>) and because, together with FUS, it is an essential structural component of paraspeckles (
							<xref rid="bib27" ref-type="bibr">Hennig et al., 2015</xref>).
						</p>
						<table-wrap id="tbl1" orientation="portrait" position="float">
							<label>Table 1.</label>
							<caption>
								<title>DDR-related FUS interactors</title>
							</caption>
							<table frame="hsides" rules="groups">
								<col width="23%" span="1"/>
								<col width="77%" span="1"/>
								<thead>
									<tr>
										<th align="left" scope="col" rowspan="1" colspan="1">Uniprot ID</th>
										<th align="left" scope="col" rowspan="1" colspan="1">Protein name</th>
									</tr>
								</thead>
								<tbody>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">Q92499</td>
										<td align="left" rowspan="1" colspan="1">ATP-dependent RNA helicase DDX</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">P54132</td>
										<td align="left" rowspan="1" colspan="1">Bloom syndrome protein</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">P49674</td>
										<td align="left" rowspan="1" colspan="1">Casein kinase I isoform &#x3B5;</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">P24941</td>
										<td align="left" rowspan="1" colspan="1">Cyclin-dependent kinase 2</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">Q03468</td>
										<td align="left" rowspan="1" colspan="1">DNA excision repair protein ERCC-6</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">P11388</td>
										<td align="left" rowspan="1" colspan="1">DNA topoisomerase 2-&#x3B1;</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">Q92547</td>
										<td align="left" rowspan="1" colspan="1">DNA topoisomerase 2-binding protein 1</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">O60870</td>
										<td align="left" rowspan="1" colspan="1">DNA/RNA-binding protein KIN17</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">P29372</td>
										<td align="left" rowspan="1" colspan="1">DNA-3-methyladenine glycosylase</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">P78527</td>
										<td align="left" rowspan="1" colspan="1">DNA-dependent protein kinase catalytic subunit</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">P24928</td>
										<td align="left" rowspan="1" colspan="1">DNA-directed RNA polymerase II subunit RPB1</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">Q9Y5B9</td>
										<td align="left" rowspan="1" colspan="1">FACT complex subunit SPT16</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">Q08945</td>
										<td align="left" rowspan="1" colspan="1">FACT complex subunit SSRP1</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">Q9UBU8</td>
										<td align="left" rowspan="1" colspan="1">Mortality factor 4-like protein 1</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">Q15014</td>
										<td align="left" rowspan="1" colspan="1">Mortality factor 4-like protein 2</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">Q15233</td>
										<td align="left" rowspan="1" colspan="1">Non-POU domain-containing octamer-binding protein</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">P06748</td>
										<td align="left" rowspan="1" colspan="1">Nucleophosmin</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">P09874</td>
										<td align="left" rowspan="1" colspan="1">Poly[ADP-ribose] polymerase 1</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">Q9UGN5</td>
										<td align="left" rowspan="1" colspan="1">Poly[ADP-ribose] polymerase 2</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">Q9C0J8</td>
										<td align="left" rowspan="1" colspan="1">Pre-mRNA 3&#x2032; end processing protein WDR33</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">Q9UMS4</td>
										<td align="left" rowspan="1" colspan="1">Pre-mRNA-processing factor 19</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">Q9HCS7</td>
										<td align="left" rowspan="1" colspan="1">Pre-mRNA-splicing factor SYF1</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">P25789</td>
										<td align="left" rowspan="1" colspan="1">Proteasome subunit &#x3B1; type-4</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">P35251</td>
										<td align="left" rowspan="1" colspan="1">Replication factor C subunit 1</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">P35250</td>
										<td align="left" rowspan="1" colspan="1">Replication factor C subunit 2</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">P40938</td>
										<td align="left" rowspan="1" colspan="1">Replication factor C subunit 3</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">P35249</td>
										<td align="left" rowspan="1" colspan="1">Replication factor C subunit 4</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">P40937</td>
										<td align="left" rowspan="1" colspan="1">Replication factor C subunit 5</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">Q96PK6</td>
										<td align="left" rowspan="1" colspan="1">RNA-binding protein 14</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">Q9Y230</td>
										<td align="left" rowspan="1" colspan="1">RuvB-like 2</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">P23246</td>
										<td align="left" rowspan="1" colspan="1">Splicing factor, proline- and glutamine-rich</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">Q9NTJ3</td>
										<td align="left" rowspan="1" colspan="1">Structural maintenance of chromosomes protein 4</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">Q13263</td>
										<td align="left" rowspan="1" colspan="1">Transcription intermediary factor 1-&#x3B2;</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">P07948</td>
										<td align="left" rowspan="1" colspan="1">Tyrosine-protein kinase Lyn</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">Q14694</td>
										<td align="left" rowspan="1" colspan="1">Ubiquitin carboxyl-terminal hydrolase 10</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">P13010</td>
										<td align="left" rowspan="1" colspan="1">X-ray repair cross-complementing protein 5</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">P12956</td>
										<td align="left" rowspan="1" colspan="1">X-ray repair cross-complementing protein 6</td>
									</tr>
								</tbody>
							</table>
							<table-wrap-foot>
								<p>Compiled from
									<xref rid="bib67" ref-type="bibr">Reber et al. (2016)</xref>.
								</p>
							</table-wrap-foot>
						</table-wrap>
						<table-wrap id="tbl2" orientation="portrait" position="float">
							<label>Table 2.</label>
							<caption>
								<title>LCD-containing FUS interactors</title>
							</caption>
							<table frame="hsides" rules="groups">
								<col width="19%" span="1"/>
								<col width="18%" span="1"/>
								<col width="31%" span="1"/>
								<col width="32%" span="1"/>
								<thead>
									<tr>
										<th align="left" scope="col" rowspan="1" colspan="1">Gene name</th>
										<th align="left" scope="col" rowspan="1" colspan="1">Uniprot ID</th>
										<th align="left" scope="col" rowspan="1" colspan="1">Repeats in LCD</th>
										<th align="left" scope="col" rowspan="1" colspan="1">References for DDR involvement</th>
									</tr>
								</thead>
								<tbody>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">
											<italic>HNRNPA1</italic>
										</td>
										<td align="left" rowspan="1" colspan="1">P09651</td>
										<td align="left" rowspan="1" colspan="1">2 &#xD7; [G/S]Y[G/S]</td>
										<td align="left" rowspan="1" colspan="1"/>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">
											<italic>HNRNPA2/B1</italic>
										</td>
										<td align="left" rowspan="1" colspan="1">P22626</td>
										<td align="left" rowspan="1" colspan="1">7 &#xD7; [G/S]Y[G/S]</td>
										<td align="left" rowspan="1" colspan="1"/>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">
											<italic>HNRNPF</italic>
										</td>
										<td align="left" rowspan="1" colspan="1">P52597</td>
										<td align="left" rowspan="1" colspan="1">2 &#xD7; YXXQ, 5 &#xD7; [S/G]Y[S/G}</td>
										<td align="left" rowspan="1" colspan="1"/>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">
											<italic>HNRNPH1</italic>
										</td>
										<td align="left" rowspan="1" colspan="1">P31943</td>
										<td align="left" rowspan="1" colspan="1">7 &#xD7; [G/S]Y[G/S]</td>
										<td align="left" rowspan="1" colspan="1"/>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">
											<italic>HNRNPH3</italic>
										</td>
										<td align="left" rowspan="1" colspan="1">P31942</td>
										<td align="left" rowspan="1" colspan="1">6 &#xD7; [G/S]Y[G/S]</td>
										<td align="left" rowspan="1" colspan="1"/>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">
											<italic>HNRNPK</italic>
										</td>
										<td align="left" rowspan="1" colspan="1">P61978</td>
										<td align="left" rowspan="1" colspan="1">2 &#xD7; [G/S]Y[G/S]</td>
										<td align="left" rowspan="1" colspan="1">
											<xref rid="bib53" ref-type="bibr">Moumen et al., 2013</xref>
										</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">
											<italic>HNRNPR</italic>
										</td>
										<td align="left" rowspan="1" colspan="1">O43390</td>
										<td align="left" rowspan="1" colspan="1">1 &#xD7; YNQ, 1 &#xD7; YGQQ</td>
										<td align="left" rowspan="1" colspan="1">
											<xref rid="bib74" ref-type="bibr">Sui et al., 2015</xref>
										</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">
											<italic>HNRNPUL1</italic>
										</td>
										<td align="left" rowspan="1" colspan="1">Q9BUJ2</td>
										<td align="left" rowspan="1" colspan="1">8 &#xD7; YXQ, 8 &#xD7; [G/S]Y[G/S]</td>
										<td align="left" rowspan="1" colspan="1">
											<xref rid="bib26" ref-type="bibr">Harrison and Shorter, 2017</xref>;
											<xref rid="bib62" ref-type="bibr">Polo et al., 2012</xref>
										</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">
											<italic>MATR3</italic>
										</td>
										<td align="left" rowspan="1" colspan="1">P43243</td>
										<td align="left" rowspan="1" colspan="1"/>
										<td align="left" rowspan="1" colspan="1">
											<xref rid="bib68" ref-type="bibr">Salton et al., 2010</xref>
										</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">
											<italic>RBM14</italic>
										</td>
										<td align="left" rowspan="1" colspan="1">Q96PK6</td>
										<td align="left" rowspan="1" colspan="1">19 &#xD7; Y[G/N/A/S]AQ, 2 &#xD7; [S/G]YG</td>
										<td align="left" rowspan="1" colspan="1">
											<xref rid="bib71" ref-type="bibr">Simon et al., 2017</xref>
										</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">
											<italic>SFPQ</italic>
										</td>
										<td align="left" rowspan="1" colspan="1">P23246</td>
										<td align="left" rowspan="1" colspan="1">1 &#xD7; SYQ</td>
										<td align="left" rowspan="1" colspan="1">
											<xref rid="bib64" ref-type="bibr">Rajesh et al., 2011</xref>;
											<xref rid="bib68" ref-type="bibr">Salton et al., 2010</xref>
										</td>
									</tr>
									<tr>
										<td align="left" scope="row" rowspan="1" colspan="1">
											<italic>TAF15</italic>
										</td>
										<td align="left" rowspan="1" colspan="1">Q86X94</td>
										<td align="left" rowspan="1" colspan="1">12 &#xD7; [G/S]Y[G/S], 9 &#xD7; Y[G/S]Q</td>
										<td align="left" rowspan="1" colspan="1"/>
									</tr>
								</tbody>
							</table>
							<table-wrap-foot>
								<p>Compiled from
									<xref rid="bib27" ref-type="bibr">Hennig et al. (2015)</xref> and
									<xref rid="bib15" ref-type="bibr">Couthouis et al. (2011)</xref>.
								</p>
							</table-wrap-foot>
						</table-wrap>
						<p>To determine whether SFPQ functions in DNA repair depended on FUS, we first compared the recruitment kinetics of the two proteins (
							<xref ref-type="fig" rid="fig4">Fig. 4, A and B</xref>). HeLa WT cells expressing either GFP-FUS or GFP-SFPQ were subjected to laser microirradiation to induce localized DNA damage, as confirmed by anti-&#x3B3;H2AX staining (
							<xref ref-type="fig" rid="fig4">Fig. 4 C</xref>). While FUS was promptly recruited and reached a maximum after 40 s, the redistribution of SFPQ to laser-induced damage sites was slower, reaching a peak after &#x223C;100 s (
							<xref ref-type="fig" rid="fig4">Fig. 4, A and B</xref>). Then, we examined whether the recruitment of SFPQ is altered in the absence of FUS. As shown in
							<xref ref-type="fig" rid="fig4">Fig. 4 D</xref>, SFPQ accumulation was severely delayed and impaired in FUS-KO cells, indicating that the recruitment of SFPQ to DSB sites is FUS dependent (
							<xref ref-type="fig" rid="video1">Video 1</xref>). Since laser microirradiation also generates single-strand breaks (SSBs), we tested whether the lack of FUS also affected the recruitment of XRCC1, a protein involved in base excision repair and the SSB repair pathway, by cotransfecting FUS-KO cells with both SFPQ-GFP and XRCC1-RFP. XRCC1 was efficiently recruited to DNA damage sites after laser microirradiation both in WT and in FUS-KO cells, indicating that FUS is specifically required for the recruitment of SFPQ (
							<xref ref-type="fig" rid="figS5">Fig. S5, A&#x2013;C</xref>).
						</p>
						<fig fig-type="figure" id="fig4" orientation="portrait" position="float">
							<label>Figure 4.</label>
							<caption>
								<p>
									<bold>FUS recruitment to DSBs precedes SFPQ, and its absence strongly reduces SFPQ accumulation.</bold>
									<bold>(A)</bold> WT HeLa cells were transiently transfected either with SFPQ-GFP or FUS-GFP plasmid and then laser microirradiated.
									<bold>(B)</bold> Comparison of FUS and SFPQ recruitment kinetics.
									<bold>(C)</bold> HeLa cells were transiently transfected with a GFP-tagged FUS expression plasmid and then laser microirradiated. Cells were then immunostained for &#x3B3;H2AX. H2AX is phosphorylated at laser microirradiation sites and colocalized with FUS-GFP.
									<bold>(D)</bold> HeLa WT and FUS-KO cells were transiently transfected with a SFPQ-GFP&#x2013;expressing plasmid. Upper panel: Representative micrographs of selected time points (see
									<xref ref-type="fig" rid="video1">Video 1</xref>). Lower panel: Time course for SFPQ-GFP recruitment. In all graphs, data are plotted as normalized average &#xB1; SEM. Scale bars: 2 &#xB5;m. Arrows indicate microirradiated area.
								</p>
							</caption>
							<graphic xlink:href="JCB_202008030_Fig4"/>
						</fig>
						<fig fig-type="video" id="video1" orientation="portrait" position="float">
							<object-id pub-id-type="doi">10.1083/jcb.202008030.v1</object-id>
							<label>Video 1.</label>
							<caption>
								<p>
									<bold>SFPQ recruitment in HeLa WT versus FUS-KO cells</bold>
									<bold>. </bold>HeLa WT and FUS-KO cells were transiently transfected with SFPQ-GFP plasmid and laser microirradiated in the area indicated. Video was made by 183 sequential micrographs (3 pre- and 180 post-irradiation) and runs at 10&#xD7; speed. It is possible to observe that the absence of FUS both delays and impairs the recruitment of SFPQ. Scale bar: 5 &#xB5;m. Playback: 30 frames/s.
								</p>
							</caption>
							<alternatives>
								<media content-type="glencoe" xlink:href="https://movie.rupress.org/media/by_doi/10.1083/jcb.202008030.v1.mp4/source" orientation="portrait" id="d24e1095" position="anchor"/>
								<media content-type="media-archive" xlink:href="JCB_202008030_V1.mp4" orientation="portrait" id="d24e1096" position="anchor" mimetype="video"/>
							</alternatives>
						</fig>
						<fig fig-type="figure" id="figS5" orientation="portrait" position="float">
							<label>Figure S5.</label>
							<caption>
								<p>
									<bold>Loss of FUS specifically affects SFPQ but not XRCC1 recruitment to DSB.</bold>
									<bold>(A)</bold> WT HeLa cells were transiently cotransfected with SFPQ-GFP and XRCC1-RFP plasmids and submitted to laser microirradiation as described in Materials and methods. Recruitment of these proteins was assessed for a 3-min period, and images were taken every 20 s. Scale bar: 2 &#xB5;m.
									<bold>(B)</bold> Recruitment and accumulation of SFPQ, as shown in
									<xref ref-type="fig" rid="fig4">Fig. 4 D</xref>, is severely impaired in FUS-KO cells.
									<bold>(C)</bold> Recruitment of XRCC1 is very high (saturated fluorescence signal) and the same for WT and FUS-KO cells. Error bars represent SE.
								</p>
							</caption>
							<graphic xlink:href="JCB_202008030_FigS5"/>
						</fig>
						<p>Both FUS and SFPQ LCDs were shown to liquid&#x2013;liquid phase separate and to form hydrogels in vitro (
							<xref rid="bib44" ref-type="bibr">Lee et al., 2015</xref>;
							<xref rid="bib81" ref-type="bibr">Yamazaki et al., 2018</xref>). FUS is able to drive LLPS at low protein concentrations and physiological salt concentrations (
							<xref rid="bib77" ref-type="bibr">Wang et al., 2018</xref>). Thus, we next tested whether the recruitment of FUS and SFPQ at DNA damage sites is dependent on LLPS and, more specifically, whether the recruitment of SFPQ is dependent on FUS-induced LLPS. We performed microirradiation experiments in the presence of chemicals that were previously shown to disrupt phase separation in vivo. First, we exposed HeLa cells to 2% 1,6-hexanediol (1,6-HD, 30 min), an aliphatic alcohol that is known to dissolve various cytoplasmic and nuclear membraneless compartments in vivo by disrupting their multivalent hydrophobic interactions (
							<xref rid="bib5" ref-type="bibr">Allodi et al., 2016</xref>;
							<xref rid="bib39" ref-type="bibr">Kroschwald et al., 2015</xref>;
							<xref rid="bib76" ref-type="bibr">Updike et al., 2011</xref>;
							<xref rid="bib81" ref-type="bibr">Yamazaki et al., 2018</xref>), and which was shown to partially dissolve FUS polymers in vitro (
							<xref rid="bib5" ref-type="bibr">Allodi et al., 2016</xref>;
							<xref rid="bib35" ref-type="bibr">Kato and McKnight, 2018</xref>). At this concentration, we observed that cells were able to recover their normal morphology 2 h after withdrawal from the alcohol (
							<xref ref-type="fig" rid="figS6">Fig. S6 A</xref>). Cajal bodies were partially disrupted, while nuclear speckles were affected to a lesser extent (
							<xref ref-type="fig" rid="figS6">Fig. S6, B and C</xref>). These observations indicate that this 1,6-HD treatment condition was mild enough not to disrupt all subcellular structures. Incubation of transiently transfected HeLa cells with 1,6-HD reduced FUS relocation to DNA damage sites (
							<xref ref-type="fig" rid="fig5">Fig. 5 A</xref>), an effect that was even more dramatic on the recruitment of SFPQ (
							<xref ref-type="fig" rid="fig5">Fig. 5 B</xref>). As control, we performed experiments in the presence of 2% 2,5-HD, a less hydrophobic isomer of 1,6-HD that does not affect LLPS (
							<xref rid="bib5" ref-type="bibr">Allodi et al., 2016</xref>;
							<xref rid="bib35" ref-type="bibr">Kato and McKnight, 2018</xref>). The presence of 2,5-HD did not affect FUS or SFPQ relocation (
							<xref ref-type="fig" rid="fig5">Fig. 5, A and B</xref>).
						</p>
						<fig fig-type="figure" id="figS6" orientation="portrait" position="float">
							<label>Figure S6.</label>
							<caption>
								<p>
									<bold>2% 1,6-HD treatment does not irreversibly affect the morphology and vitality of cells.</bold>
									<bold>(A)</bold> Bright-field micrograph of HeLa cells treated with 1,6-HD as described in Materials and methods. Cells were allowed to recover in alcohol-free medium. Cells returned to a normal morphology within 120 min after 1,6-HD withdrawal. Scale bar: 20 &#xB5;m.
									<bold>(B)</bold> Representative images of HeLa WT cells treated or not with 1,6-HD for 30 min and stained for Cajal bodies (CBs, &#x3B1;-coilin antibody) or nuclear speckles (NSs, &#x3B1;-SC-35 antibody). Scale bar: 20 &#xB5;m.
									<bold>(C)</bold> Quantification of Cajal bodies and nuclear speckles in untreated and 1,6-HD&#x2013;treated cells. HeLa cells were treated with 2% 1,6-HD for 30 min and then stained with DAPI and either anti-coilin or anti-SC35 antibodies. Quantification was performed as in Materials and methods. Experiments were done in duplicate, and 200 cells were analyzed per experiment. Statistics: Student&#x2019;s
									<italic>t</italic> test (***, P &lt; 0.001).
								</p>
							</caption>
							<graphic xlink:href="JCB_202008030_FigS6"/>
						</fig>
						<fig fig-type="figure" id="fig5" orientation="portrait" position="float">
							<label>Figure 5.</label>
							<caption>
								<p>
									<bold>LLPS is required for FUS and SFPQ recruitment to DNA damage sites.</bold>
									<bold>(A)</bold> HeLa WT cells were transiently transfected with a FUS-GFP&#x2013;expressing plasmid and incubated with either 2% 1,6-HD or 2% 2,5-HD for 30 min before laser microirradiation. Upper panel: Representative micrographs of selected time points. Lower panel: Time course of FUS recruitment.
									<bold>(B)</bold> HeLa WT cells were transiently transfected with a SFPQ-GFP&#x2013;expressing plasmid and treated as in A. Upper panel: Representative micrographs of selected time points. Lower panel: Time course of SFPQ recruitment.
									<bold>(C)</bold> HeLa WT cells were transiently transfected with a FUS-GFP&#x2013;expressing plasmid and incubated with 50 or 100 mM Am. Ac. for 30 min before laser microirradiation. Upper panel: Representative micrographs of selected time points. Lower panel: Time course of FUS recruitment.
									<bold>(D)</bold> HeLa WT cells were transiently transfected with a SFPQ-GFP&#x2013;expressing plasmid and treated as in C. Upper panel: Representative micrographs of selected time points. Lower panel: Time course of SFPQ recruitment. In all graphs, data are plotted as normalized average &#xB1; SEM. Scale bars: 2 &#xB5;m. Arrows indicate microirradiated area.
								</p>
							</caption>
							<graphic xlink:href="JCB_202008030_Fig5"/>
						</fig>
						<p>To further substantiate the role of LLPS in FUS and SFPQ accumulation at laser-induced DNA damage sites, we assessed the effect of ammonium acetate (Am. Ac.), which promptly permeates cells and inhibits RNA-protein gelation without perturbing intracellular pH (
							<xref rid="bib25" ref-type="bibr">Hamaguchi et al., 1997</xref>;
							<xref rid="bib33" ref-type="bibr">Jain and Vale, 2017</xref>). At 100-mM concentration, Am. Ac. can effectively lead to the disappearance of nuclear CAG-repeat RNA foci and of nuclear speckles, ribonucleoprotein bodies that depend on ionic interactions (
							<xref rid="bib33" ref-type="bibr">Jain and Vale, 2017</xref>). Recently, it was shown that Am. Ac. can rapidly dissolve 53BP1 foci (
							<xref rid="bib61" ref-type="bibr">Pessina et al., 2019</xref>). Therefore, we incubated cells for 30 min before laser microirradiation with either 50 mM or with 100 mM Am. Ac. As shown in
							<xref ref-type="fig" rid="fig5">Fig. 5, C and D</xref>, similar to what we had observed in the presence of 1,6-HD, Am. Ac. severely affected the relocation of both FUS and SFPQ to DNA damage sites. Overall, these results support the idea that LLPS occurs at sites of DNA damage and is required for the efficient recruitment of FUS and SFPQ.
						</p>
						<p>To determine if the impaired recruitment of SFPQ in FUS-KO cells could be due to the absence of FUS-induced LLPS, we took advantage of LLPS-deficient FUS constructs previously characterized by
							<xref rid="bib77" ref-type="bibr">Wang et al. (2018)</xref>. We tested the FUS LCD Y&#x2192;S (YS) and RNA-binding domain R&#x2192;K (RK) variants, which strongly affect phase separation, and as a control, the FUS LCD Q&#x2192;G (QG) variant, which instead affects the hardening of droplets (
							<xref rid="bib77" ref-type="bibr">Wang et al., 2018</xref>). As shown in
							<xref ref-type="fig" rid="fig6">Fig. 6, A and B</xref>, while WT FUS and the Q/G FUS variant were similarly recruited to DNA damage sites, the accumulation of Y/S and R/K FUS variants was significantly reduced. To test whether these FUS variants influence the recruitment of SFPQ, HeLa FUS-KO cells were cotransfected with plasmids expressing SFPQ-GFP and one of the FUS-mCherry constructs (WT, YS, QG, or RK). While complementation of FUS-KO cells with the WT FUS or the QG FUS variant increased SFPQ recruitment, expression of the YS FUS variant did not improve its relocation (
							<xref ref-type="fig" rid="fig6">Fig. 6, A and C</xref>). In the presence of the RK FUS variant, SFPQ was initially recruited but prematurely released from the DSB sites. Overall, these observations implicate a requirement for FUS-driven LLPS for the efficient recruitment and retention of SFPQ at DNA damage sites.
						</p>
						<fig fig-type="figure" id="fig6" orientation="portrait" position="float">
							<label>Figure 6.</label>
							<caption>
								<p>
									<bold>LLPS-deficient FUS variants do not rescue SFPQ recruitment.</bold> HeLa FUS-KO cells were transiently cotransfected with one mCherry FUS construct (WT or the mutants RK, YS, or QG) and SFPQ-GFP before laser microirradiation.
									<bold>(A)</bold> Representative confocal micrographs of the recruitment of SFPQ and FUS in HeLa FUS-KO cells transiently transfected with both SFPQ and a FUS construct (WT or RK, YS, or QG mutants).
									<bold>(B)</bold> Time course of recruitment of WT and mutant FUS-mCherry.
									<bold>(C)</bold> Time course of SFPQ-GFP in FUS-KO cells either not transfected with FUS or transfected with FUS WT, FUS RK, FUS YS, or FUS QG. In all graphs, data are plotted as normalized average &#xB1; SEM. Scale bars: 2 &#xB5;m. Arrows indicate microirradiated area.
								</p>
							</caption>
							<graphic xlink:href="JCB_202008030_Fig6"/>
						</fig>
					</sec>
					<sec id="s6">
						<title>LLPS is required to maintain the integrity of DNA damage foci</title>
						<p>We then speculated that the actual formation of DDR foci might involve some form of phase separation. We first tested this hypothesis by exposing HeLa cells to either 2% 1,6-HD or to 50 mM or 100 mM Am. Ac., together with ETO, for 30 min (
							<xref ref-type="fig" rid="fig7">Fig. 7, A and B</xref>). While 1,6-HD treatment severely impaired the formation of &#x3B3;H2AX foci, 53BP1 foci were only partially dissolved. In the presence of Am. Ac., &#x3B3;H2AX foci formation was severely impaired, similar to what we had observed with the aliphatic alcohol. Am. Ac. also affected 53BP1 foci formation, as previously reported (
							<xref rid="bib61" ref-type="bibr">Pessina et al., 2019</xref>). In addition to compromising foci integrity, 1,6-HD and Am. Ac. treatments compromised the phosphorylation of ATM, H2AX, and TRIM28 (
							<xref ref-type="fig" rid="fig7">Fig. 7 C</xref>). To test whether the recruitment of key DDR factors to sites of DNA damage is also dependent on LLPS, we assessed the effect of the aliphatic alcohol on the recruitment of KU80-GFP (
							<xref ref-type="fig" rid="fig8">Fig. 8 A</xref>) and NBS1-GFP (
							<xref ref-type="fig" rid="fig8">Fig. 8 B</xref>). We observed a reduction in the recruitment of both DDR factors in the presence of 1,6-HD, but not in the presence of the control alcohol 2,5-HD. Overall, these data indicate that LLPS is required for the proper formation of DNA damage foci and activation of the DDR signaling cascade.
						</p>
						<fig fig-type="figure" id="fig7" orientation="portrait" position="float">
							<label>Figure 7.</label>
							<caption>
								<p>
									<bold>LLPS is required for DDR activation and foci formation.</bold>
									<bold>(A)</bold> Representative confocal micrographs of HeLa cells that were treated with ETO alone, ETO plus 1,6-HD (upper micrographs), or ETO plus 50 or 100 mM Am. Ac. (lower micrographs) before immunostaining for &#x3B3;H2AX or 53BP1. Scale bars: 20 &#xB5;m.
									<bold>(B)</bold> Quantification of &#x3B3;H2AX 1 foci in the experiments in A. In the HD experiment, 200 cells were analyzed per condition, and in the Am. Ac. experiment, 150 cells per condition, and experiments were performed in duplicate. Graphs represent the number of foci per cell and are shown as violin plots with all samples. Statistics: one-way ANOVA and Bonferroni post hoc test.
									<bold>(C)</bold> Quantification of 53BP1 foci in the experiments in A. Experiments, quantifications, and statistics were performed as described in B.
									<bold>(D)</bold> Western blot analysis of total extracts prepared from HeLa cells treated with ETO alone, ETO and 2% 1,6-HD, or ETO and Am. Ac. (50 or 100 &#xB5;M). Phosphorylation of ATM, TRIM28, and H2AX was assessed (loading control: Actin). MW, molecular weight. ***, P &lt; 0.001.&#xA0;
								</p>
							</caption>
							<graphic xlink:href="JCB_202008030_Fig7"/>
						</fig>
						<fig fig-type="figure" id="fig8" orientation="portrait" position="float">
							<label>Figure 8.</label>
							<caption>
								<p>
									<bold>LLPS is required for the proper recruitment of HR- and NHEJ-related proteins.</bold>
									<bold>(A)</bold> HeLa WT cells were transiently transfected with KU80-GFP&#x2013;expressing plasmids and then incubated with 2% 1,6-HD for 30 min before laser microirradiation. Upper panel: Representative micrographs of selected time points. Lower panel: Time course of KU80 recruitment.
									<bold>(B)</bold> HeLa WT cells were transiently transfected with NBS1-GFP&#x2013;expressing plasmids and then incubated with 2% 1,6-HD for 30 min before laser microirradiation. Upper panel: Representative micrographs of selected time points. Lower panel: Time course of NBS1 recruitment.
									<bold>(C)</bold> Recruitment of KU80-GFP in FUS-KO cells either untransfected or transfected with FUS WT, FUS RK, or FUS YS. Upper panel: Representative micrographs of selected time points. Lower panel: Time course of KU80 recruitment. In all graphs, data are plotted as normalized average &#xB1; SEM. Scale bars: 2 &#xB5;m. Arrows indicate microirradiated area.
								</p>
							</caption>
							<graphic xlink:href="JCB_202008030_Fig8"/>
						</fig>
						<p>To strengthen the link between LLPS of FUS and the DDR, we tested the effect of the reconstitution of FUS-KO cells with the two FUS variants that are the most affected in LLPS, the YS and RK mutations, on KU80 recruitment (
							<xref rid="bib9" ref-type="bibr">Bogaert et al., 2018</xref>;
							<xref rid="bib46" ref-type="bibr">Maharana et al., 2018</xref>). Both FUS variants were unable to rescue KU80 accumulation at laser-induced DNA damage sites (
							<xref ref-type="fig" rid="fig8">Fig. 8 C</xref>), providing further evidence for the requirement of FUS LLPS for the efficient assembly of the DDR machinery.
						</p>
					</sec>
					<sec id="s7">
						<title>FUS is required for &#x3B3;H2AX cluster formation</title>
						<p>We have recently shown using 3D structured illumination microscopy (SIM) that &#x3B3;H2AX foci consist of spatially clustered &#x3B3;H2AX nanofoci (
							<xref rid="bib57" ref-type="bibr">Natale et al., 2017</xref>). Given that FUS-KO cells have defective recruitment of DNA damage factors and formation of DNA damage foci, we next assessed whether FUS may be required for the proper organization of the 3D arrangement of &#x3B3;H2AX-decorated chromatin. We thus quantified &#x3B3;H2AX nanofoci in WT and FUS-KO cells treated with 10 &#xB5;M ETO for 1 h using 3D-SIM (
							<xref ref-type="fig" rid="fig9">Fig. 9, A&#x2013;C</xref>).
						</p>
						<fig fig-type="figure" id="fig9" orientation="portrait" position="float">
							<label>Figure 9.</label>
							<caption>
								<p>
									<bold>FUS is required for &#x3B3;H2AX nanofoci clustering.</bold>
									<bold>(A)</bold> Image analysis workflow for 3D-SIM &#x3B3;H2AX cluster analysis. Nuclei and &#x3B3;H2AX nanofoci are segmented; centroid-centroid distances for the nanofoci are computed; and nanofoci with a centroid-centroid distance shorter than 500 nm are assigned to the same cluster. Clusters are quantified as structures that contain more than seven nanofoci.
									<bold>(B)</bold> Images of HeLa WT and FUS-KO cells treated for 1 h with ETO or DMSO, respectively. Additionally, HeLa-FUS-KO cells transiently transfected with FUS-Flag plasmid were analyzed after ETO treatment. The main images show the merged DAPI and &#x3B3;H2AX nanofoci in pseudo-color (scale: 5 &#xB5;m). The lower half of the image shows the outline of the segmented nanofoci. Crop areas are highlighted with yellow boxes, and the magnified regions are shown below (scale bar: 1 &#xB5;m).
									<bold>(C)</bold> Quantification of nanofoci per cell in the different conditions indicated. Red lines indicate the median. Statistics: Wilcoxon&#x2019;s rank sum test.
									<bold>(D)</bold> Frequency of nanofoci found in clusters, as compared with the total number of nanofoci in the cell. Red lines indicate the median. Statistics as in C. *, P &lt; 0.05; **, P &lt; 0.01; ***, P &lt; 0.001.
								</p>
							</caption>
							<graphic xlink:href="JCB_202008030_Fig9"/>
						</fig>
						<p>
							<xref ref-type="fig" rid="fig9">Fig. 9 A</xref> displays the workflow for foci segmentation and cluster identification. Consistent with the data obtained by confocal microscopy (
							<xref ref-type="fig" rid="fig1">Fig. 1, B and C</xref>), DMSO-treated WT control cells exhibited a low number of &#x3B3;H2AX nanofoci, while foci were significantly increased in control FUS-KO cells (
							<xref ref-type="fig" rid="fig9">Fig. 9 C</xref>). Upon ETO treatment, we did not observe a significant difference between the total number of nanofoci in WT versus FUS-KO cells (
							<xref ref-type="fig" rid="fig9">Fig. 9 C</xref>), similar to the results we obtained by confocal microscopy.
						</p>
						<p>We then studied the spatial distribution of &#x3B3;H2AX nanofoci in terms of cluster formation. We assessed the relative number of nanofoci contained in clusters compared with the total number of nanofoci per cell. Unsurprisingly, considering the extremely low number of &#x3B3;H2AX nanofoci in DMSO-treated WT cells, we found the fraction of &#x3B3;H2AX nanofoci clusters in these cells to be extremely low. In contrast, the fraction of clusters was higher in DMSO-treated FUS-KO cells, probably due to their increased total number of &#x3B3;H2AX nanofoci. Upon ETO treatment, while WT cells showed a significantly increased fraction of &#x3B3;H2AX nanofoci organized in typical clusters, these were significantly reduced in FUS-KO cells (
							<xref ref-type="fig" rid="fig9">Fig. 9, B and D</xref>), indicating that FUS is required for the proper organization of the 3D arrangement of &#x3B3;H2AX-decorated chromatin. To support this conclusion, we transiently transfected HeLa FUS-KO cells with an FUS-Flag construct and quantified the number of &#x3B3;H2AX nanofoci and clusters upon ETO treatment (
							<xref ref-type="fig" rid="fig9">Fig. 9 B</xref>, right panel). Unlike untransfected FUS-KO cells, FUS-Flag transfected FUS-KO cells showed a similar total number of total clustered nanofoci as WT cells (
							<xref ref-type="fig" rid="fig9">Fig. 9, C and D</xref>). These findings demonstrate that FUS is an additional factor, besides CTCF (CCCTC-binding factor) and direct chromatin contacts (
							<xref rid="bib14" ref-type="bibr">Collins et al., 2020</xref>;
							<xref rid="bib30" ref-type="bibr">Hwang et al., 2019</xref>;
							<xref rid="bib57" ref-type="bibr">Natale et al., 2017</xref>), that is required for the orchestrated formation of &#x3B3;H2AX-decorated chromatin domains. These domains are the essential basis for the subsequent steps of DSB repair, and our results indicate that the defective DNA damage repair in FUS-KO cells is associated with inefficient clustering of &#x3B3;H2AX nanofoci.
						</p>
					</sec>
				</sec>
				<sec sec-type="discussion" id="s8">
					<title>Discussion</title>
					<p>The results reported here provide the first evidence that FUS plays an important early role in the DDR by promoting LLPS at DNA damage sites, thereby physically contributing to the efficient recruitment of key DDR factors. Previous reports have already implicated FUS in DNA damage repair (
						<xref rid="bib48" ref-type="bibr">Mastrocola et al., 2013</xref>;
						<xref rid="bib72" ref-type="bibr">Singatulina et al., 2019</xref>;
						<xref rid="bib78" ref-type="bibr">Wang et al., 2013</xref>), and more recently, review articles have proposed that FUS, and more generally RBPs, contribute to the DDR and to DNA repair by promoting phase separation at damage sites (
						<xref rid="bib16" ref-type="bibr">D&#x2019;Alessandro and d&#x2019;Adda di Fagagna, 2017</xref>;
						<xref rid="bib34" ref-type="bibr">Kai, 2016</xref>;
						<xref rid="bib59" ref-type="bibr">Patel et al., 2015</xref>). However, in vivo experimental evidence of their molecular function in this process remained to be established.
					</p>
					<p>We screened DDR proteins for their recruitment to laser-induced damage sites in FUS-KO cell lines. We found that FUS is required at a very early step for the retention at DSBs of the 80-kD subunit of the DSB sensor KU70/80. Interestingly, whereas in FUS-KO cells the retention of KU80 is impaired, the recruitment of NBS1, one of the three subunits of the MRN complex, is increased by &gt;50%. On the one hand, these observations may explain at least in part the higher phosphorylation of ATM, and of downstream DDR factors, that we observed in FUS-KO cells, since NBS1 directly interacts with ATM (
						<xref rid="bib21" ref-type="bibr">Falck et al., 2005</xref>), and the MRN complex is required for ATM activation (
						<xref rid="bib42" ref-type="bibr">Lee and Paull, 2005</xref>). On the other hand, they are consistent with the idea that, due to its high abundance and strong affinity for DNA, KU heterodimer is the first DDR factor that binds to the DNA broken ends irrespective of the cell cycle phase (
						<xref rid="bib69" ref-type="bibr">Shibata et al., 2018</xref>). KU70/80 is then removed by the endonucleolytic activity of the MRN complex (
						<xref rid="bib12" ref-type="bibr">Chanut et al., 2016</xref>;
						<xref rid="bib56" ref-type="bibr">Myler et al., 2017</xref>) or by phosphorylation of KU70 (
						<xref rid="bib43" ref-type="bibr">Lee et al., 2016</xref>). Therefore, KU70/80 is recruited but not efficiently retained in the absence of FUS, allowing the MRN complex to successfully compete for binding to the DNA broken ends. However, this is not sufficient for efficient repair, since we and others have demonstrated that the silencing of FUS affects both HR- and NHEJ-mediated repair (
						<xref rid="bib48" ref-type="bibr">Mastrocola et al., 2013</xref>;
						<xref rid="bib78" ref-type="bibr">Wang et al., 2013</xref>). This justified the continuing quest for FUS-dependent events during the DDR.
					</p>
					<p>Indeed, FUS is also required for the relocation of 53BP1 to DNA damage sites, and consistently, the formation of 53BP1 foci is delayed in FUS-KO cells. In line with the inhibitory role that 53BP1 exerts on BRCA1 at DSB sites (
						<xref rid="bib20" ref-type="bibr">Escribano-D&#xED;az et al., 2013</xref>), we observed that in FUS-KO cells, in which 53BP1 recruitment at laser-induced DNA damage sites is impaired, the association of BRCA1 is more efficient. We also discovered that FUS is necessary for the recruitment to damage sites of SFPQ, an RBP that had already been implicated in DNA damage repair (
						<xref rid="bib7" ref-type="bibr">Bladen et al., 2005</xref>;
						<xref rid="bib32" ref-type="bibr">Jaafar et al., 2017</xref>;
						<xref rid="bib64" ref-type="bibr">Rajesh et al., 2011</xref>;
						<xref rid="bib71" ref-type="bibr">Simon et al., 2017</xref>). Intriguingly, FUS and SFPQ are both core components of paraspeckles, phase-separated membraneless organelles that assemble on the NEAT1 lncRNA, which induces LLPS via interaction with SFPQ/NONO (
						<xref rid="bib81" ref-type="bibr">Yamazaki et al., 2018</xref>). The purified LCD of FUS forms a hydrogel at high concentrations in vitro, and this region is essential for paraspeckle formation in vivo (
						<xref rid="bib27" ref-type="bibr">Hennig et al., 2015</xref>). Based on these observations, it was tempting to hypothesize that FUS and SFPQ play a similar role in the DDR, inducing LLPS at DSBs to promote the efficient assembly of DNA repair complexes. Indeed, we show that efficient relocation of SFPQ requires LLPS-competent FUS.
					</p>
					<p>Consistent with a physical role of FUS in triggering the formation of DDR protein assemblies around DSBs through LLPS, we found that &#x3B3;H2AX foci are sensitive to treatment with two different LLPS inhibitors, indicating that LLPS occurs very early during the DDR. 53BP1 foci were also recently shown to be phase-separated droplet-like compartments (
						<xref rid="bib37" ref-type="bibr">Kilic et al., 2019</xref>;
						<xref rid="bib61" ref-type="bibr">Pessina et al., 2019</xref>). Interestingly, we observed that &#x3B3;H2AX foci are more sensitive to the LLPS inhibitor 1,6-HD compared with 53BP1 foci: while &#x3B3;H2AX foci were completely dissolved by 2% 1,6-HD, disassembly of 53BP1 foci could only be observed with a concentration of &#x2265;4% (data not shown and
						<xref rid="bib37" ref-type="bibr">Kilic et al., 2019</xref>). Since 1,6-HD can disrupt structures that depend on weak interactions between sticky LCDs but is ineffective in disrupting solid amyloid-like aggregates (
						<xref rid="bib39" ref-type="bibr">Kroschwald et al., 2015</xref>), our observations suggest that 53BP1 foci are more solid-like in comparison with &#x3B3;H2AX foci, possibly because of their different protein composition. Remarkably, however, the number of both &#x3B3;H2AX and 53BP1 foci decreased upon addition of Am. Ac., which can prevent RNA gelation and can disrupt nuclear speckles, ribonucleoprotein bodies that depend on ionic interactions (
						<xref rid="bib33" ref-type="bibr">Jain and Vale, 2017</xref>;
						<xref rid="bib39" ref-type="bibr">Kroschwald et al., 2015</xref>). The effect of Am. Ac. on &#x3B3;H2AX and 53BP1 foci is consistent with a role for RNA in the earliest DDR events (
						<xref rid="bib10" ref-type="bibr">Bonath et al., 2018</xref>;
						<xref rid="bib22" ref-type="bibr">Francia et al., 2012</xref>;
						<xref rid="bib50" ref-type="bibr">Michelini et al., 2017</xref>).
					</p>
					<p>In addition, we observed that LLPS inhibition impairs the recruitment of FUS, SFPQ, KU80, and NBS1 and affects DDR signaling. In fact, FUS forms LLPS-specific interactions with additional DNA damage repair proteins (
						<xref rid="bib65" ref-type="bibr">Reber et al., 2019</xref>
						<italic>Preprint</italic>). Our findings are consistent with two recent studies showing that LLPS is necessary for the subsequent recruitment of the downstream effector 53BP1 to DNA damage foci (
						<xref rid="bib37" ref-type="bibr">Kilic et al., 2019</xref>;
						<xref rid="bib61" ref-type="bibr">Pessina et al., 2019</xref>).
					</p>
					<p>To support the idea that FUS-dependent LLPS at DSBs is required for the efficient assembly of DNA repair complexes, we investigated the structure of H2AX foci formed in the absence of FUS using superresolution microscopy. We reported previously that &#x3B3;H2AX foci formed following ionizing radiation exposure consist of spatially clustered nanofoci of &#x223C;200-nm diameter (
						<xref rid="bib57" ref-type="bibr">Natale et al., 2017</xref>). Here we characterized &#x3B3;H2AX foci in WT and FUS-KO cells treated with ETO. We found that FUS contributes to the spatial clustering of &#x3B3;H2AX foci. The impairment of the structural organizations of &#x3B3;H2AX nanofoci in FUS-KO cells upon genotoxic damage is reminiscent of what we observed upon depletion of the chromatin architectural protein CTCF (
						<xref rid="bib57" ref-type="bibr">Natale et al., 2017</xref>). Thus, we propose that FUS exerts an early role in DDR by promoting LLPS. This, and the presence of CTCF, contributes to the 3D organization of chromatin around DSBs, enabling the activation of an efficient DDR.
					</p>
					<p>The question remains open as to what recruits FUS to broken DNA ends. In this regard, the formation of a complex between KU and FUS is supported by several recent reports (
						<xref rid="bib1" ref-type="bibr">Abbasi and Schild-Poulter, 2019</xref>;
						<xref rid="bib52" ref-type="bibr">Morchikh et al., 2017</xref>). Based on our data and on the study by
						<xref rid="bib4" ref-type="bibr">Aleksandrov et al. (2018)</xref>, who measured, clustered, and modeled the kinetics of recruitment and dissociation of 70 DNA repair proteins to laser-induced DNA damage sites, we propose that FUS relocates to DSBs, where it promotes LLPS together with SFPQ. This stabilizes KU70/80 on the broken DNA ends and leads to the further recruitment of multiple proteins required for DSB repair. Intriguingly, several of these proteins are RBPs, which supports the idea that RNAs are involved in DSB repair (
						<xref rid="bib50" ref-type="bibr">Michelini et al., 2017</xref>;
						<xref rid="bib61" ref-type="bibr">Pessina et al., 2019</xref>). How FUS and other RBPs are recruited to broken ends remains to be established. Most likely, this occurs through binding to poly-ADP ribose chains that are deposited at sites of DNA damage by PARP1, which is among the first proteins that are recruited (have half-times between 1.8 and 3.7 s;
						<xref rid="bib4" ref-type="bibr">Aleksandrov et al., 2018</xref>). Both FUS and the SFPQ/NONO heterodimer have been shown to bind to poly (ADP-ribose) (
						<xref rid="bib38" ref-type="bibr">Krietsch et al., 2012</xref>;
						<xref rid="bib48" ref-type="bibr">Mastrocola et al., 2013</xref>). While further work is required to understand the role of all the different RBPs that have been involved in DNA repair, and also of RNA itself, our data will facilitate mechanistic investigations to uncover their precise activities.
					</p>
					<p>The elucidation of FUS&#x2019;s role in the activation of the DDR upon DNA damage will also be relevant for the design of novel therapeutic approaches for neurodegenerative diseases and cancers in which FUS plays a pathological role. FUS was initially identified &#x223C;20 yr ago as a fusion oncogene in human myxoid liposarcomas with the C/EBP homologous protein transcription factor. More recently, FUS fusions have been found in Ewing&#x2019;s sarcoma and acute myeloid leukemia (
						<xref rid="bib70" ref-type="bibr">Shing et al., 2003</xref>;
						<xref rid="bib82" ref-type="bibr">Zerkalenkova et al., 2018</xref>). These translocations involve the fusion of FUS N-terminal LCD with different transcription factors. In addition, FUS is associated with a variety of neurodegenerative diseases, including amyotrophic lateral sclerosis, frontotemporal lobar degeneration, and polyglutamine diseases (
						<xref rid="bib17" ref-type="bibr">Deng et al., 2014a</xref>), where it is found in cytoplasmic inclusions. To explain the pathological role of FUS in neurons, two hypotheses have been proposed: the gain-of-function model, in which FUS gains a toxic function in the cytoplasm through aggregate formation and sequestration of important regulators; alternatively, the relocalization of FUS to the cytoplasm depletes the nuclear protein pool affecting transcription, alternative splicing, and DNA repair. Indeed, H2AX phosphorylation has been observed in motor neurons carrying FUS nuclear localization signal mutations (
						<xref rid="bib58" ref-type="bibr">Naumann et al., 2018</xref>;
						<xref rid="bib78" ref-type="bibr">Wang et al., 2013</xref>), suggesting that a chronic DDR activation may exacerbate neuroinflammation, contributing to neuronal death. Therefore, elucidation of the molecular function of FUS in the DDR could provide new insight into its role in the pathogenesis of neurodegenerative diseases and in cancer, allowing the design of novel therapeutic strategies.
					</p>
				</sec>
				<sec sec-type="materials|methods" id="s9">
					<title>Materials and methods</title>
					<sec id="s10">
						<title>Cell lines, cell culture, and treatments</title>
						<p>HEK293T cells stably expressing Flag-tagged FUS and HeLa FUS-KO were described in
							<xref rid="bib67" ref-type="bibr">Reber et al. (2016)</xref>. U2OS cells stably expressing HR and NHEJ repair reporters were a kind gift from J.M. Stark (Beckman Research Institute of City of Hope, Duarte, CA) and were described in
							<xref rid="bib24" ref-type="bibr">Gunn and Stark (2012)</xref>. HeLa and SH-SY-5Y FUS-KO cells were generated by CRISPR-trap (
							<xref rid="bib66" ref-type="bibr">Reber et al., 2018</xref>). All cell lines were tested for mycoplasma contamination and were found to be negative. Cells were cultured in DMEM (high glucose) supplemented with 10% FBS, 2 mM
							<sc>l</sc>-glutamine, 100 IU/ml penicillin, and 0.1 mg/ml streptomycin (all EuroClone). Cells were grown at 37&#xB0;C and 5% CO
							<sub>2</sub> in a humidified incubator.
						</p>
						<p>ETO treatment, where not specified otherwise, was performed for 1 h with 10 &#xB5;M diluted in DMSO (Enzo Lifesciences). Where specified, cells were treated with 2% 1,6-HD (diluted in growth medium; Sigma-Aldrich), 2% 2,5-HD (diluted in growth medium; Sigma Aldrich), or 50 or 100 mM Am. Ac. (diluted in water; Sigma Aldrich) for 30 min.</p>
						<p>Plasmid DNA transfections were performed using Lipofectamine 2000 (Invitrogen), while siRNA transfections were done using Lipofectamine RNAiMAX (Invitrogen), according to the manufacturer&#x2019;s instructions. The synthetic siRNAs used in this study were purchased from Riboxx Life Sciences.</p>
					</sec>
					<sec id="s11">
						<title>Trypan blue assay</title>
						<p>HeLa WT and FUS-KO cells were seeded at a concentration of 2 &#xD7; 10
							<sup>3</sup> cells/well in 96-well plates. Cells were allowed to attach overnight and were then treated with increasing concentrations of ETO (DMSO, 0.5 or 1 &#xB5;M) or CPT (DMSO, 0.1 or 0.5 &#xB5;M) for 18 h. Cells were then detached with trypsin and diluted 1:2 in Trypan blue. Living cells were visualized and counted with a hemocytometer using a bright-field microscope. Data are expressed as the percentage of cells in relation to their respective control (DMSO).
						</p>
					</sec>
					<sec id="s12">
						<title>DNA constructs</title>
						<p>NBS1-GFP was kindly provided by Dr. A. Nussenzweig (Laboratory of Genome Integrity, National Institutes of Health, Bethesda, MD;
							<xref rid="bib40" ref-type="bibr">Kruhlak et al., 2006</xref>). KU80-EGFP was purchased from AddGene (#46958). SFPQ-EGFP was generated by subcloning the SFPQ ORF obtained from the Myc-PSF-WT plasmid (#35183; AddGene). The FUS-EGFP plasmid was generated by inserting the FUS ORF into pcDNA6F-EGFP. The generation of the XRCC1-RFP plasmid (pc1156) is described in detail in
							<xref rid="bib55" ref-type="bibr">Muster et al. (2017)</xref>. FUS-mCherry plasmids (WT, RK, YS, and QG) were kindly provided by Dr. J. Wang and Dr. S. Alberti (Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany;
							<xref rid="bib77" ref-type="bibr">Wang et al., 2018</xref>). The sequences of the oligonucleotides/siRNAs used are as follows): siXRCC5, 5&#x2032;-AAG&#x200B;AGC&#x200B;UAA&#x200B;UCC&#x200B;UCA&#x200B;AGU&#x200B;CUU-3&#x2032;; siTOPBP1, 5&#x2032;-CUCACCUUAUUGCAGGAGAdTdT-3&#x2032;; siFUS1, 5&#x2032;-AGC&#x200B;CCA&#x200B;UGA&#x200B;UUA&#x200B;AUU&#x200B;UGU&#x200B;ATT-3&#x2032;; siFUS_sh, 5&#x2032;-GGA&#x200B;CAG&#x200B;CAG&#x200B;CAA&#x200B;AGC&#x200B;UAU&#x200B;ATT-3&#x2032;; siRNA pool negative control, catalog no. SKU# K-00100 (iBONI; Riboxx&#x2019;s design).
						</p>
					</sec>
					<sec id="s13">
						<title>Protein collection, quantification, and Western blotting</title>
						<p>Adherent cells were washed twice with PBS and then scraped and digested on ice for 30 min with a homemade radioimmunoprecipitation assay medium (50 mM Tris-HCl, pH 7.5, 15 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, and 0.1% SDS, supplemented with protease inhibitors [Roche] and phosphatase inhibitors [Sigma-Aldrich]). Cell extracts were centrifuged at 16,000
							<italic>g</italic> for 20 min at 4&#xB0;C, and only the soluble fraction (supernatant) was used. Proteins were quantified using a validated bicinchoninic acid Protein Assay Kit (EuroClone) protocol. For Western blotting, the same amount of proteins was loaded, diluted in homemade sample buffer (6&#xD7; Laemmli sample buffer: 1 M Tris-HCl, pH 6.8, 10% SDS, 40% glycerol, 12% &#x3B2;-mercaptoethanol, and bromophenol blue). Running buffer was prepared with Tris-glycine 1&#xD7; and SDS 0.1% using a homemade gel (7&#x2013;12% bis-acrylamide; Bio-Rad), which ran at 100 V for &#x223C;2.5 h. After the run, the proteins were transferred to a nitrocellulose membrane (0.45-&#xB5;m pore size; Amersham). Transfer was performed at 80 V at 4&#xB0;C for 1.5&#x2013;2.5 h using a 20% methanol transfer buffer. Transfer of 53BP1 was done using a modified transfer buffer with 18% methanol and 0.1% SDS. Membranes were stained with Ponceau (Sigma-Aldrich) for 8 min, and images were acquired using a ChemiDoc (Bio-Rad). After removal of the Ponceau by washing once with TBS-T (TBS 1&#xD7; and Tween 0.05%), membranes were blocked for 1 h with 5% milk or 4% BSA (for phosphorylated proteins), diluted in TBS-T. Membranes were then incubated overnight at 4&#xB0;C with a primary antibody diluted in 5% milk or 4% BSA. The membrane was then washed three times with TBS-T for 5 min and incubated with a secondary antibody diluted in 5% milk for 1 h at RT. The membrane was finally washed three times with TBS-T for 10 min. Acquisition was made using Cyanagen ECL according to the manufacturer&#x2019;s protocol, exposing the membrane in the trans-illuminator ChemiDoc (Bio-Rad). The quantification of the signal intensity was performed using Image Lab v6.0.
						</p>
						<p>The antibodies used for Western blot experiments are as follows: rabbit &#x3B1;-&#x3B3;H2AX, #9718; Cell Signaling (1:1,000); rabbit &#x3B1;-pATM, #5883; Cell Signaling (1:1,000); rabbit &#x3B1;-pATR, #2853; Cell Signaling (1:1,000); rabbit &#x3B1;-pCHK1, #2348, Cell Signaling (1:1,000); rabbit &#x3B1;-pCHK2, #2197; Cell Signaling (1:1,000); rabbit &#x3B1;-pTRIM28, A300-767A-T; Bethyl (1:1,000); rabbit &#x3B1;-pBRCA1, #9009; Cell Signaling (1:1,000); rabbit &#x3B1;-53BP1, #4937S; Cell Signaling (1:1,500); rabbit &#x3B1;-FUS, homemade by M.-D. Ruepp (1:3,000;
							<xref rid="bib63" ref-type="bibr">Raczynska et al., 2015</xref>); rabbit &#x3B1;-KU80, #2753S; Cell Signaling (1:1,000); mouse &#x3B1;-TOPBP1, sc271043; Santa Cruz Biotechnology (1:1,000); mouse &#x3B1;-Tubulin, sc-5286; Santa Cruz Biotechnology (1:3,000); mouse &#x3B1;-&#x3B2;-Actin, ab8226; Abcam (1:1,000); goat &#x3B1;-rabbit IgG HRP-linked, #7074; Cell Signaling (1:8,000); and horse &#x3B1;-mouse IgG HRP-linked, #7076; Cell Signaling (1:8,000).
						</p>
					</sec>
					<sec id="s14">
						<title>Immunofluorescence, confocal imaging, and quantification</title>
						<p>Cells were fixed with 4% PFA (diluted in PBS, pH 7.4) at RT for 15 min and, after three washes with PBS, were permeabilized with 0.25% Triton X-100 in PBS for 5 min. Permeabilized cells were blocked in blocking solution (20% FBS and 0.05% Tween in PBS) for 1 h at RT. Primary antibodies were diluted in wash buffer (0.2% BSA in PBS) and incubated for 1 h at RT. After three washes with wash buffer, cells were incubated with the respective secondary antibodies (diluted in wash buffer) for 1 h at RT. After three washes with wash buffer, cells were counterstained with DAPI (D9542; Sigma-Aldrich; 1 &#xB5;g/ml in PBS) diluted in PBS for 10 min. Coverslips were washed twice with PBS and once with water and mounted onto microscope slides using an antifade mounting medium (FluorSave; Calbiochem). The antibodies used were mouse &#x3B1;-&#x3B3;H2AX, ab26350; Abcam (1:100); rabbit &#x3B1;-53BP1, NB100-305; NovusBio (1:200); rabbit &#x3B1;-Coilin, A.I. Lamond (1:100; University of Dundee, Scotland); mouse &#x3B1;-SC35, S4045; Sigma-Aldrich (1:100); Alexa Fluor 488 goat &#x3B1;-rabbit IgG, A11008; Invitrogen (1:4,000); and Alexa Fluor 647 goat &#x3B1;-mouse IgG, A21235; Invitrogen (1:4,000).</p>
						<p>Cell imaging was performed using a confocal microscope ECLIPSE Ti A1 (Nikon) and acquisition software NIS-Elements. Between 6&#x2013;10 images were taken per coverslip (randomly) using the 60&#xD7; oil objective. Quantification of DNA damage foci (&#x3B3;H2AX and 53BP1) and subnuclear bodies (Cajal bodies and nuclear speckles) was performed using the software Fiji ImageJ v2.0. To that end, a mask of the nucleus was made using DAPI staining (filter Gaussian blur radius 2 followed by adjusting the threshold and then analyzing particles). Nuclear foci were measured using the function Find Maxima (by setting a noise tolerance and dividing the final image by 255). For baseline experiments (WT vs. FUS-KO), data are shown as the average number of foci per nucleus. For all other experiments, data were normalized by the WT DMSO group (which was considered 100%). At least 100 cells were counted per experiment, which were done at least in duplicate.</p>
						<p>For SG imaging, HeLa WT and HeLa FUS-KO cells were seeded in 24-well plates fitted with coverslips. 24 h later, the cells were stressed for 1 h by addition of 0.5 mM sodium (meta)arsenite (S7400; Sigma-Aldrich) to the medium. Cells were then fixed in 4% PFA for 30 min at RT. Subsequently, cells were washed 3 &#xD7; 5 min with PBS and then permeabilized in TBS supplemented with 0.5% Triton X-100 and 6% BSA for 30 min at RT. Primary antibody incubation was conducted in 0.1% Triton X-100 and 6% BSA in TBS overnight at 4&#xB0;C. Cells were washed 3 &#xD7; 5 min with PBS, incubated with secondary antibodies in 0.1% Triton X-100 and 6% BSA in TBS for 2 h at RT, and then counterstained with 100 ng/ml DAPI (Sigma-Aldrich) for 10 min at RT. Cells were then washed 2 &#xD7; 5 min with PBS and subsequently rinsed with H
							<sub>2</sub>O before mounting onto microscope slides using Vectashield hardset antifade mounting medium (Vectashield; H-1400). Antibodies used were mouse &#x3B1;-FUS, sc47711; Santa Cruz (1:200); goat &#x3B1;-TIA1, sc1751; Santa Cruz (1:500); Alexa Fluor 488 donkey &#x3B1;-goat IgG, A11055; Invitrogen (1:500); and Alexa Fluor 546 donkey &#x3B1;-mouse IgG, A10036; Invitrogen (1:500).
						</p>
					</sec>
					<sec id="s15">
						<title>Laser microirradiation</title>
						<p>HeLa WT and/or FUS-KO cells were transiently transfected with the indicated GFP- or mCherry-tagged plasmids 2 d before irradiation. The following day, transfected cells were plated onto 35-mm plates with a glass bottom and allowed to attach overnight. 30 min before irradiation, the cell medium was replaced by phenol red&#x2013;free medium containing 0.5 &#xB5;g/ml Hoechst 33342 (B2261; Sigma-Aldrich). Three images were taken as baseline (preirradiation), and then cells were irradiated for 4 s using the 405-nm laser at 25% power. The fluorescence intensity of the irradiated area and of two other nuclear regions of interest (ROIs) and one background ROI were assessed. Protein recruitment to the irradiated area was analyzed by removing the background fluorescence intensity from each of the other ROIs, and then calculating the percentage change at each time point from the average of the three baseline images (preirradiation). Finally, the difference between the fluorescence signal in the irradiated region and the average of the two control regions in the nucleus was calculated. The formula used to calculate the protein recruitment: Recruitment (%) = % from baseline in irradiated ROI &#x2212; [(% from baseline in control ROI 1 + % from baseline in control ROI 2)/2]. All the microirradiation experiments were performed in a confocal microscope ECLIPSE Ti A1 (Nikon), using a 60&#xD7; oil objective plus 5&#xD7; digital zoom. During microirradiation, cell plates were maintained in a humidified chamber at 37&#xB0;C and 5% CO
							<sub>2</sub>. Experiments were done in duplicate, and 10 cells were assessed per experiment (for a total of 20 cells per group), except for the recruitment of BRCA1, in which four independent experiments were performed with 10 cells assessed per experiment (for a total of 40 cells).
						</p>
					</sec>
					<sec id="s16">
						<title>HR and NHEJ repair reporter assays</title>
						<p>DSB repair assays were performed in Direct Repeats&#x2013;GFP or EJ5-GFP U2OS cell lines (
							<xref rid="bib24" ref-type="bibr">Gunn and Stark, 2012</xref>). The constructs are based on an engineered GFP gene containing recognition sites for the I-SceI endonuclease for enzymatic induction of DSBs. The starting constructs are GFP negative, as the GFP gene is inactivated by an additional exon or by mutations. Successful repair of the I-SceI&#x2013;induced breaks by NHEJ or HR restores the functional GFP gene. The number of GFP-positive cells, as counted by flow cytometry, provides a quantitative measure of the NHEJ or HR efficiency.
						</p>
						<p>Briefly, cells were transfected with siRNAs. 2 d later, cells were cotransfected with a plasmid expressing I-SceI (pCBA-I-SceI) together with indicated siRNAs using Lipofectamine 2000 (Invitrogen). Cells were harvested 3 d after transfection and subjected to flow cytometric analysis to identify and quantify GFP-positive cells (BD FACS Calibur and CellQuest software). The repair efficiency was scored as the percentage of GFP-positive cells, and data were normalized to a control siRNA treatment in each individual experiment. Experiments were done in triplicate, and &#x2265;10,000 cells were assessed per experiment.</p>
					</sec>
					<sec id="s17">
						<title>3D SIM imaging and analysis</title>
						<p>Cells were plated on high-precision coverslips (18 &#xD7; 18 mm, #1.5 thickness with low variance). After treatment, cells were fixed with 2% formaldehyde at RT for 10 min and then washed three times (first time by removing only two thirds of fixation solution) with 0.02% Tween 20 in PBS (PBST). Cells were permeabilized with 0.5% Triton X-100 in PBST for 10 min and blocked with 2% BSA in PBST for 1 h at RT. After blocking, primary antibody diluted in blocking solution was added for 1 h at RT, followed by three washes with PBST. Secondary antibody diluted in blocking solution was then added for 1 h at RT, followed by three washes with PBST. Samples were postfixed with 4% formaldehyde for 10 min at RT and then washed three times with PBST. DAPI counterstaining (Sigma Aldrich; 1 &#xB5;g/ml in PBST) was done for 10 min at RT and then washed once with PBST and once with double distilled H
							<sub>2</sub>O before mounting onto a microscope slide using Vectashield antifade mounting medium and sealed with nail polish. The antibodies used were mouse &#x3B1;-Flag M2, F1804; Sigma-Aldrich (1:250); rabbit &#x3B1;-&#x3B3;H2AX, #9718S; Cell Signaling (1:150); Alexa Fluor 488 goat &#x3B1;-rabbit IgG, A11008; Invitrogen (1:4,000); and Alexa Fluor 647 goat &#x3B1;-mouse IgG, A21235; Invitrogen (1:4,000).
						</p>
						<p>A two-step analysis of &#x3B3;H2AX clusters was done with Volocity software v6.1.2 (PerkinElmer) and with the software R (R Foundation). First, aligned 3D-SIM RGB image stacks were used in Volocity, and the respective channels were separated for the segmentation of &#x3B3;H2AX structures and DAPI-stained nuclei. &#x3B3;H2AX segmentation was performed for all cells with the following commands: (1) Find Objects (threshold using intensity, lower: 32, upper: 255); (2) Separate Touching Objects with an object size guide of 0.002 &#xB5;m
							<sup>3</sup>; and (3) Exclude Objects by Size, excluding structures &lt;0.005 &#xB5;m
							<sup>3</sup>. Besides volume measurements, the centroid position of each &#x3B3;H2AX volume was always registered. For the challenging segmentation of nuclei, we used the commands Find Objects, Dilate, Erode, and Fill Holes in Objects with specific settings. To obtain only &#x3B3;H2AX structures within a nucleus, the Intersect and Compartmentalize commands were used. In a second step, the provided information of &#x3B3;H2AX structures (centroid position, etc.) was transferred to R. Here the Euclidean centroid-to-centroid distances were computed for all nanofoci structures within one nucleus, and then nanofoci with a centroid&#x2013;centroid distance &lt;500 nm were assigned to the same cluster. Obtained clusters were filtered for structures that contained a minimum of seven nanofoci.
						</p>
					</sec>
					<sec id="s18">
						<title>Statistical analysis</title>
						<p>Bar graphs show average &#xB1; SEM, while violin plots display median (red line) and quartiles (blue dotted lines). Statistical analysis was performed using the software IBM SPSS Statistics v26. Data distribution was assumed to be normal, but this was not formally tested. Comparison of two groups was done by two-sided Student&#x2019;s
							<italic>t</italic> test, while more groups were compared by one-way ANOVA. Two variable comparisons were performed using two-way ANOVA. All post hoc analysis, when necessary, was done using Bonferroni post hoc test. Values of P &lt; 0.05 were considered significant. Significant values are shown by *, P &lt; 0.05; **, P &lt; 0.001; and ***, P &lt; 0.001.
						</p>
					</sec>
					<sec id="s19">
						<title>Online supplemental material</title>
						<p>
							<xref ref-type="fig" rid="figS1">Fig. S1</xref> shows that loss of FUS results in an accumulation of DNA damage and sensitization to genotoxic insult in SH-SY5Y cells.
							<xref ref-type="fig" rid="figS2">Fig. S2</xref> shows that loss of FUS does not affect SG assembly.
							<xref ref-type="fig" rid="figS3">Fig. S3</xref> shows that FUS is required for efficient DSB repair and DNA damage foci formation upon genotoxic insult.
							<xref ref-type="fig" rid="figS4">Fig. S4</xref> shows that microirradiation experiments are not influenced by differential expression of KU80-GFP or NBS1-GFP in WT versus FUS-KO cell lines.
							<xref ref-type="fig" rid="figS5">Fig. S5</xref> shows that loss of FUS specifically affects SFPQ but not XRCC1 recruitment to DSBs.
							<xref ref-type="fig" rid="figS6">Fig. S6</xref> shows that 2% 1,6-HD treatment does not irreversibly affect the morphology and vitality of cells.
							<xref ref-type="fig" rid="video1">Video 1</xref> shows SFPQ recruitment in HeLa WT versus FUS-KO cells.
						</p>
					</sec>
				</sec>
				<sec sec-type="supplementary-material">
					<title>Supplementary Material</title>
					<supplementary-material content-type="local-data">
						<label>Review History</label>
						<media xlink:href="JCB_202008030_review_history.pdf">
							<caption>
								<p>Click here for additional data file.</p>
							</caption>
						</media>
					</supplementary-material>
				</sec>
			</body>
			<back>
				<ack>
					<title>Acknowledgments</title>
					<p>We are grateful to J. Stark for the U2OS cells (HR/NHEJ reporters), J. Wang and S. Alberti for FUS constructs, and A. Nussenzweig for the NBS1 construct. We thank G. Chenell (Wohl Cellular Imaging Centre, King&#x2019;s College London, London, UK) for technical support, M. Colombo for bioinformatics support, D. Jutzi for assistance in generating the FUS-KO cells, and M.E. Bianchi for critically reading the manuscript.</p>
					<p>This work was partially supported by the Swiss National Fond Sinergia (grant CRSII3_136222 to O. M&#xFC;hlemann and S.M.L. Barabino), the UK Dementia Research Institute (to M.-D. Ruepp), the NOMIS Foundation (to M.-D. Ruepp), and the Deutsche Forschungsgemeinschaft (grant LE 721/18-1 to H. Leonhardt and CA 198/16-1 to M.C. Cardoso).</p>
					<p>The authors declare no competing financial interests.</p>
					<p>Author contributions: B.R. Levone conceived and performed the experiments and the data analysis for Figs. 1&#x2013;8 and associated supplementary data and participated in the preparation of figures and tables. S.C. Lenzken conceived and performed the experiments and the data analysis for Figs. 1 and 2 and associated supplementary data and participated in the preparation of figures and tables. M. Antonaci performed the experiments in Figs. 1 A, 2 A, and 7 C and associated supplementary data. A. Maiser and A. Rapp performed the experiments and data analysis for Fig. 9. F. Conte performed the experiments in Figs. 1 D and 2 A. S. Reber and M.-D. Ruepp generated KO lines and FUS constructs. J. Mechtersheimer performed the experiment in Fig. S2. A.E. Ronchi, O. M&#xFC;hlemann, and M.-D. Ruepp critically revised the manuscript. H. Leonhardt and M.C. Cardoso supervised the experiments in Fig. 9 and critically revised the manuscript. S.M.L. Barabino conceived the study and wrote the manuscript. All authors provided discussion and data interpretation and contributed to the final version of the manuscript.</p>
				</ack>
				<ref-list>
					<title>References</title>
					<ref id="bib1">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Abbasi</surname>,
									<given-names>S.</given-names>
								</string-name>, and
								<string-name>
									<given-names>C.</given-names>
									<surname>Schild-Poulter</surname>
								</string-name>
							</person-group>.
							<year>2019</year>.
							<article-title>Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells</article-title>.
							<source>J. Proteome Res.</source>
							<volume>18</volume>:
							<fpage>1064</fpage>&#x2013;
							<lpage>1077</lpage>.
							<pub-id pub-id-type="doi">10.1021/acs.jproteome.8b00771</pub-id>
							<pub-id pub-id-type="pmid">30585729</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib2">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Aguirre</surname>,
									<given-names>N.</given-names>
								</string-name>,
								<string-name>
									<given-names>M.F.</given-names>
									<surname>Beal</surname>
								</string-name>,
								<string-name>
									<given-names>W.R.</given-names>
									<surname>Matson</surname>
								</string-name>, and
								<string-name>
									<given-names>M.B.</given-names>
									<surname>Bogdanov</surname>
								</string-name>
							</person-group>.
							<year>2005</year>.
							<article-title>Increased oxidative damage to DNA in an animal model of amyotrophic lateral sclerosis</article-title>.
							<source>Free Radic. Res.</source>
							<volume>39</volume>:
							<fpage>383</fpage>&#x2013;
							<lpage>388</lpage>.
							<pub-id pub-id-type="doi">10.1080/10715760400027979</pub-id>
							<pub-id pub-id-type="pmid">16028363</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib3">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Akhmedov</surname>,
									<given-names>A.T.</given-names>
								</string-name>, and
								<string-name>
									<given-names>B.S.</given-names>
									<surname>Lopez</surname>
								</string-name>
							</person-group>.
							<year>2000</year>.
							<article-title>Human 100-kDa homologous DNA-pairing protein is the splicing factor PSF and promotes DNA strand invasion</article-title>.
							<source>Nucleic Acids Res.</source>
							<volume>28</volume>:
							<fpage>3022</fpage>&#x2013;
							<lpage>3030</lpage>.
							<pub-id pub-id-type="doi">10.1093/nar/28.16.3022</pub-id>
							<pub-id pub-id-type="pmid">10931916</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib4">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Aleksandrov</surname>,
									<given-names>R.</given-names>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Dotchev</surname>
								</string-name>,
								<string-name>
									<given-names>I.</given-names>
									<surname>Poser</surname>
								</string-name>,
								<string-name>
									<given-names>D.</given-names>
									<surname>Krastev</surname>
								</string-name>,
								<string-name>
									<given-names>G.</given-names>
									<surname>Georgiev</surname>
								</string-name>,
								<string-name>
									<given-names>G.</given-names>
									<surname>Panova</surname>
								</string-name>,
								<string-name>
									<given-names>Y.</given-names>
									<surname>Babukov</surname>
								</string-name>,
								<string-name>
									<given-names>G.</given-names>
									<surname>Danovski</surname>
								</string-name>,
								<string-name>
									<given-names>T.</given-names>
									<surname>Dyankova</surname>
								</string-name>,
								<string-name>
									<given-names>L.</given-names>
									<surname>Hubatsch</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2018</year>.
							<article-title>Protein Dynamics in Complex DNA Lesions</article-title>.
							<source>Mol. Cell.</source>
							<volume>69</volume>:
							<fpage>1046</fpage>&#x2013;
							<lpage>1061.e5</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.molcel.2018.02.016</pub-id>
							<pub-id pub-id-type="pmid">29547717</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib5">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Allodi</surname>,
									<given-names>I.</given-names>
								</string-name>,
								<string-name>
									<given-names>L.</given-names>
									<surname>Comley</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Nichterwitz</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Nizzardo</surname>
								</string-name>,
								<string-name>
									<given-names>C.</given-names>
									<surname>Simone</surname>
								</string-name>,
								<string-name>
									<given-names>J.A.</given-names>
									<surname>Benitez</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Cao</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Corti</surname>
								</string-name>, and
								<string-name>
									<given-names>E.</given-names>
									<surname>Hedlund</surname>
								</string-name>
							</person-group>.
							<year>2016</year>.
							<article-title>Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS</article-title>.
							<source>Sci. Rep.</source>
							<volume>6</volume>:
							<fpage>25960</fpage>.
							<pub-id pub-id-type="doi">10.1038/srep25960</pub-id>
							<pub-id pub-id-type="pmid">27180807</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib6">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Baechtold</surname>,
									<given-names>H.</given-names>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Kuroda</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Sok</surname>
								</string-name>,
								<string-name>
									<given-names>D.</given-names>
									<surname>Ron</surname>
								</string-name>,
								<string-name>
									<given-names>B.S.</given-names>
									<surname>Lopez</surname>
								</string-name>, and
								<string-name>
									<given-names>A.T.</given-names>
									<surname>Akhmedov</surname>
								</string-name>
							</person-group>.
							<year>1999</year>.
							<article-title>Human 75-kDa DNA-pairing protein is identical to the pro-oncoprotein TLS/FUS and is able to promote D-loop formation</article-title>.
							<source>J. Biol. Chem.</source>
							<volume>274</volume>:
							<fpage>34337</fpage>&#x2013;
							<lpage>34342</lpage>.
							<pub-id pub-id-type="doi">10.1074/jbc.274.48.34337</pub-id>
							<pub-id pub-id-type="pmid">10567410</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib7">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Bladen</surname>,
									<given-names>C.L.</given-names>
								</string-name>,
								<string-name>
									<given-names>D.</given-names>
									<surname>Udayakumar</surname>
								</string-name>,
								<string-name>
									<given-names>Y.</given-names>
									<surname>Takeda</surname>
								</string-name>, and
								<string-name>
									<given-names>W.S.</given-names>
									<surname>Dynan</surname>
								</string-name>
							</person-group>.
							<year>2005</year>.
							<article-title>Identification of the polypyrimidine tract binding protein-associated splicing factor.p54(nrb) complex as a candidate DNA double-strand break rejoining factor</article-title>.
							<source>J. Biol. Chem.</source>
							<volume>280</volume>:
							<fpage>5205</fpage>&#x2013;
							<lpage>5210</lpage>.
							<pub-id pub-id-type="doi">10.1074/jbc.M412758200</pub-id>
							<pub-id pub-id-type="pmid">15590677</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib8">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Boeynaems</surname>,
									<given-names>S.</given-names>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Alberti</surname>
								</string-name>,
								<string-name>
									<given-names>N.L.</given-names>
									<surname>Fawzi</surname>
								</string-name>,
								<string-name>
									<given-names>T.</given-names>
									<surname>Mittag</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Polymenidou</surname>
								</string-name>,
								<string-name>
									<given-names>F.</given-names>
									<surname>Rousseau</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Schymkowitz</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Shorter</surname>
								</string-name>,
								<string-name>
									<given-names>B.</given-names>
									<surname>Wolozin</surname>
								</string-name>,
								<string-name>
									<given-names>L.</given-names>
									<surname>Van Den Bosch</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2018</year>.
							<article-title>Protein Phase Separation: A New Phase in Cell Biology</article-title>.
							<source>Trends Cell Biol.</source>
							<volume>28</volume>:
							<fpage>420</fpage>&#x2013;
							<lpage>435</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.tcb.2018.02.004</pub-id>
							<pub-id pub-id-type="pmid">29602697</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib9">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Bogaert</surname>,
									<given-names>E.</given-names>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Boeynaems</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Kato</surname>
								</string-name>,
								<string-name>
									<given-names>L.</given-names>
									<surname>Guo</surname>
								</string-name>,
								<string-name>
									<given-names>T.R.</given-names>
									<surname>Caulfield</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Steyaert</surname>
								</string-name>,
								<string-name>
									<given-names>W.</given-names>
									<surname>Scheveneels</surname>
								</string-name>,
								<string-name>
									<given-names>N.</given-names>
									<surname>Wilmans</surname>
								</string-name>,
								<string-name>
									<given-names>W.</given-names>
									<surname>Haeck</surname>
								</string-name>,
								<string-name>
									<given-names>N.</given-names>
									<surname>Hersmus</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2018</year>.
							<article-title>Molecular Dissection of FUS Points at Synergistic Effect of Low-Complexity Domains in Toxicity</article-title>.
							<source>Cell Rep.</source>
							<volume>24</volume>:
							<fpage>529</fpage>&#x2013;
							<lpage>537.e4</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.celrep.2018.06.070</pub-id>
							<pub-id pub-id-type="pmid">30021151</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib10">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Bonath</surname>,
									<given-names>F.</given-names>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Domingo-Prim</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Tarbier</surname>
								</string-name>,
								<string-name>
									<given-names>M.R.</given-names>
									<surname>Friedl&#xE4;nder</surname>
								</string-name>, and
								<string-name>
									<given-names>N.</given-names>
									<surname>Visa</surname>
								</string-name>
							</person-group>.
							<year>2018</year>.
							<article-title>Next-generation sequencing reveals two populations of damage-induced small RNAs at endogenous DNA double-strand breaks</article-title>.
							<source>Nucleic Acids Res.</source>
							<volume>46</volume>:
							<fpage>11869</fpage>&#x2013;
							<lpage>11882</lpage>.
							<pub-id pub-id-type="doi">10.1093/nar/gky1107</pub-id>
							<pub-id pub-id-type="pmid">30418607</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib11">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Burke</surname>,
									<given-names>K.A.</given-names>
								</string-name>,
								<string-name>
									<given-names>A.M.</given-names>
									<surname>Janke</surname>
								</string-name>,
								<string-name>
									<given-names>C.L.</given-names>
									<surname>Rhine</surname>
								</string-name>, and
								<string-name>
									<given-names>N.L.</given-names>
									<surname>Fawzi</surname>
								</string-name>
							</person-group>.
							<year>2015</year>.
							<article-title>Residue-by-Residue View of In&#xA0;Vitro FUS Granules that Bind the C-Terminal Domain of RNA Polymerase II</article-title>.
							<source>Mol. Cell.</source>
							<volume>60</volume>:
							<fpage>231</fpage>&#x2013;
							<lpage>241</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.molcel.2015.09.006</pub-id>
							<pub-id pub-id-type="pmid">26455390</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib12">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Chanut</surname>,
									<given-names>P.</given-names>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Britton</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Coates</surname>
								</string-name>,
								<string-name>
									<given-names>S.P.</given-names>
									<surname>Jackson</surname>
								</string-name>, and
								<string-name>
									<given-names>P.</given-names>
									<surname>Calsou</surname>
								</string-name>
							</person-group>.
							<year>2016</year>.
							<article-title>Coordinated nuclease activities counteract Ku at single-ended DNA double-strand breaks</article-title>.
							<source>Nat. Commun.</source>
							<volume>7</volume>:
							<fpage>12889</fpage>.
							<pub-id pub-id-type="doi">10.1038/ncomms12889</pub-id>
							<pub-id pub-id-type="pmid">27641979</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib13">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Chuang</surname>,
									<given-names>T.W.</given-names>
								</string-name>,
								<string-name>
									<given-names>C.C.</given-names>
									<surname>Lu</surname>
								</string-name>,
								<string-name>
									<given-names>C.H.</given-names>
									<surname>Su</surname>
								</string-name>,
								<string-name>
									<given-names>P.Y.</given-names>
									<surname>Wu</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Easwvaran</surname>
								</string-name>,
								<string-name>
									<given-names>C.C.</given-names>
									<surname>Lee</surname>
								</string-name>,
								<string-name>
									<given-names>H.C.</given-names>
									<surname>Kuo</surname>
								</string-name>,
								<string-name>
									<given-names>K.Y.</given-names>
									<surname>Hung</surname>
								</string-name>,
								<string-name>
									<given-names>K.M.</given-names>
									<surname>Lee</surname>
								</string-name>,
								<string-name>
									<given-names>C.Y.</given-names>
									<surname>Tsai</surname>
								</string-name>, and
								<string-name>
									<given-names>W.Y.</given-names>
									<surname>Tarn</surname>
								</string-name>
							</person-group>.
							<year>2019</year>.
							<article-title>The RNA Processing Factor Y14 Participates in DNA Damage Response and Repair</article-title>.
							<source>iScience.</source>
							<volume>13</volume>:
							<fpage>402</fpage>&#x2013;
							<lpage>415</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.isci.2019.03.005</pub-id>
							<pub-id pub-id-type="pmid">30901577</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib14">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Collins</surname>,
									<given-names>P.L.</given-names>
								</string-name>,
								<string-name>
									<given-names>C.</given-names>
									<surname>Purman</surname>
								</string-name>,
								<string-name>
									<given-names>S.I.</given-names>
									<surname>Porter</surname>
								</string-name>,
								<string-name>
									<given-names>V.</given-names>
									<surname>Nganga</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Saini</surname>
								</string-name>,
								<string-name>
									<given-names>K.E.</given-names>
									<surname>Hayer</surname>
								</string-name>,
								<string-name>
									<given-names>G.L.</given-names>
									<surname>Gurewitz</surname>
								</string-name>,
								<string-name>
									<given-names>B.P.</given-names>
									<surname>Sleckman</surname>
								</string-name>,
								<string-name>
									<given-names>J.J.</given-names>
									<surname>Bednarski</surname>
								</string-name>,
								<string-name>
									<given-names>C.H.</given-names>
									<surname>Bassing</surname>
								</string-name>, and
								<string-name>
									<given-names>E.M.</given-names>
									<surname>Oltz</surname>
								</string-name>
							</person-group>.
							<year>2020</year>.
							<article-title>DNA double-strand breaks induce H2Ax phosphorylation domains in a contact-dependent manner</article-title>.
							<source>Nat. Commun.</source>
							<volume>11</volume>:
							<fpage>3158</fpage>.
							<pub-id pub-id-type="doi">10.1038/s41467-020-16926-x</pub-id>
							<pub-id pub-id-type="pmid">32572033</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib15">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Couthouis</surname>,
									<given-names>J.</given-names>
								</string-name>,
								<string-name>
									<given-names>M.P.</given-names>
									<surname>Hart</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Shorter</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>DeJesus-Hernandez</surname>
								</string-name>,
								<string-name>
									<given-names>R.</given-names>
									<surname>Erion</surname>
								</string-name>,
								<string-name>
									<given-names>R.</given-names>
									<surname>Oristano</surname>
								</string-name>,
								<string-name>
									<given-names>A.X.</given-names>
									<surname>Liu</surname>
								</string-name>,
								<string-name>
									<given-names>D.</given-names>
									<surname>Ramos</surname>
								</string-name>,
								<string-name>
									<given-names>N.</given-names>
									<surname>Jethava</surname>
								</string-name>,
								<string-name>
									<given-names>D.</given-names>
									<surname>Hosangadi</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2011</year>.
							<article-title>A yeast functional screen predicts new candidate ALS disease genes</article-title>.
							<source>Proc. Natl. Acad. Sci. USA.</source>
							<volume>108</volume>:
							<fpage>20881</fpage>&#x2013;
							<lpage>20890</lpage>.
							<pub-id pub-id-type="doi">10.1073/pnas.1109434108</pub-id>
							<pub-id pub-id-type="pmid">22065782</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib16">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>D&#x2019;Alessandro</surname>,
									<given-names>G.</given-names>
								</string-name>, and
								<string-name>
									<given-names>F.</given-names>
									<surname>d&#x2019;Adda di Fagagna</surname>
								</string-name>
							</person-group>.
							<year>2017</year>.
							<article-title>Transcription and DNA Damage: Holding Hands or Crossing Swords?</article-title>
							<source>J. Mol. Biol.</source>
							<volume>429</volume>:
							<fpage>3215</fpage>&#x2013;
							<lpage>3229</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.jmb.2016.11.002</pub-id>
							<pub-id pub-id-type="pmid">27825959</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib17">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Deng</surname>,
									<given-names>H.</given-names>
								</string-name>,
								<string-name>
									<given-names>K.</given-names>
									<surname>Gao</surname>
								</string-name>, and
								<string-name>
									<given-names>J.</given-names>
									<surname>Jankovic</surname>
								</string-name>
							</person-group>.
							<year>2014</year>
							<comment>a</comment>.
							<article-title>The role of FUS gene variants in neurodegenerative diseases</article-title>.
							<source>Nat. Rev. Neurol.</source>
							<volume>10</volume>:
							<fpage>337</fpage>&#x2013;
							<lpage>348</lpage>.
							<pub-id pub-id-type="doi">10.1038/nrneurol.2014.78</pub-id>
							<pub-id pub-id-type="pmid">24840975</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib18">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Deng</surname>,
									<given-names>Q.</given-names>
								</string-name>,
								<string-name>
									<given-names>C.J.</given-names>
									<surname>Holler</surname>
								</string-name>,
								<string-name>
									<given-names>G.</given-names>
									<surname>Taylor</surname>
								</string-name>,
								<string-name>
									<given-names>K.F.</given-names>
									<surname>Hudson</surname>
								</string-name>,
								<string-name>
									<given-names>W.</given-names>
									<surname>Watkins</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Gearing</surname>
								</string-name>,
								<string-name>
									<given-names>D.</given-names>
									<surname>Ito</surname>
								</string-name>,
								<string-name>
									<given-names>M.E.</given-names>
									<surname>Murray</surname>
								</string-name>,
								<string-name>
									<given-names>D.W.</given-names>
									<surname>Dickson</surname>
								</string-name>,
								<string-name>
									<given-names>N.T.</given-names>
									<surname>Seyfried</surname>
								</string-name>, and
								<string-name>
									<given-names>T.</given-names>
									<surname>Kukar</surname>
								</string-name>
							</person-group>.
							<year>2014</year>
							<comment>b</comment>.
							<article-title>FUS is phosphorylated by DNA-PK and accumulates in the cytoplasm after DNA damage</article-title>.
							<source>J. Neurosci.</source>
							<volume>34</volume>:
							<fpage>7802</fpage>&#x2013;
							<lpage>7813</lpage>.
							<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0172-14.2014</pub-id>
							<pub-id pub-id-type="pmid">24899704</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib19">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Dormann</surname>,
									<given-names>D.</given-names>
								</string-name>, and
								<string-name>
									<given-names>C.</given-names>
									<surname>Haass</surname>
								</string-name>
							</person-group>.
							<year>2013</year>.
							<article-title>Fused in sarcoma (FUS): an oncogene goes awry in neurodegeneration</article-title>.
							<source>Mol. Cell. Neurosci.</source>
							<volume>56</volume>:
							<fpage>475</fpage>&#x2013;
							<lpage>486</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.mcn.2013.03.006</pub-id>
							<pub-id pub-id-type="pmid">23557964</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib20">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Escribano-D&#xED;az</surname>,
									<given-names>C.</given-names>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Orthwein</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Fradet-Turcotte</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Xing</surname>
								</string-name>,
								<string-name>
									<given-names>J.T.</given-names>
									<surname>Young</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Tk&#xE1;&#x10D;</surname>
								</string-name>,
								<string-name>
									<given-names>M.A.</given-names>
									<surname>Cook</surname>
								</string-name>,
								<string-name>
									<given-names>A.P.</given-names>
									<surname>Rosebrock</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Munro</surname>
								</string-name>,
								<string-name>
									<given-names>M.D.</given-names>
									<surname>Canny</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2013</year>.
							<article-title>A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice</article-title>.
							<source>Mol. Cell.</source>
							<volume>49</volume>:
							<fpage>872</fpage>&#x2013;
							<lpage>883</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.molcel.2013.01.001</pub-id>
							<pub-id pub-id-type="pmid">23333306</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib21">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Falck</surname>,
									<given-names>J.</given-names>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Coates</surname>
								</string-name>, and
								<string-name>
									<given-names>S.P.</given-names>
									<surname>Jackson</surname>
								</string-name>
							</person-group>.
							<year>2005</year>.
							<article-title>Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage</article-title>.
							<source>Nature.</source>
							<volume>434</volume>:
							<fpage>605</fpage>&#x2013;
							<lpage>611</lpage>.
							<pub-id pub-id-type="doi">10.1038/nature03442</pub-id>
							<pub-id pub-id-type="pmid">15758953</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib22">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Francia</surname>,
									<given-names>S.</given-names>
								</string-name>,
								<string-name>
									<given-names>F.</given-names>
									<surname>Michelini</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Saxena</surname>
								</string-name>,
								<string-name>
									<given-names>D.</given-names>
									<surname>Tang</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>de Hoon</surname>
								</string-name>,
								<string-name>
									<given-names>V.</given-names>
									<surname>Anelli</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Mione</surname>
								</string-name>,
								<string-name>
									<given-names>P.</given-names>
									<surname>Carninci</surname>
								</string-name>, and
								<string-name>
									<given-names>F.</given-names>
									<surname>d&#x2019;Adda di Fagagna</surname>
								</string-name>
							</person-group>.
							<year>2012</year>.
							<article-title>Site-specific DICER and DROSHA RNA products control the DNA-damage response</article-title>.
							<source>Nature.</source>
							<volume>488</volume>:
							<fpage>231</fpage>&#x2013;
							<lpage>235</lpage>.
							<pub-id pub-id-type="doi">10.1038/nature11179</pub-id>
							<pub-id pub-id-type="pmid">22722852</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib23">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Gardiner</surname>,
									<given-names>M.</given-names>
								</string-name>,
								<string-name>
									<given-names>R.</given-names>
									<surname>Toth</surname>
								</string-name>,
								<string-name>
									<given-names>F.</given-names>
									<surname>Vandermoere</surname>
								</string-name>,
								<string-name>
									<given-names>N.A.</given-names>
									<surname>Morrice</surname>
								</string-name>, and
								<string-name>
									<given-names>J.</given-names>
									<surname>Rouse</surname>
								</string-name>
							</person-group>.
							<year>2008</year>.
							<article-title>Identification and characterization of FUS/TLS as a new target of ATM</article-title>.
							<source>Biochem. J.</source>
							<volume>415</volume>:
							<fpage>297</fpage>&#x2013;
							<lpage>307</lpage>.
							<pub-id pub-id-type="doi">10.1042/BJ20081135</pub-id>
							<pub-id pub-id-type="pmid">18620545</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib24">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Gunn</surname>,
									<given-names>A.</given-names>
								</string-name>, and
								<string-name>
									<given-names>J.M.</given-names>
									<surname>Stark</surname>
								</string-name>
							</person-group>.
							<year>2012</year>.
							<article-title>I-SceI-based assays to examine distinct repair outcomes of mammalian chromosomal double strand breaks</article-title>.
							<source>Methods Mol. Biol.</source>
							<volume>920</volume>:
							<fpage>379</fpage>&#x2013;
							<lpage>391</lpage>.
							<pub-id pub-id-type="doi">10.1007/978-1-61779-998-3_27</pub-id>
							<pub-id pub-id-type="pmid">22941618</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib25">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Hamaguchi</surname>,
									<given-names>M.S.</given-names>
								</string-name>,
								<string-name>
									<given-names>K.</given-names>
									<surname>Watanabe</surname>
								</string-name>, and
								<string-name>
									<given-names>Y.</given-names>
									<surname>Hamaguchi</surname>
								</string-name>
							</person-group>.
							<year>1997</year>.
							<article-title>Regulation of intracellular pH in sea urchin eggs by medium containing both weak acid and base</article-title>.
							<source>Cell Struct. Funct.</source>
							<volume>22</volume>:
							<fpage>387</fpage>&#x2013;
							<lpage>398</lpage>.
							<pub-id pub-id-type="doi">10.1247/csf.22.387</pub-id>
							<pub-id pub-id-type="pmid">9368712</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib26">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Harrison</surname>,
									<given-names>A.F.</given-names>
								</string-name>, and
								<string-name>
									<given-names>J.</given-names>
									<surname>Shorter</surname>
								</string-name>
							</person-group>.
							<year>2017</year>.
							<article-title>RNA-binding proteins with prion-like domains in health and disease</article-title>.
							<source>Biochem. J.</source>
							<volume>474</volume>:
							<fpage>1417</fpage>&#x2013;
							<lpage>1438</lpage>.
							<pub-id pub-id-type="doi">10.1042/BCJ20160499</pub-id>
							<pub-id pub-id-type="pmid">28389532</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib27">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Hennig</surname>,
									<given-names>S.</given-names>
								</string-name>,
								<string-name>
									<given-names>G.</given-names>
									<surname>Kong</surname>
								</string-name>,
								<string-name>
									<given-names>T.</given-names>
									<surname>Mannen</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Sadowska</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Kobelke</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Blythe</surname>
								</string-name>,
								<string-name>
									<given-names>G.J.</given-names>
									<surname>Knott</surname>
								</string-name>,
								<string-name>
									<given-names>K.S.</given-names>
									<surname>Iyer</surname>
								</string-name>,
								<string-name>
									<given-names>D.</given-names>
									<surname>Ho</surname>
								</string-name>,
								<string-name>
									<given-names>E.A.</given-names>
									<surname>Newcombe</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2015</year>.
							<article-title>Prion-like domains in RNA binding proteins are essential for building subnuclear paraspeckles</article-title>.
							<source>J. Cell Biol.</source>
							<volume>210</volume>:
							<fpage>529</fpage>&#x2013;
							<lpage>539</lpage>.
							<pub-id pub-id-type="doi">10.1083/jcb.201504117</pub-id>
							<pub-id pub-id-type="pmid">26283796</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib28">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Hicks</surname>,
									<given-names>G.G.</given-names>
								</string-name>,
								<string-name>
									<given-names>N.</given-names>
									<surname>Singh</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Nashabi</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Mai</surname>
								</string-name>,
								<string-name>
									<given-names>G.</given-names>
									<surname>Bozek</surname>
								</string-name>,
								<string-name>
									<given-names>L.</given-names>
									<surname>Klewes</surname>
								</string-name>,
								<string-name>
									<given-names>D.</given-names>
									<surname>Arapovic</surname>
								</string-name>,
								<string-name>
									<given-names>E.K.</given-names>
									<surname>White</surname>
								</string-name>,
								<string-name>
									<given-names>M.J.</given-names>
									<surname>Koury</surname>
								</string-name>,
								<string-name>
									<given-names>E.M.</given-names>
									<surname>Oltz</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2000</year>.
							<article-title>Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death</article-title>.
							<source>Nat. Genet.</source>
							<volume>24</volume>:
							<fpage>175</fpage>&#x2013;
							<lpage>179</lpage>.
							<pub-id pub-id-type="doi">10.1038/72842</pub-id>
							<pub-id pub-id-type="pmid">10655065</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib29">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Hirose</surname>,
									<given-names>T.</given-names>
								</string-name>,
								<string-name>
									<given-names>T.</given-names>
									<surname>Yamazaki</surname>
								</string-name>, and
								<string-name>
									<given-names>S.</given-names>
									<surname>Nakagawa</surname>
								</string-name>
							</person-group>.
							<year>2019</year>.
							<article-title>Molecular anatomy of the architectural NEAT1 noncoding RNA: The domains, interactors, and biogenesis pathway required to build phase-separated nuclear paraspeckles</article-title>.
							<source>Wiley Interdiscip. Rev. RNA.</source>
							<volume>10</volume>:
							<elocation-id>e1545</elocation-id>.
							<pub-id pub-id-type="doi">10.1002/wrna.1545</pub-id>
							<pub-id pub-id-type="pmid">31044562</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib85">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Hock</surname>,
									<given-names>E.M.</given-names>
								</string-name>,
								<string-name>
									<given-names>Z.</given-names>
									<surname>Maniecka</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Hruska-Plochan</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Reber</surname>
								</string-name>,
								<string-name>
									<given-names>F.</given-names>
									<surname>Laferri&#xE8;re</surname>
								</string-name>,
								<string-name>
									<given-names>M.K.</given-names>
									<surname>Sonu Sahadevan</surname>
								</string-name>,
								<string-name>
									<given-names>H.</given-names>
									<surname>Ederle</surname>
								</string-name>,
								<string-name>
									<given-names>L.</given-names>
									<surname>Gittings</surname>
								</string-name>,
								<string-name>
									<given-names>L.</given-names>
									<surname>Pelkmans</surname>
								</string-name>,
								<string-name>
									<given-names>L.</given-names>
									<surname>Dupuis</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2018</year>.
							<article-title>Hypertonic Stress Causes Cytoplasmic Translocation of Neuronal, but Not Astrocytic, FUS due to Impaired Transportin Function</article-title>.
							<source>Cell. Rep</source>.
							<volume>24</volume>:
							<fpage>987</fpage>&#x2013;
							<lpage>1000.e7</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.celrep.2018.06.094</pub-id>
							<pub-id pub-id-type="pmid">30044993</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib30">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Hwang</surname>,
									<given-names>S.Y.</given-names>
								</string-name>,
								<string-name>
									<given-names>M.A.</given-names>
									<surname>Kang</surname>
								</string-name>,
								<string-name>
									<given-names>C.J.</given-names>
									<surname>Baik</surname>
								</string-name>,
								<string-name>
									<given-names>Y.</given-names>
									<surname>Lee</surname>
								</string-name>,
								<string-name>
									<given-names>N.T.</given-names>
									<surname>Hang</surname>
								</string-name>,
								<string-name>
									<given-names>B.G.</given-names>
									<surname>Kim</surname>
								</string-name>,
								<string-name>
									<given-names>J.S.</given-names>
									<surname>Han</surname>
								</string-name>,
								<string-name>
									<given-names>J.H.</given-names>
									<surname>Jeong</surname>
								</string-name>,
								<string-name>
									<given-names>D.</given-names>
									<surname>Park</surname>
								</string-name>,
								<string-name>
									<given-names>K.</given-names>
									<surname>Myung</surname>
								</string-name>, and
								<string-name>
									<given-names>J.S.</given-names>
									<surname>Lee</surname>
								</string-name>
							</person-group>.
							<year>2019</year>.
							<article-title>CTCF cooperates with CtIP to drive homologous recombination repair of double-strand breaks</article-title>.
							<source>Nucleic Acids Res.</source>
							<volume>47</volume>:
							<fpage>9160</fpage>&#x2013;
							<lpage>9179</lpage>.
							<pub-id pub-id-type="doi">10.1093/nar/gkz639</pub-id>
							<pub-id pub-id-type="pmid">31340001</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib31">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Izhar</surname>,
									<given-names>L.</given-names>
								</string-name>,
								<string-name>
									<given-names>B.</given-names>
									<surname>Adamson</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Ciccia</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Lewis</surname>
								</string-name>,
								<string-name>
									<given-names>L.</given-names>
									<surname>Pontano-Vaites</surname>
								</string-name>,
								<string-name>
									<given-names>Y.</given-names>
									<surname>Leng</surname>
								</string-name>,
								<string-name>
									<given-names>A.C.</given-names>
									<surname>Liang</surname>
								</string-name>,
								<string-name>
									<given-names>T.F.</given-names>
									<surname>Westbrook</surname>
								</string-name>,
								<string-name>
									<given-names>J.W.</given-names>
									<surname>Harper</surname>
								</string-name>, and
								<string-name>
									<given-names>S.J.</given-names>
									<surname>Elledge</surname>
								</string-name>
							</person-group>.
							<year>2015</year>.
							<article-title>A Systematic Analysis of Factors Localized to Damaged Chromatin Reveals PARP-Dependent Recruitment of Transcription Factors</article-title>.
							<source>Cell Rep.</source>
							<volume>11</volume>:
							<fpage>1486</fpage>&#x2013;
							<lpage>1500</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.celrep.2015.04.053</pub-id>
							<pub-id pub-id-type="pmid">26004182</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib32">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Jaafar</surname>,
									<given-names>L.</given-names>
								</string-name>,
								<string-name>
									<given-names>Z.</given-names>
									<surname>Li</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Li</surname>
								</string-name>, and
								<string-name>
									<given-names>W.S.</given-names>
									<surname>Dynan</surname>
								</string-name>
							</person-group>.
							<year>2017</year>.
							<article-title>SFPQ&#x2022;NONO and XLF function separately and together to promote DNA double-strand break repair via canonical nonhomologous end joining</article-title>.
							<source>Nucleic Acids Res.</source>
							<volume>45</volume>:
							<fpage>1848</fpage>&#x2013;
							<lpage>1859</lpage>.
							<pub-id pub-id-type="doi">10.1093/nar/gkw1209</pub-id>
							<pub-id pub-id-type="pmid">27924002</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib33">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Jain</surname>,
									<given-names>A.</given-names>
								</string-name>, and
								<string-name>
									<given-names>R.D.</given-names>
									<surname>Vale</surname>
								</string-name>
							</person-group>.
							<year>2017</year>.
							<article-title>RNA phase transitions in repeat expansion disorders</article-title>.
							<source>Nature.</source>
							<volume>546</volume>:
							<fpage>243</fpage>&#x2013;
							<lpage>247</lpage>.
							<pub-id pub-id-type="doi">10.1038/nature22386</pub-id>
							<pub-id pub-id-type="pmid">28562589</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib34">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Kai</surname>,
									<given-names>M.</given-names>
								</string-name>
							</person-group>
							<year>2016</year>.
							<article-title>Roles of RNA-Binding Proteins in DNA Damage Response</article-title>.
							<source>Int. J. Mol. Sci.</source>
							<volume>17</volume>:
							<fpage>310</fpage>.
							<pub-id pub-id-type="doi">10.3390/ijms17030310</pub-id>
							<pub-id pub-id-type="pmid">26927092</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib35">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Kato</surname>,
									<given-names>M.</given-names>
								</string-name>, and
								<string-name>
									<given-names>S.L.</given-names>
									<surname>McKnight</surname>
								</string-name>
							</person-group>.
							<year>2018</year>.
							<article-title>A Solid-State Conceptualization of Information Transfer from Gene to Message to Protein</article-title>.
							<source>Annu. Rev. Biochem.</source>
							<volume>87</volume>:
							<fpage>351</fpage>&#x2013;
							<lpage>390</lpage>.
							<pub-id pub-id-type="doi">10.1146/annurev-biochem-061516-044700</pub-id>
							<pub-id pub-id-type="pmid">29195049</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib36">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Kato</surname>,
									<given-names>M.</given-names>
								</string-name>,
								<string-name>
									<given-names>T.W.</given-names>
									<surname>Han</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Xie</surname>
								</string-name>,
								<string-name>
									<given-names>K.</given-names>
									<surname>Shi</surname>
								</string-name>,
								<string-name>
									<given-names>X.</given-names>
									<surname>Du</surname>
								</string-name>,
								<string-name>
									<given-names>L.C.</given-names>
									<surname>Wu</surname>
								</string-name>,
								<string-name>
									<given-names>H.</given-names>
									<surname>Mirzaei</surname>
								</string-name>,
								<string-name>
									<given-names>E.J.</given-names>
									<surname>Goldsmith</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Longgood</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Pei</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2012</year>.
							<article-title>Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels</article-title>.
							<source>Cell.</source>
							<volume>149</volume>:
							<fpage>753</fpage>&#x2013;
							<lpage>767</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.cell.2012.04.017</pub-id>
							<pub-id pub-id-type="pmid">22579281</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib37">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Kilic</surname>,
									<given-names>S.</given-names>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Lezaja</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Gatti</surname>
								</string-name>,
								<string-name>
									<given-names>E.</given-names>
									<surname>Bianco</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Michelena</surname>
								</string-name>,
								<string-name>
									<given-names>R.</given-names>
									<surname>Imhof</surname>
								</string-name>, and
								<string-name>
									<given-names>M.</given-names>
									<surname>Altmeyer</surname>
								</string-name>
							</person-group>.
							<year>2019</year>.
							<article-title>Phase separation of 53BP1 determines liquid-like behavior of DNA repair compartments</article-title>.
							<source>EMBO J.</source>
							<volume>38</volume>:
							<elocation-id>e101379</elocation-id>.
							<pub-id pub-id-type="doi">10.15252/embj.2018101379</pub-id>
							<pub-id pub-id-type="pmid">31267591</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib38">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Krietsch</surname>,
									<given-names>J.</given-names>
								</string-name>,
								<string-name>
									<given-names>M.C.</given-names>
									<surname>Caron</surname>
								</string-name>,
								<string-name>
									<given-names>J.P.</given-names>
									<surname>Gagn&#xE9;</surname>
								</string-name>,
								<string-name>
									<given-names>C.</given-names>
									<surname>Ethier</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Vignard</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Vincent</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Rouleau</surname>
								</string-name>,
								<string-name>
									<given-names>M.J.</given-names>
									<surname>Hendzel</surname>
								</string-name>,
								<string-name>
									<given-names>G.G.</given-names>
									<surname>Poirier</surname>
								</string-name>, and
								<string-name>
									<given-names>J.Y.</given-names>
									<surname>Masson</surname>
								</string-name>
							</person-group>.
							<year>2012</year>.
							<article-title>PARP activation regulates the RNA-binding protein NONO in the DNA damage response to DNA double-strand breaks</article-title>.
							<source>Nucleic Acids Res.</source>
							<volume>40</volume>:
							<fpage>10287</fpage>&#x2013;
							<lpage>10301</lpage>.
							<pub-id pub-id-type="doi">10.1093/nar/gks798</pub-id>
							<pub-id pub-id-type="pmid">22941645</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib39">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Kroschwald</surname>,
									<given-names>S.</given-names>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Maharana</surname>
								</string-name>,
								<string-name>
									<given-names>D.</given-names>
									<surname>Mateju</surname>
								</string-name>,
								<string-name>
									<given-names>L.</given-names>
									<surname>Malinovska</surname>
								</string-name>,
								<string-name>
									<given-names>E.</given-names>
									<surname>N&#xFC;ske</surname>
								</string-name>,
								<string-name>
									<given-names>I.</given-names>
									<surname>Poser</surname>
								</string-name>,
								<string-name>
									<given-names>D.</given-names>
									<surname>Richter</surname>
								</string-name>, and
								<string-name>
									<given-names>S.</given-names>
									<surname>Alberti</surname>
								</string-name>
							</person-group>.
							<year>2015</year>.
							<article-title>Promiscuous interactions and protein disaggregases determine the material state of stress-inducible RNP granules</article-title>.
							<source>eLife.</source>
							<volume>4</volume>:
							<elocation-id>e06807</elocation-id>.
							<pub-id pub-id-type="doi">10.7554/eLife.06807</pub-id>
							<pub-id pub-id-type="pmid">26238190</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib40">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Kruhlak</surname>,
									<given-names>M.J.</given-names>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Celeste</surname>
								</string-name>,
								<string-name>
									<given-names>G.</given-names>
									<surname>Dellaire</surname>
								</string-name>,
								<string-name>
									<given-names>O.</given-names>
									<surname>Fernandez-Capetillo</surname>
								</string-name>,
								<string-name>
									<given-names>W.G.</given-names>
									<surname>M&#xFC;ller</surname>
								</string-name>,
								<string-name>
									<given-names>J.G.</given-names>
									<surname>McNally</surname>
								</string-name>,
								<string-name>
									<given-names>D.P.</given-names>
									<surname>Bazett-Jones</surname>
								</string-name>, and
								<string-name>
									<given-names>A.</given-names>
									<surname>Nussenzweig</surname>
								</string-name>
							</person-group>.
							<year>2006</year>.
							<article-title>Changes in chromatin structure and mobility in living cells at sites of DNA double-strand breaks</article-title>.
							<source>J. Cell Biol.</source>
							<volume>172</volume>:
							<fpage>823</fpage>&#x2013;
							<lpage>834</lpage>.
							<pub-id pub-id-type="doi">10.1083/jcb.200510015</pub-id>
							<pub-id pub-id-type="pmid">16520385</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib41">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Kuroda</surname>,
									<given-names>M.</given-names>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Sok</surname>
								</string-name>,
								<string-name>
									<given-names>L.</given-names>
									<surname>Webb</surname>
								</string-name>,
								<string-name>
									<given-names>H.</given-names>
									<surname>Baechtold</surname>
								</string-name>,
								<string-name>
									<given-names>F.</given-names>
									<surname>Urano</surname>
								</string-name>,
								<string-name>
									<given-names>Y.</given-names>
									<surname>Yin</surname>
								</string-name>,
								<string-name>
									<given-names>P.</given-names>
									<surname>Chung</surname>
								</string-name>,
								<string-name>
									<given-names>D.G.</given-names>
									<surname>de Rooij</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Akhmedov</surname>
								</string-name>,
								<string-name>
									<given-names>T.</given-names>
									<surname>Ashley</surname>
								</string-name>, and
								<string-name>
									<given-names>D.</given-names>
									<surname>Ron</surname>
								</string-name>
							</person-group>.
							<year>2000</year>.
							<article-title>Male sterility and enhanced radiation sensitivity in TLS(-/-) mice</article-title>.
							<source>EMBO J.</source>
							<volume>19</volume>:
							<fpage>453</fpage>&#x2013;
							<lpage>462</lpage>.
							<pub-id pub-id-type="doi">10.1093/emboj/19.3.453</pub-id>
							<pub-id pub-id-type="pmid">10654943</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib42">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Lee</surname>,
									<given-names>J.H.</given-names>
								</string-name>, and
								<string-name>
									<given-names>T.T.</given-names>
									<surname>Paull</surname>
								</string-name>
							</person-group>.
							<year>2005</year>.
							<article-title>ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex</article-title>.
							<source>Science.</source>
							<volume>308</volume>:
							<fpage>551</fpage>&#x2013;
							<lpage>554</lpage>.
							<pub-id pub-id-type="doi">10.1126/science.1108297</pub-id>
							<pub-id pub-id-type="pmid">15790808</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib43">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Lee</surname>,
									<given-names>K.H.</given-names>
								</string-name>,
								<string-name>
									<given-names>P.</given-names>
									<surname>Zhang</surname>
								</string-name>,
								<string-name>
									<given-names>H.J.</given-names>
									<surname>Kim</surname>
								</string-name>,
								<string-name>
									<given-names>D.M.</given-names>
									<surname>Mitrea</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Sarkar</surname>
								</string-name>,
								<string-name>
									<given-names>B.D.</given-names>
									<surname>Freibaum</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Cika</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Coughlin</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Messing</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Molliex</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2016</year>.
							<article-title>C9orf72 Dipeptide Repeats Impair the Assembly, Dynamics, and Function of Membrane-Less Organelles</article-title>.
							<source>Cell.</source>
							<volume>167</volume>:
							<fpage>774</fpage>&#x2013;
							<lpage>788.e17</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.cell.2016.10.002</pub-id>
							<pub-id pub-id-type="pmid">27768896</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib44">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Lee</surname>,
									<given-names>M.</given-names>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Sadowska</surname>
								</string-name>,
								<string-name>
									<given-names>I.</given-names>
									<surname>Bekere</surname>
								</string-name>,
								<string-name>
									<given-names>D.</given-names>
									<surname>Ho</surname>
								</string-name>,
								<string-name>
									<given-names>B.S.</given-names>
									<surname>Gully</surname>
								</string-name>,
								<string-name>
									<given-names>Y.</given-names>
									<surname>Lu</surname>
								</string-name>,
								<string-name>
									<given-names>K.S.</given-names>
									<surname>Iyer</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Trewhella</surname>
								</string-name>,
								<string-name>
									<given-names>A.H.</given-names>
									<surname>Fox</surname>
								</string-name>, and
								<string-name>
									<given-names>C.S.</given-names>
									<surname>Bond</surname>
								</string-name>
							</person-group>.
							<year>2015</year>.
							<article-title>The structure of human SFPQ reveals a coiled-coil mediated polymer essential for functional aggregation in gene regulation</article-title>.
							<source>Nucleic Acids Res.</source>
							<volume>43</volume>:
							<fpage>3826</fpage>&#x2013;
							<lpage>3840</lpage>.
							<pub-id pub-id-type="doi">10.1093/nar/gkv156</pub-id>
							<pub-id pub-id-type="pmid">25765647</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib45">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Lopez Perez</surname>,
									<given-names>R.</given-names>
								</string-name>,
								<string-name>
									<given-names>G.</given-names>
									<surname>Best</surname>
								</string-name>,
								<string-name>
									<given-names>N.H.</given-names>
									<surname>Nicolay</surname>
								</string-name>,
								<string-name>
									<given-names>C.</given-names>
									<surname>Greubel</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Rossberger</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Reindl</surname>
								</string-name>,
								<string-name>
									<given-names>G.</given-names>
									<surname>Dollinger</surname>
								</string-name>,
								<string-name>
									<given-names>K.J.</given-names>
									<surname>Weber</surname>
								</string-name>,
								<string-name>
									<given-names>C.</given-names>
									<surname>Cremer</surname>
								</string-name>, and
								<string-name>
									<given-names>P.E.</given-names>
									<surname>Huber</surname>
								</string-name>
							</person-group>.
							<year>2016</year>.
							<article-title>Superresolution light microscopy shows nanostructure of carbon ion radiation-induced DNA double-strand break repair foci</article-title>.
							<source>FASEB J.</source>
							<volume>30</volume>:
							<fpage>2767</fpage>&#x2013;
							<lpage>2776</lpage>.
							<pub-id pub-id-type="doi">10.1096/fj.201500106R</pub-id>
							<pub-id pub-id-type="pmid">27166088</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib46">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Maharana</surname>,
									<given-names>S.</given-names>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Wang</surname>
								</string-name>,
								<string-name>
									<given-names>D.K.</given-names>
									<surname>Papadopoulos</surname>
								</string-name>,
								<string-name>
									<given-names>D.</given-names>
									<surname>Richter</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Pozniakovsky</surname>
								</string-name>,
								<string-name>
									<given-names>I.</given-names>
									<surname>Poser</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Bickle</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Rizk</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Guill&#xE9;n-Boixet</surname>
								</string-name>,
								<string-name>
									<given-names>T.M.</given-names>
									<surname>Franzmann</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2018</year>.
							<article-title>RNA buffers the phase separation behavior of prion-like RNA binding proteins</article-title>.
							<source>Science.</source>
							<volume>360</volume>:
							<fpage>918</fpage>&#x2013;
							<lpage>921</lpage>.
							<pub-id pub-id-type="doi">10.1126/science.aar7366</pub-id>
							<pub-id pub-id-type="pmid">29650702</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib47">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Marchesini</surname>,
									<given-names>M.</given-names>
								</string-name>,
								<string-name>
									<given-names>Y.</given-names>
									<surname>Ogoti</surname>
								</string-name>,
								<string-name>
									<given-names>E.</given-names>
									<surname>Fiorini</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Aktas Samur</surname>
								</string-name>,
								<string-name>
									<given-names>L.</given-names>
									<surname>Nezi</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>D&#x2019;Anca</surname>
								</string-name>,
								<string-name>
									<given-names>P.</given-names>
									<surname>Storti</surname>
								</string-name>,
								<string-name>
									<given-names>M.K.</given-names>
									<surname>Samur</surname>
								</string-name>,
								<string-name>
									<given-names>I.</given-names>
									<surname>Ganan-Gomez</surname>
								</string-name>,
								<string-name>
									<given-names>M.T.</given-names>
									<surname>Fulciniti</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2017</year>.
							<article-title>ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma</article-title>.
							<source>Cancer Cell.</source>
							<volume>32</volume>:
							<fpage>88</fpage>&#x2013;
							<lpage>100.e6</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.ccell.2017.05.011</pub-id>
							<pub-id pub-id-type="pmid">28669490</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib48">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Mastrocola</surname>,
									<given-names>A.S.</given-names>
								</string-name>,
								<string-name>
									<given-names>S.H.</given-names>
									<surname>Kim</surname>
								</string-name>,
								<string-name>
									<given-names>A.T.</given-names>
									<surname>Trinh</surname>
								</string-name>,
								<string-name>
									<given-names>L.A.</given-names>
									<surname>Rodenkirch</surname>
								</string-name>, and
								<string-name>
									<given-names>R.S.</given-names>
									<surname>Tibbetts</surname>
								</string-name>
							</person-group>.
							<year>2013</year>.
							<article-title>The RNA-binding protein fused in sarcoma (FUS) functions downstream of poly(ADP-ribose) polymerase (PARP) in response to DNA damage</article-title>.
							<source>J. Biol. Chem.</source>
							<volume>288</volume>:
							<fpage>24731</fpage>&#x2013;
							<lpage>24741</lpage>.
							<pub-id pub-id-type="doi">10.1074/jbc.M113.497974</pub-id>
							<pub-id pub-id-type="pmid">23833192</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib49">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Matsuoka</surname>,
									<given-names>S.</given-names>
								</string-name>,
								<string-name>
									<given-names>B.A.</given-names>
									<surname>Ballif</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Smogorzewska</surname>
								</string-name>,
								<string-name>
									<given-names>E.R.</given-names>
									<surname>McDonald</surname>
									<suffix>III</suffix>
								</string-name>,
								<string-name>
									<given-names>K.E.</given-names>
									<surname>Hurov</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Luo</surname>
								</string-name>,
								<string-name>
									<given-names>C.E.</given-names>
									<surname>Bakalarski</surname>
								</string-name>,
								<string-name>
									<given-names>Z.</given-names>
									<surname>Zhao</surname>
								</string-name>,
								<string-name>
									<given-names>N.</given-names>
									<surname>Solimini</surname>
								</string-name>,
								<string-name>
									<given-names>Y.</given-names>
									<surname>Lerenthal</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2007</year>.
							<article-title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage</article-title>.
							<source>Science.</source>
							<volume>316</volume>:
							<fpage>1160</fpage>&#x2013;
							<lpage>1166</lpage>.
							<pub-id pub-id-type="doi">10.1126/science.1140321</pub-id>
							<pub-id pub-id-type="pmid">17525332</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib50">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Michelini</surname>,
									<given-names>F.</given-names>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Pitchiaya</surname>
								</string-name>,
								<string-name>
									<given-names>V.</given-names>
									<surname>Vitelli</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Sharma</surname>
								</string-name>,
								<string-name>
									<given-names>U.</given-names>
									<surname>Gioia</surname>
								</string-name>,
								<string-name>
									<given-names>F.</given-names>
									<surname>Pessina</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Cabrini</surname>
								</string-name>,
								<string-name>
									<given-names>Y.</given-names>
									<surname>Wang</surname>
								</string-name>,
								<string-name>
									<given-names>I.</given-names>
									<surname>Capozzo</surname>
								</string-name>,
								<string-name>
									<given-names>F.</given-names>
									<surname>Iannelli</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2017</year>.
							<article-title>Damage-induced lncRNAs control the DNA damage response through interaction with DDRNAs at individual double-strand breaks</article-title>.
							<source>Nat. Cell Biol.</source>
							<volume>19</volume>:
							<fpage>1400</fpage>&#x2013;
							<lpage>1411</lpage>.
							<pub-id pub-id-type="doi">10.1038/ncb3643</pub-id>
							<pub-id pub-id-type="pmid">29180822</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib51">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Mikolaskova</surname>,
									<given-names>B.</given-names>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Jurcik</surname>
								</string-name>,
								<string-name>
									<given-names>I.</given-names>
									<surname>Cipakova</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Kretova</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Chovanec</surname>
								</string-name>, and
								<string-name>
									<given-names>L.</given-names>
									<surname>Cipak</surname>
								</string-name>
							</person-group>.
							<year>2018</year>.
							<article-title>Maintenance of genome stability: the unifying role of interconnections between the DNA damage response and RNA-processing pathways</article-title>.
							<source>Curr. Genet.</source>
							<volume>64</volume>:
							<fpage>971</fpage>&#x2013;
							<lpage>983</lpage>.
							<pub-id pub-id-type="doi">10.1007/s00294-018-0819-7</pub-id>
							<pub-id pub-id-type="pmid">29497809</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib83">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Mootha</surname>,
									<given-names>V.K.</given-names>
								</string-name>,
								<string-name>
									<given-names>C.M.</given-names>
									<surname>Lindgren</surname>
								</string-name>,
								<string-name>
									<given-names>K.-F.</given-names>
									<surname>Eriksson</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Subramanian</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Sihag</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Lehar</surname>
								</string-name>,
								<string-name>
									<given-names>P.</given-names>
									<surname>Puigserver</surname>
								</string-name>,
								<string-name>
									<given-names>E.</given-names>
									<surname>Carlsson</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Ridderstr&#xE5;le</surname>
								</string-name>,
								<string-name>
									<given-names>E.</given-names>
									<surname>Laurila</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2003</year>.
							<article-title>PGC-1&#x3B1;-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes</article-title>.
							<source>Nat. Genet</source>.
							<volume>34</volume>:
							<fpage>267</fpage>&#x2013;
							<lpage>273</lpage>.
							<pub-id pub-id-type="doi">10.1038/ng1180</pub-id>
							<pub-id pub-id-type="pmid">12808457</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib52">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Morchikh</surname>,
									<given-names>M.</given-names>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Cribier</surname>
								</string-name>,
								<string-name>
									<given-names>R.</given-names>
									<surname>Raffel</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Amraoui</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Cau</surname>
								</string-name>,
								<string-name>
									<given-names>D.</given-names>
									<surname>Severac</surname>
								</string-name>,
								<string-name>
									<given-names>E.</given-names>
									<surname>Dubois</surname>
								</string-name>,
								<string-name>
									<given-names>O.</given-names>
									<surname>Schwartz</surname>
								</string-name>,
								<string-name>
									<given-names>Y.</given-names>
									<surname>Bennasser</surname>
								</string-name>, and
								<string-name>
									<given-names>M.</given-names>
									<surname>Benkirane</surname>
								</string-name>
							</person-group>.
							<year>2017</year>.
							<article-title>HEXIM1 and NEAT1 Long Non-coding RNA Form a Multi-subunit Complex that Regulates DNA-Mediated Innate Immune Response</article-title>.
							<source>Mol. Cell.</source>
							<volume>67</volume>:
							<fpage>387</fpage>&#x2013;
							<lpage>399.e5</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.molcel.2017.06.020</pub-id>
							<pub-id pub-id-type="pmid">28712728</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib53">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Moumen</surname>,
									<given-names>A.</given-names>
								</string-name>,
								<string-name>
									<given-names>C.</given-names>
									<surname>Magill</surname>
								</string-name>,
								<string-name>
									<given-names>K.L.</given-names>
									<surname>Dry</surname>
								</string-name>, and
								<string-name>
									<given-names>S.P.</given-names>
									<surname>Jackson</surname>
								</string-name>
							</person-group>.
							<year>2013</year>.
							<article-title>ATM-dependent phosphorylation of heterogeneous nuclear ribonucleoprotein K promotes p53 transcriptional activation in response to DNA damage</article-title>.
							<source>Cell Cycle.</source>
							<volume>12</volume>:
							<fpage>698</fpage>&#x2013;
							<lpage>704</lpage>.
							<pub-id pub-id-type="doi">10.4161/cc.23592</pub-id>
							<pub-id pub-id-type="pmid">23343766</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib54">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Murakami</surname>,
									<given-names>T.</given-names>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Qamar</surname>
								</string-name>,
								<string-name>
									<given-names>J.Q.</given-names>
									<surname>Lin</surname>
								</string-name>,
								<string-name>
									<given-names>G.S.</given-names>
									<surname>Schierle</surname>
								</string-name>,
								<string-name>
									<given-names>E.</given-names>
									<surname>Rees</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Miyashita</surname>
								</string-name>,
								<string-name>
									<given-names>A.R.</given-names>
									<surname>Costa</surname>
								</string-name>,
								<string-name>
									<given-names>R.B.</given-names>
									<surname>Dodd</surname>
								</string-name>,
								<string-name>
									<given-names>F.T.</given-names>
									<surname>Chan</surname>
								</string-name>,
								<string-name>
									<given-names>C.H.</given-names>
									<surname>Michel</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2015</year>.
							<article-title>ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function</article-title>.
							<source>Neuron.</source>
							<volume>88</volume>:
							<fpage>678</fpage>&#x2013;
							<lpage>690</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.neuron.2015.10.030</pub-id>
							<pub-id pub-id-type="pmid">26526393</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib55">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Muster</surname>,
									<given-names>B.</given-names>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Rapp</surname>
								</string-name>, and
								<string-name>
									<given-names>M.C.</given-names>
									<surname>Cardoso</surname>
								</string-name>
							</person-group>.
							<year>2017</year>.
							<article-title>Systematic analysis of DNA damage induction and DNA repair pathway activation by continuous wave visible light laser micro-irradiation</article-title>.
							<source>AIMS Genet.</source>
							<volume>4</volume>:
							<fpage>47</fpage>&#x2013;
							<lpage>68</lpage>.
							<pub-id pub-id-type="doi">10.3934/genet.2017.1.47</pub-id>
							<pub-id pub-id-type="pmid">31435503</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib56">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Myler</surname>,
									<given-names>L.R.</given-names>
								</string-name>,
								<string-name>
									<given-names>I.F.</given-names>
									<surname>Gallardo</surname>
								</string-name>,
								<string-name>
									<given-names>M.M.</given-names>
									<surname>Soniat</surname>
								</string-name>,
								<string-name>
									<given-names>R.A.</given-names>
									<surname>Deshpande</surname>
								</string-name>,
								<string-name>
									<given-names>X.B.</given-names>
									<surname>Gonzalez</surname>
								</string-name>,
								<string-name>
									<given-names>Y.</given-names>
									<surname>Kim</surname>
								</string-name>,
								<string-name>
									<given-names>T.T.</given-names>
									<surname>Paull</surname>
								</string-name>, and
								<string-name>
									<given-names>I.J.</given-names>
									<surname>Finkelstein</surname>
								</string-name>
							</person-group>.
							<year>2017</year>.
							<article-title>Single-Molecule Imaging Reveals How Mre11-Rad50-Nbs1 Initiates DNA Break Repair</article-title>.
							<source>Mol. Cell.</source>
							<volume>67</volume>:
							<fpage>891</fpage>&#x2013;
							<lpage>898.e4</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.molcel.2017.08.002</pub-id>
							<pub-id pub-id-type="pmid">28867292</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib57">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Natale</surname>,
									<given-names>F.</given-names>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Rapp</surname>
								</string-name>,
								<string-name>
									<given-names>W.</given-names>
									<surname>Yu</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Maiser</surname>
								</string-name>,
								<string-name>
									<given-names>H.</given-names>
									<surname>Harz</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Scholl</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Grulich</surname>
								</string-name>,
								<string-name>
									<given-names>T.</given-names>
									<surname>Anton</surname>
								</string-name>,
								<string-name>
									<given-names>D.</given-names>
									<surname>H&#xF6;rl</surname>
								</string-name>,
								<string-name>
									<given-names>W.</given-names>
									<surname>Chen</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2017</year>.
							<article-title>Identification of the elementary structural units of the DNA damage response</article-title>.
							<source>Nat. Commun.</source>
							<volume>8</volume>:
							<fpage>15760</fpage>.
							<pub-id pub-id-type="doi">10.1038/ncomms15760</pub-id>
							<pub-id pub-id-type="pmid">28604675</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib58">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Naumann</surname>,
									<given-names>M.</given-names>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Pal</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Goswami</surname>
								</string-name>,
								<string-name>
									<given-names>X.</given-names>
									<surname>Lojewski</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Japtok</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Vehlow</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Naujock</surname>
								</string-name>,
								<string-name>
									<given-names>R.</given-names>
									<surname>G&#xFC;nther</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Jin</surname>
								</string-name>,
								<string-name>
									<given-names>N.</given-names>
									<surname>Stanslowsky</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2018</year>.
							<article-title>Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation</article-title>.
							<source>Nat. Commun.</source>
							<volume>9</volume>:
							<fpage>335</fpage>.
							<pub-id pub-id-type="doi">10.1038/s41467-017-02299-1</pub-id>
							<pub-id pub-id-type="pmid">29362359</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib59">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Patel</surname>,
									<given-names>A.</given-names>
								</string-name>,
								<string-name>
									<given-names>H.O.</given-names>
									<surname>Lee</surname>
								</string-name>,
								<string-name>
									<given-names>L.</given-names>
									<surname>Jawerth</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Maharana</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Jahnel</surname>
								</string-name>,
								<string-name>
									<given-names>M.Y.</given-names>
									<surname>Hein</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Stoynov</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Mahamid</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Saha</surname>
								</string-name>,
								<string-name>
									<given-names>T.M.</given-names>
									<surname>Franzmann</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2015</year>.
							<article-title>A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation</article-title>.
							<source>Cell.</source>
							<volume>162</volume>:
							<fpage>1066</fpage>&#x2013;
							<lpage>1077</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.cell.2015.07.047</pub-id>
							<pub-id pub-id-type="pmid">26317470</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib60">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Paulsen</surname>,
									<given-names>R.D.</given-names>
								</string-name>,
								<string-name>
									<given-names>D.V.</given-names>
									<surname>Soni</surname>
								</string-name>,
								<string-name>
									<given-names>R.</given-names>
									<surname>Wollman</surname>
								</string-name>,
								<string-name>
									<given-names>A.T.</given-names>
									<surname>Hahn</surname>
								</string-name>,
								<string-name>
									<given-names>M.C.</given-names>
									<surname>Yee</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Guan</surname>
								</string-name>,
								<string-name>
									<given-names>J.A.</given-names>
									<surname>Hesley</surname>
								</string-name>,
								<string-name>
									<given-names>S.C.</given-names>
									<surname>Miller</surname>
								</string-name>,
								<string-name>
									<given-names>E.F.</given-names>
									<surname>Cromwell</surname>
								</string-name>,
								<string-name>
									<given-names>D.E.</given-names>
									<surname>Solow-Cordero</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2009</year>.
							<article-title>A genome-wide siRNA screen reveals diverse cellular processes and pathways that mediate genome stability</article-title>.
							<source>Mol. Cell.</source>
							<volume>35</volume>:
							<fpage>228</fpage>&#x2013;
							<lpage>239</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.molcel.2009.06.021</pub-id>
							<pub-id pub-id-type="pmid">19647519</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib61">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Pessina</surname>,
									<given-names>F.</given-names>
								</string-name>,
								<string-name>
									<given-names>F.</given-names>
									<surname>Giavazzi</surname>
								</string-name>,
								<string-name>
									<given-names>Y.</given-names>
									<surname>Yin</surname>
								</string-name>,
								<string-name>
									<given-names>U.</given-names>
									<surname>Gioia</surname>
								</string-name>,
								<string-name>
									<given-names>V.</given-names>
									<surname>Vitelli</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Galbiati</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Barozzi</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Garre</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Oldani</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Flaus</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2019</year>.
							<article-title>Functional transcription promoters at DNA double-strand breaks mediate RNA-driven phase separation of damage-response factors</article-title>.
							<source>Nat. Cell Biol.</source>
							<volume>21</volume>:
							<fpage>1286</fpage>&#x2013;
							<lpage>1299</lpage>.
							<pub-id pub-id-type="doi">10.1038/s41556-019-0392-4</pub-id>
							<pub-id pub-id-type="pmid">31570834</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib62">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Polo</surname>,
									<given-names>S.E.</given-names>
								</string-name>,
								<string-name>
									<given-names>A.N.</given-names>
									<surname>Blackford</surname>
								</string-name>,
								<string-name>
									<given-names>J.R.</given-names>
									<surname>Chapman</surname>
								</string-name>,
								<string-name>
									<given-names>L.</given-names>
									<surname>Baskcomb</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Gravel</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Rusch</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Thomas</surname>
								</string-name>,
								<string-name>
									<given-names>R.</given-names>
									<surname>Blundred</surname>
								</string-name>,
								<string-name>
									<given-names>P.</given-names>
									<surname>Smith</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Kzhyshkowska</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2012</year>.
							<article-title>Regulation of DNA-end resection by hnRNPU-like proteins promotes DNA double-strand break signaling and repair</article-title>.
							<source>Mol. Cell.</source>
							<volume>45</volume>:
							<fpage>505</fpage>&#x2013;
							<lpage>516</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.molcel.2011.12.035</pub-id>
							<pub-id pub-id-type="pmid">22365830</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib63">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Raczynska</surname>,
									<given-names>K.D.</given-names>
								</string-name>,
								<string-name>
									<given-names>M.D.</given-names>
									<surname>Ruepp</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Brzek</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Reber</surname>
								</string-name>,
								<string-name>
									<given-names>V.</given-names>
									<surname>Romeo</surname>
								</string-name>,
								<string-name>
									<given-names>B.</given-names>
									<surname>Rindlisbacher</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Heller</surname>
								</string-name>,
								<string-name>
									<given-names>Z.</given-names>
									<surname>Szweykowska-Kulinska</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Jarmolowski</surname>
								</string-name>, and
								<string-name>
									<given-names>D.</given-names>
									<surname>Sch&#xFC;mperli</surname>
								</string-name>
							</person-group>.
							<year>2015</year>.
							<article-title>FUS/TLS contributes to replication-dependent histone gene expression by interaction with U7 snRNPs and histone-specific transcription factors</article-title>.
							<source>Nucleic Acids Res.</source>
							<volume>43</volume>:
							<fpage>9711</fpage>&#x2013;
							<lpage>9728</lpage>.
							<pub-id pub-id-type="doi">10.1093/nar/gkv794</pub-id>
							<pub-id pub-id-type="pmid">26250115</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib64">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Rajesh</surname>,
									<given-names>C.</given-names>
								</string-name>,
								<string-name>
									<given-names>D.K.</given-names>
									<surname>Baker</surname>
								</string-name>,
								<string-name>
									<given-names>A.J.</given-names>
									<surname>Pierce</surname>
								</string-name>, and
								<string-name>
									<given-names>D.L.</given-names>
									<surname>Pittman</surname>
								</string-name>
							</person-group>.
							<year>2011</year>.
							<article-title>The splicing-factor related protein SFPQ/PSF interacts with RAD51D and is necessary for homology-directed repair and sister chromatid cohesion</article-title>.
							<source>Nucleic Acids Res.</source>
							<volume>39</volume>:
							<fpage>132</fpage>&#x2013;
							<lpage>145</lpage>.
							<pub-id pub-id-type="doi">10.1093/nar/gkq738</pub-id>
							<pub-id pub-id-type="pmid">20813759</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib65">
						<mixed-citation publication-type="preprint">
							<person-group person-group-type="author">
								<string-name>
									<surname>Reber</surname>,
									<given-names>S.</given-names>
								</string-name>,
								<string-name>
									<given-names>H.</given-names>
									<surname>Lindsay</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Devoy</surname>
								</string-name>,
								<string-name>
									<given-names>D.</given-names>
									<surname>Jutzi</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Mechtersheimer</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Domanski</surname>
								</string-name>,
								<string-name>
									<given-names>O.</given-names>
									<surname>M&#xFC;hlemann</surname>
								</string-name>,
								<string-name>
									<given-names>S.M.L.</given-names>
									<surname>Barabino</surname>
								</string-name>, and
								<string-name>
									<given-names>M.-D.</given-names>
									<surname>Ruepp</surname>
								</string-name>
							</person-group>.
							<year>2019</year>.
							<article-title>The phase separation-dependent FUS interactome reveals nuclear and cytoplasmic function of liquid-liquid phase separation.</article-title>
							<source>BioRxiv</source>.
							<pub-id pub-id-type="doi">10.1101/806158</pub-id> (Preprint posted October 15, 2019)
						</mixed-citation>
					</ref>
					<ref id="bib66">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Reber</surname>,
									<given-names>S.</given-names>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Mechtersheimer</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Nasif</surname>
								</string-name>,
								<string-name>
									<given-names>J.A.</given-names>
									<surname>Benitez</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Colombo</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Domanski</surname>
								</string-name>,
								<string-name>
									<given-names>D.</given-names>
									<surname>Jutzi</surname>
								</string-name>,
								<string-name>
									<given-names>E.</given-names>
									<surname>Hedlund</surname>
								</string-name>, and
								<string-name>
									<given-names>M.D.</given-names>
									<surname>Ruepp</surname>
								</string-name>
							</person-group>.
							<year>2018</year>.
							<article-title>CRISPR-Trap: a clean approach for the generation of gene knockouts and gene replacements in human cells</article-title>.
							<source>Mol. Biol. Cell.</source>
							<volume>29</volume>:
							<fpage>75</fpage>&#x2013;
							<lpage>83</lpage>.
							<pub-id pub-id-type="doi">10.1091/mbc.E17-05-0288</pub-id>
							<pub-id pub-id-type="pmid">29167381</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib67">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Reber</surname>,
									<given-names>S.</given-names>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Stettler</surname>
								</string-name>,
								<string-name>
									<given-names>G.</given-names>
									<surname>Filosa</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Colombo</surname>
								</string-name>,
								<string-name>
									<given-names>D.</given-names>
									<surname>Jutzi</surname>
								</string-name>,
								<string-name>
									<given-names>S.C.</given-names>
									<surname>Lenzken</surname>
								</string-name>,
								<string-name>
									<given-names>C.</given-names>
									<surname>Schweingruber</surname>
								</string-name>,
								<string-name>
									<given-names>R.</given-names>
									<surname>Bruggmann</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Bachi</surname>
								</string-name>,
								<string-name>
									<given-names>S.M.</given-names>
									<surname>Barabino</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2016</year>.
							<article-title>Minor intron splicing is regulated by FUS and affected by ALS-associated FUS mutants</article-title>.
							<source>EMBO J.</source>
							<volume>35</volume>:
							<fpage>1504</fpage>&#x2013;
							<lpage>1521</lpage>.
							<pub-id pub-id-type="doi">10.15252/embj.201593791</pub-id>
							<pub-id pub-id-type="pmid">27252488</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib68">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Salton</surname>,
									<given-names>M.</given-names>
								</string-name>,
								<string-name>
									<given-names>Y.</given-names>
									<surname>Lerenthal</surname>
								</string-name>,
								<string-name>
									<given-names>S.Y.</given-names>
									<surname>Wang</surname>
								</string-name>,
								<string-name>
									<given-names>D.J.</given-names>
									<surname>Chen</surname>
								</string-name>, and
								<string-name>
									<given-names>Y.</given-names>
									<surname>Shiloh</surname>
								</string-name>
							</person-group>.
							<year>2010</year>.
							<article-title>Involvement of Matrin 3 and SFPQ/NONO in the DNA damage response</article-title>.
							<source>Cell Cycle.</source>
							<volume>9</volume>:
							<fpage>1568</fpage>&#x2013;
							<lpage>1576</lpage>.
							<pub-id pub-id-type="doi">10.4161/cc.9.8.11298</pub-id>
							<pub-id pub-id-type="pmid">20421735</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib86">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Sama</surname>,
									<given-names>R.R.</given-names>
								</string-name>,
								<string-name>
									<given-names>C.L.</given-names>
									<surname>Ward</surname>
								</string-name>,
								<string-name>
									<given-names>L.J.</given-names>
									<surname>Kaushansky</surname>
								</string-name>,
								<string-name>
									<given-names>N.</given-names>
									<surname>Lemay</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Ishigaki</surname>
								</string-name>,
								<string-name>
									<given-names>F.</given-names>
									<surname>Urano</surname>
								</string-name>, and
								<string-name>
									<given-names>D.A.</given-names>
									<surname>Bosco</surname>
								</string-name>
							</person-group>.
							<year>2013</year>.
							<article-title>FUS/TLS assembles into stress granules and is a prosurvival factor during hyperosmolar stress</article-title>.
							<source>J. Cell Physiol</source>.
							<volume>228</volume>:
							<fpage>2222</fpage>&#x2013;
							<lpage>2231</lpage>.
							<pub-id pub-id-type="doi">10.1002/jcp.24395</pub-id>
							<pub-id pub-id-type="pmid">23625794</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib69">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Shibata</surname>,
									<given-names>A.</given-names>
								</string-name>,
								<string-name>
									<given-names>P.</given-names>
									<surname>Jeggo</surname>
								</string-name>, and
								<string-name>
									<given-names>M.</given-names>
									<surname>L&#xF6;brich</surname>
								</string-name>
							</person-group>.
							<year>2018</year>.
							<article-title>The pendulum of the Ku-Ku clock</article-title>.
							<source>DNA Repair (Amst.).</source>
							<volume>71</volume>:
							<fpage>164</fpage>&#x2013;
							<lpage>171</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.dnarep.2018.08.020</pub-id>
							<pub-id pub-id-type="pmid">30177438</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib70">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Shing</surname>,
									<given-names>D.C.</given-names>
								</string-name>,
								<string-name>
									<given-names>D.J.</given-names>
									<surname>McMullan</surname>
								</string-name>,
								<string-name>
									<given-names>P.</given-names>
									<surname>Roberts</surname>
								</string-name>,
								<string-name>
									<given-names>K.</given-names>
									<surname>Smith</surname>
								</string-name>,
								<string-name>
									<given-names>S.F.</given-names>
									<surname>Chin</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Nicholson</surname>
								</string-name>,
								<string-name>
									<given-names>R.M.</given-names>
									<surname>Tillman</surname>
								</string-name>,
								<string-name>
									<given-names>P.</given-names>
									<surname>Ramani</surname>
								</string-name>,
								<string-name>
									<given-names>C.</given-names>
									<surname>Cullinane</surname>
								</string-name>, and
								<string-name>
									<given-names>N.</given-names>
									<surname>Coleman</surname>
								</string-name>
							</person-group>.
							<year>2003</year>.
							<article-title>FUS/ERG gene fusions in Ewing&#x2019;s tumors</article-title>.
							<source>Cancer Res.</source>
							<volume>63</volume>:
							<fpage>4568</fpage>&#x2013;
							<lpage>4576</lpage>.
							<pub-id pub-id-type="pmid">12907633</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib71">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Simon</surname>,
									<given-names>N.E.</given-names>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Yuan</surname>
								</string-name>, and
								<string-name>
									<given-names>M.</given-names>
									<surname>Kai</surname>
								</string-name>
							</person-group>.
							<year>2017</year>.
							<article-title>RNA-binding protein RBM14 regulates dissociation and association of non-homologous end joining proteins</article-title>.
							<source>Cell Cycle.</source>
							<volume>16</volume>:
							<fpage>1175</fpage>&#x2013;
							<lpage>1180</lpage>.
							<pub-id pub-id-type="doi">10.1080/15384101.2017.1317419</pub-id>
							<pub-id pub-id-type="pmid">28426349</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib72">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Singatulina</surname>,
									<given-names>A.S.</given-names>
								</string-name>,
								<string-name>
									<given-names>L.</given-names>
									<surname>Hamon</surname>
								</string-name>,
								<string-name>
									<given-names>M.V.</given-names>
									<surname>Sukhanova</surname>
								</string-name>,
								<string-name>
									<given-names>B.</given-names>
									<surname>Desforges</surname>
								</string-name>,
								<string-name>
									<given-names>V.</given-names>
									<surname>Joshi</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Bouhss</surname>
								</string-name>,
								<string-name>
									<given-names>O.I.</given-names>
									<surname>Lavrik</surname>
								</string-name>, and
								<string-name>
									<given-names>D.</given-names>
									<surname>Pastr&#xE9;</surname>
								</string-name>
							</person-group>.
							<year>2019</year>.
							<article-title>PARP-1 Activation Directs FUS to DNA Damage Sites to Form PARG-Reversible Compartments Enriched in Damaged DNA</article-title>.
							<source>Cell Rep.</source>
							<volume>27</volume>:
							<fpage>1809</fpage>&#x2013;
							<lpage>1821.e5</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.celrep.2019.04.031</pub-id>
							<pub-id pub-id-type="pmid">31067465</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib73">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Stucki</surname>,
									<given-names>M.</given-names>
								</string-name>, and
								<string-name>
									<given-names>S.P.</given-names>
									<surname>Jackson</surname>
								</string-name>
							</person-group>.
							<year>2006</year>.
							<article-title>gammaH2AX and MDC1: anchoring the DNA-damage-response machinery to broken chromosomes</article-title>.
							<source>DNA Repair (Amst.).</source>
							<volume>5</volume>:
							<fpage>534</fpage>&#x2013;
							<lpage>543</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.dnarep.2006.01.012</pub-id>
							<pub-id pub-id-type="pmid">16531125</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib84">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Subramanian</surname>,
									<given-names>A.</given-names>
								</string-name>,
								<string-name>
									<given-names>P.</given-names>
									<surname>Tamayo</surname>
								</string-name>,
								<string-name>
									<given-names>V.K.</given-names>
									<surname>Mootha</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Mukherjee</surname>
								</string-name>,
								<string-name>
									<given-names>B.L.</given-names>
									<surname>Ebert</surname>
								</string-name>,
								<string-name>
									<given-names>M.A.</given-names>
									<surname>Gillette</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Paulovich</surname>
								</string-name>,
								<string-name>
									<given-names>S.L.</given-names>
									<surname>Pomeroy</surname>
								</string-name>,
								<string-name>
									<given-names>T.R.</given-names>
									<surname>Golub</surname>
								</string-name>,
								<string-name>
									<given-names>E.S.</given-names>
									<surname>Lander</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2005</year>.
							<article-title>Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles</article-title>.
							<source>Proc. Natl. Acad. Sci. USA</source>.
							<volume>102</volume>:
							<fpage>15545</fpage>&#x2013;
							<lpage>15550</lpage>.
							<pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id>
							<pub-id pub-id-type="pmid">16199517</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib74">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Sui</surname>,
									<given-names>J.</given-names>
								</string-name>,
								<string-name>
									<given-names>Y.F.</given-names>
									<surname>Lin</surname>
								</string-name>,
								<string-name>
									<given-names>K.</given-names>
									<surname>Xu</surname>
								</string-name>,
								<string-name>
									<given-names>K.J.</given-names>
									<surname>Lee</surname>
								</string-name>,
								<string-name>
									<given-names>D.</given-names>
									<surname>Wang</surname>
								</string-name>, and
								<string-name>
									<given-names>B.P.</given-names>
									<surname>Chen</surname>
								</string-name>
							</person-group>.
							<year>2015</year>.
							<article-title>DNA-PKcs phosphorylates hnRNP-A1 to facilitate the RPA-to-POT1 switch and telomere capping after replication</article-title>.
							<source>Nucleic Acids Res.</source>
							<volume>43</volume>:
							<fpage>5971</fpage>&#x2013;
							<lpage>5983</lpage>.
							<pub-id pub-id-type="doi">10.1093/nar/gkv539</pub-id>
							<pub-id pub-id-type="pmid">25999341</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib75">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Sun</surname>,
									<given-names>Z.</given-names>
								</string-name>,
								<string-name>
									<given-names>Z.</given-names>
									<surname>Diaz</surname>
								</string-name>,
								<string-name>
									<given-names>X.</given-names>
									<surname>Fang</surname>
								</string-name>,
								<string-name>
									<given-names>M.P.</given-names>
									<surname>Hart</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Chesi</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Shorter</surname>
								</string-name>, and
								<string-name>
									<given-names>A.D.</given-names>
									<surname>Gitler</surname>
								</string-name>
							</person-group>.
							<year>2011</year>.
							<article-title>Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS</article-title>.
							<source>PLoS Biol.</source>
							<volume>9</volume>:
							<elocation-id>e1000614</elocation-id>.
							<pub-id pub-id-type="doi">10.1371/journal.pbio.1000614</pub-id>
							<pub-id pub-id-type="pmid">21541367</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib76">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Updike</surname>,
									<given-names>D.L.</given-names>
								</string-name>,
								<string-name>
									<given-names>S.J.</given-names>
									<surname>Hachey</surname>
								</string-name>,
								<string-name>
									<given-names>J.</given-names>
									<surname>Kreher</surname>
								</string-name>, and
								<string-name>
									<given-names>S.</given-names>
									<surname>Strome</surname>
								</string-name>
							</person-group>.
							<year>2011</year>.
							<article-title>P granules extend the nuclear pore complex environment in the C. elegans germ line</article-title>.
							<source>J. Cell Biol.</source>
							<volume>192</volume>:
							<fpage>939</fpage>&#x2013;
							<lpage>948</lpage>.
							<pub-id pub-id-type="doi">10.1083/jcb.201010104</pub-id>
							<pub-id pub-id-type="pmid">21402789</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib77">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Wang</surname>,
									<given-names>J.</given-names>
								</string-name>,
								<string-name>
									<given-names>J.M.</given-names>
									<surname>Choi</surname>
								</string-name>,
								<string-name>
									<given-names>A.S.</given-names>
									<surname>Holehouse</surname>
								</string-name>,
								<string-name>
									<given-names>H.O.</given-names>
									<surname>Lee</surname>
								</string-name>,
								<string-name>
									<given-names>X.</given-names>
									<surname>Zhang</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Jahnel</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Maharana</surname>
								</string-name>,
								<string-name>
									<given-names>R.</given-names>
									<surname>Lemaitre</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Pozniakovsky</surname>
								</string-name>,
								<string-name>
									<given-names>D.</given-names>
									<surname>Drechsel</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2018</year>.
							<article-title>A Molecular Grammar Governing the Driving Forces for Phase Separation of Prion-like RNA Binding Proteins</article-title>.
							<source>Cell.</source>
							<volume>174</volume>:
							<fpage>688</fpage>&#x2013;
							<lpage>699.e16</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.cell.2018.06.006</pub-id>
							<pub-id pub-id-type="pmid">29961577</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib78">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Wang</surname>,
									<given-names>W.Y.</given-names>
								</string-name>,
								<string-name>
									<given-names>L.</given-names>
									<surname>Pan</surname>
								</string-name>,
								<string-name>
									<given-names>S.C.</given-names>
									<surname>Su</surname>
								</string-name>,
								<string-name>
									<given-names>E.J.</given-names>
									<surname>Quinn</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Sasaki</surname>
								</string-name>,
								<string-name>
									<given-names>J.C.</given-names>
									<surname>Jimenez</surname>
								</string-name>,
								<string-name>
									<given-names>I.R.</given-names>
									<surname>Mackenzie</surname>
								</string-name>,
								<string-name>
									<given-names>E.J.</given-names>
									<surname>Huang</surname>
								</string-name>, and
								<string-name>
									<given-names>L.H.</given-names>
									<surname>Tsai</surname>
								</string-name>
							</person-group>.
							<year>2013</year>.
							<article-title>Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons</article-title>.
							<source>Nat. Neurosci.</source>
							<volume>16</volume>:
							<fpage>1383</fpage>&#x2013;
							<lpage>1391</lpage>.
							<pub-id pub-id-type="doi">10.1038/nn.3514</pub-id>
							<pub-id pub-id-type="pmid">24036913</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib79">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Ward</surname>,
									<given-names>C.L.</given-names>
								</string-name>,
								<string-name>
									<given-names>K.J.</given-names>
									<surname>Boggio</surname>
								</string-name>,
								<string-name>
									<given-names>B.N.</given-names>
									<surname>Johnson</surname>
								</string-name>,
								<string-name>
									<given-names>J.B.</given-names>
									<surname>Boyd</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Douthwright</surname>
								</string-name>,
								<string-name>
									<given-names>S.A.</given-names>
									<surname>Shaffer</surname>
								</string-name>,
								<string-name>
									<given-names>J.E.</given-names>
									<surname>Landers</surname>
								</string-name>,
								<string-name>
									<given-names>M.A.</given-names>
									<surname>Glicksman</surname>
								</string-name>, and
								<string-name>
									<given-names>D.A.</given-names>
									<surname>Bosco</surname>
								</string-name>
							</person-group>.
							<year>2014</year>.
							<article-title>A loss of FUS/TLS function leads to impaired cellular proliferation</article-title>.
							<source>Cell Death Dis.</source>
							<volume>5</volume>:
							<elocation-id>e1572</elocation-id>.
							<pub-id pub-id-type="doi">10.1038/cddis.2014.508</pub-id>
							<pub-id pub-id-type="pmid">25501833</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib80">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>West</surname>,
									<given-names>J.A.</given-names>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Mito</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Kurosaka</surname>
								</string-name>,
								<string-name>
									<given-names>T.</given-names>
									<surname>Takumi</surname>
								</string-name>,
								<string-name>
									<given-names>C.</given-names>
									<surname>Tanegashima</surname>
								</string-name>,
								<string-name>
									<given-names>T.</given-names>
									<surname>Chujo</surname>
								</string-name>,
								<string-name>
									<given-names>K.</given-names>
									<surname>Yanaka</surname>
								</string-name>,
								<string-name>
									<given-names>R.E.</given-names>
									<surname>Kingston</surname>
								</string-name>,
								<string-name>
									<given-names>T.</given-names>
									<surname>Hirose</surname>
								</string-name>,
								<string-name>
									<given-names>C.</given-names>
									<surname>Bond</surname>
								</string-name>,
								<etal/>
							</person-group>.
							<year>2016</year>.
							<article-title>Structural, super-resolution microscopy analysis of paraspeckle nuclear body organization</article-title>.
							<source>J. Cell Biol.</source>
							<volume>214</volume>:
							<fpage>817</fpage>&#x2013;
							<lpage>830</lpage>.
							<pub-id pub-id-type="doi">10.1083/jcb.201601071</pub-id>
							<pub-id pub-id-type="pmid">27646274</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib81">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Yamazaki</surname>,
									<given-names>T.</given-names>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Souquere</surname>
								</string-name>,
								<string-name>
									<given-names>T.</given-names>
									<surname>Chujo</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Kobelke</surname>
								</string-name>,
								<string-name>
									<given-names>Y.S.</given-names>
									<surname>Chong</surname>
								</string-name>,
								<string-name>
									<given-names>A.H.</given-names>
									<surname>Fox</surname>
								</string-name>,
								<string-name>
									<given-names>C.S.</given-names>
									<surname>Bond</surname>
								</string-name>,
								<string-name>
									<given-names>S.</given-names>
									<surname>Nakagawa</surname>
								</string-name>,
								<string-name>
									<given-names>G.</given-names>
									<surname>Pierron</surname>
								</string-name>, and
								<string-name>
									<given-names>T.</given-names>
									<surname>Hirose</surname>
								</string-name>
							</person-group>.
							<year>2018</year>.
							<article-title>Functional Domains of NEAT1 Architectural lncRNA Induce Paraspeckle Assembly through Phase Separation</article-title>.
							<source>Mol. Cell.</source>
							<volume>70</volume>:
							<fpage>1038</fpage>&#x2013;
							<lpage>1053.e7</lpage>.
							<pub-id pub-id-type="doi">10.1016/j.molcel.2018.05.019</pub-id>
							<pub-id pub-id-type="pmid">29932899</pub-id>
						</mixed-citation>
					</ref>
					<ref id="bib82">
						<mixed-citation publication-type="journal">
							<person-group person-group-type="author">
								<string-name>
									<surname>Zerkalenkova</surname>,
									<given-names>E.</given-names>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Panfyorova</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Kazakova</surname>
								</string-name>,
								<string-name>
									<given-names>P.</given-names>
									<surname>Baryshev</surname>
								</string-name>,
								<string-name>
									<given-names>L.</given-names>
									<surname>Shelihova</surname>
								</string-name>,
								<string-name>
									<given-names>I.</given-names>
									<surname>Kalinina</surname>
								</string-name>,
								<string-name>
									<given-names>G.</given-names>
									<surname>Novichkova</surname>
								</string-name>,
								<string-name>
									<given-names>M.</given-names>
									<surname>Maschan</surname>
								</string-name>,
								<string-name>
									<given-names>A.</given-names>
									<surname>Maschan</surname>
								</string-name>, and
								<string-name>
									<given-names>Y.</given-names>
									<surname>Olshanskaya</surname>
								</string-name>
							</person-group>.
							<year>2018</year>.
							<article-title>Molecular characteristic of acute leukemias with t(16;21)/FUS-ERG</article-title>.
							<source>Ann. Hematol.</source>
							<volume>97</volume>:
							<fpage>977</fpage>&#x2013;
							<lpage>988</lpage>.
							<pub-id pub-id-type="doi">10.1007/s00277-018-3267-z</pub-id>
							<pub-id pub-id-type="pmid">29427188</pub-id>
						</mixed-citation>
					</ref>
				</ref-list>
			</back>
		</article>
	</pmc-articleset>